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Ablation procedures
See a/so Lasers: Rotablation; Surgery, ablation
Ablation of canine ventricular myocardium
with a cryogenic catheter: a new
closed-chest ablative technique, 186A
Attempted ablation of left sided accessory
pathways by radiofrequency current,
I68A
Autonomic influence on ventricular subsidiary
pacemakers; a study of patients post AV
nodal ablation, 232A
Catheter ablation of a posteroseptal accessory
atrioventricular connection in forty-two
patients, 169A
Catheter ablation of the atrioventricular
junction using radiofrequency energy.
169A
Catheter modification of AV nodal conduction
in drug resistant AV nodal reentrant
tachycardia (AVNRT). 176A
Catheter modification of the atrioventricular
node: a potential cure for atrioventricular
nodal reentrant tachycardia, 168A
Comparative effects of radiofrequency and
laser ablation in normal and diseased
ventricular myocardium, 175A
Direct entrainment guided ablation of the slow
conduction zone (SCZ) in human type I
atrial fluller (AF). I68A
Effect of epicardial accessory pathway ablation
or endocardial dissection for AV nodal
reentrant tachycardia on vagal innervation
of the AV node. 232A
Effects of low energy direct current
countershock on atrioventricular nodal
junction in dog using suction·ablation
catheter, 176A
Electrophysiologic effects of argon laser
irradiation during intraoperative
atrioventricular node or accessory
pathway ablation in man, 169A
Phase image triangulation of accessory
pathways in patients undergoing catheter
ablation of posteroseptal pathways, l68A
Radiofrequency or direct current for ablation
of ventricular tachycardia? 176A .
Successful radiofrequency catheter ablation of
right anteroseptal accessory
atrioventricular connections, l76A
Temperature-guided radiofrequency
coagulation of myocardial tissue, l69A
Acceleration
Low maximum acceleration measured using
aortic Doppler identifies patients at risk of
cardiac death following acute myocardial
infarction, 157A
Accessory pathways
See a/so Ablation procedures; Surgery,
ablation; Wolff·Parkinson-White
syndrome
Antegrade and retrograde conduction occurring
over separate, adjacent accessory AV
pathways, 173A
Effects of upright posture on atrioventricular
accessory pathway conduction, 205A
Noninvasive localization of accessory
pathways, 8A
Retrograde pathway in atrioventricular nodal
tachycardias: nodal tissue or extranodal
accessory pathway? 175A
AcetyIcholine
Acetylcholine causes vasoconstriction in
pre-contracted human coronary arteries in
vivo.85A
Acetylcholine is a potent vasoconstrictor in
human coronary arteries early after
cardiac transplantation, 85A
Comparison of acetylcholine and ergonovine in
the provocation of coronary vasospasm,
I32A
Contrasting effects of acetylcholine on
coronary conductance and resistance
vessels in patients with coronary artery
disease, 133A
Coronary occlusion·reperfusion attenuates
endothelium·mediated vascular response
to leukotriene 0 4 and acetylcholine, 143A
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Endothelial function influences the coronary
vasomotor response to sympathetic
stimulation in man. 202A
Genetically induced atherosclerosis attenuates
endothelially mediated relaxation, 32A
Preserved flow-mediated vasodilation despite
acetylcholine-induced vasoconstriction in
atherosclerotic coronary arteries in man,
132A
Action potentials
Effects of flecainide on action potential
duration of human arterial fibers, l40A
Frequency response of action potentials from
human myocardium. 185A
Synergistic actions of disopyramide and
lidocaine on Vmax of action potentials in
guinea pig papillary muscles, 139A
Adenosine
Adenosine thallium-20 I scintigraphy:
feasibility, safety and initial results in
man. 161A
Anti-adrenergic action of adenosine in a canine
model of chronic myocardial infarction,
139A
Effects of adenosine on the coronary
circulation in man. 132A
Electrophysiologic effects of adenosine
following orthotopic cardiac
transplantation: evidence of
supersensitivity. 163A
Reduced myocardial blood flow with persistent
vasodilator reserve: role of adrenergic
activation, 187A
Safety. efficacy and predictive value of drug
termination of ventricular tachycardia,
162A
Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
Adenosine diphosphate
Estimation of the concentration and function of
the ADP/ATP carrier in the myocardium
of patients with dilated cardiomyopathy
(OCM).251A
Adenosine receptors
Blockade of adenosine receptors with
aminophylline: effects on exercise
capacity in stable angina, 41A
Adenosine triphosphate
Does acute pharmacologic stimulation of
stunned myocardium have chronic
deleterious effects?, 219A
Estimation of the concentration and function of
the ADP/ATP carrier in the myocardium
of patients with dilated cardiomyopathy
(DCM),25IA
Adenyl cyclase
Ischemic ventricular fibrillation is distillguished
by preserved histamine-stimulated adenyl
cyclase activity, 90A
Adenylate cyclase
Alterations in the catalyst of adenylate cyclase
and the inhibitory guanine nucleotide
regulatory protein in experimental heart
failure, 179A
Adrenaline
Cardiovascular hormones in relation to
mortality in severe heart failure, 246A
Adrenergic response
Decreased adrenergic response in hypertensive
patients without left ventricular
hypertrophy, 82A
Enhanced cardiac adrenergic response in
cardiomyopathic hamster at a
pre-congestive failure stage, 87A
Hemodynamic correlates of increased cardiac
adrenergic drive in the intact failing
human heart, 245A
Adriamycin
Use of enoximone in cardiac transplant
candidates: effect on f3 adrenergic
receptors, 248A
Afterdepolarizations
Simultaneous demonstration of early- and
delayed afterdepolarizations in Ca2 loaded
cardiac cells, l85A
Afterrepolarizalions
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents, 249A
Age factors
See a/so Elderly
Age-related changes in left ventricular
performance during isometric exercise,
56A
Aging-related decrease in vasodilatory capacity
in coronary microcirculation estimated by
Doppler catheter, 57A
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Age related risk factors and mechanisms of
death following myocardial infarction.
Experience from the Multicenter
Diltiazem Postinfarction Trial, 27A
Does age modify the hemodynamic and clinical
response to converting-enzyme inhibitors
in patients with chronic heart failure?,
57A
Effect of age on pulmonary venous flow in
normal subjects, 50A
Exercise cardiac output declines with
advancing age in normal subjects, 241A
Improvement of relaxation velocity by calcium
blocker in aging rabbit myocardium, 57A
Site of age-related PR interval prolongation in
normal subjects, 57A
Air transport
Is delivery of rt-PA by helicopter transport
teams safe and time-effective?, 192A
Albumin
Oxidation of sulfhydryl groups of serum
albumin in coronary artery diseases, 44A
Alcohol
Myocardial 19A deposition: a possible marker
for alcohol related myocardial disease,
254A
Aldosterone
Direct suppression of aldosterone secretion by
endogenous atrial natriuretic peptide in
hemodynamically normal man: evidence
for physiologic role of ANP, 172A
Alpha-adrenergic blocking agents
See also specific agent
Majority of physicians use drug therapy for
isolated systolic hypertension, 13A
Alpha adrenergic receptors
Hypoxia and glucose deprivation
independently induce uncoupling of
a.-adrenergic signal transduction in
cultured myocardial cells, 252A
Role of a-adrenergic receptors in syndrome X,
150A
Alpha adrenergic tone
Reduced myocardial blood flow with persistent
vasodilator reserve: role of adrenergic
activation, 187A
Alpha tocopherol
See also Vitamin E
Effect of a-tocopherol (vitamin E) on regional
function in stunned myocardium, 144A
Aminophylline
Blockade of adenosine receptors with
aminophylline: effects of exercise capacity
on stable angina, 41A
Exercise capacity after acute aminophyline
administration in patients with syndrome
X,202A
Amiodarone
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents, 249A
Automatic implantable cardioverter-
defibrillator in patients with chronic
amiodarone: effects on the defibrillation
threshold and the rate of shocks, 177A
Chronic amiodarone administration protects
against global myocardial ischemia in the
rat,25OA
Ditferential effects of amiodarone on Vmax and
conduction velocity in anisotropic
myocardium, 139A
Disparate effects of acute and chronic
amiodarone on ventricular fibrillation
threshold in dogs, 249A
Etiology of polymorphic ventricular
tachycardia in the absence of prolonged
QT,21A
Fecal elimination of amiodarone and desethyl
amiodarone, 186A
Long-term followup of amiodarone in the
young: continued efficacy, unimpaired
growth, moderate side effects, 171A
Anaerobic threshold
Alterations in the ventilatory anaerobic
threshold after a chronic intervention
reflect changes in lactate production
during exercise in heart failure, 39A
Temporal dissociation between invasive and
non-invasive determination of anaerobic
threshold in chronic heart failure, 39A
Anastomosis
Bidirectional cavo-pulmonary anastomosis,
74A
Aneurysm
Effect of reperfusion on post-myocardial
infarction aneurysm formation at one
week,IIOA
Endocrine conversion of ventricular
cardiocytes in ventricular aneurysm, 171A
Functional left ventricular aneurysm after
anterior Q-wave myocardial infarction:
incidence, contributing factors and natural
history,45A
Surgically resectable left ventricular aneurysm:
specific characteristics by ultrafast
computerized tomography, 47A
Angina pectoris
See also Syndrome X
Antecedent angina: a clinical marker for
patients at high risk following
thrombolytic therapy, 28A
Blockade of adenosine receptors with
aminophylline: effects on exercise
capacity in stable angina, 41A
Epidural spinal stimulation in patients suffering
from intractable angina, 46A
In-hospital angina with transient ECG changes
predicts poor one-year survival only in
patients with ST depression, 93A
Inability of thrombosis related markers to
distinguish between unstable and stable
angina pectoris, l5A
Intermittent urokinase therapy as a new
strategy concept in untractable angina
pectoris, I6A
Ischemic threshold varies in response to
different types of exercise in patients with
chronic stable angina, 237A
Overriding heightened risk, prior angina
denotes a favorable response to
myocardial reperfusion, 95A
Silent ischemia during daily life is an
independent predictor of survival in stable
angina,3A
Angina pectoris, unstable
Analysis of the ischemia related coronary
artery and its predictive value in unstable
angina, 238A
Effects of urokinase and heparin on lesion
geometry in unstable angina, 15A
Impact of abnormal myocardial perfusion on
ventricular function in patients with
unstable angina, 239A
Importance of assessing ST elevation by
Holter monitoring in unstable angina,
203A
Nifedipine in unstable angina: beneficial effects
in the elderly and in patients with reduced
left ventricular function, 239A
Patients with ST segment deviation and
unstable angina have consistent increases
in thrombin activity, I5A
Predicting longterm outcome in medically
stabilized unstable angina: early Holter
ST segment monitoring, predischarge
exercise thallium scintigraphy and
coronary angiography, 238A
Prediction and prevention of myocardial
infarction during the acute phase of
unstable angina, 192A
S.T.A.I. (Study of Ticlopidine in Unstable
Angina), 238A
Thrombolytic therapy in unstable angina and
non Q wave myocardial infarction: a
randomized trial of urokinase versus
aspirin, 15A
Tissue plasminogen activator for unstable
angina pectoris: a multicenter,
randomized, double-blind,
placebo-controlled trial, 191A
Angiography
See also Arteriography
Angiographic appearances following
percutaneous coronary atherectomy, 223A
Angioscopy-more sensitive for identifying
thrombus, distal emboli, and subintimal
dissection, 146A
Colour flow imaging as intra-operative
angiography in ventricular septal
defects-advantages and pitfalls, 75A
Digital flashing tomosynthesis (DFTS}--an
alternative to cine technique in coronary
angiography, 8A
Does balloon inflation duration influence the
angiographic results of coronary
angioplasty?, 58A
Effect of x-ray dose on accuracy and precision
of quantitative digital coronary
angiography, 7A
Impact of compensatory enlargement of
atherosclerotic coronary arteries on the
angiographic assessment of coronary
artery disease, I%A
New approach to in vivo measurement of
coronary blood flow utilizing high-speed
coronary angiography, 7A
Physiologic significance of coronary lesions
assessed by exercise echocardiography
and quantitative coronary angiography,
158A
Randomized trial of ionic versus non-ionic
contrast for cardiac angiography: effect on
complications and costs, 46A
rTPA versus rTPA plus PTCA in acute
myocardial infarction: quantitative results
of early and late coronary arteriography,
54A
Single versus multiple balloon inflations in
coronary angioplasty: late angiographic
results and reCU1Tence, 58A
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Angiography, radionuclide
Exercise radionuclide angiography yields
prognostic information equivalent to
cardiac catheterization, 126A
Role of radionuclide angiography in selecting
patients for coronary bypass surgery,
213A
Angioplasty
See also Lasers; Restenosis
Coronary angioplasty dissection: in-hospital
outcome, 221A
Coronary angioplasty in patients with severe
depression of left ventricular function,
222A
Impedance measurement of absolute blood
flow using angioplasty guidewire, 194A
Patterns of dilation during coronary
angioplasty,58A
Persistent endothelial dysfunction following
experimental angioplasty, 195A
Prolonged autoperfusion angioplasty:
immediate clinical outcome and
angiographic follow-up, 155A
Radiofrequency thermal angioplasty for the
treatment of peripheral vascular occlusive
disease: preliminary results of a clinical
trial, l4A
Restenosis within coronary stents: possible
effect of previous angioplasty, 107A
Time course of improved function following
post-infarction angioplasty: evidence for
"hibernation" even in "infarcted"
myocardium, 25A
Ultrasonic angioplasty using a new flexible
wire system, 4A
Angioplasty, coronary
Acute outcome and long term follow-up of
patients with acute myocardial infarction
and single vessel disease treated with
angioplasty without thrombolytic therapy,
94A
Acute thrombotic reocclusion after
percutaneous transluminal coronary
angioplasty-should thrombolysis be
attempted?, 58A
Cardiopulmonary bypass supported coronary
angioplasty in inoperable patients, 53B
Clinical safety and early course following
prolonged inflations in elective
transluminal coronary angioplasty, 43A
Comparison of socio-economics and outcome
after multivessel coronary angioplasty or
bypass surgery, 230A
Consequences of occlusion during PTCA: the
1985-86 NHLBI PTCA Registry, 230A
Coronary atherectomy for the treatment of
unfavorable PTCA lesions, I09A
Determinants of arterial dissection during
PTCA: lesion type versus inflation rate,
229A
Determinants of improved global left
ventricular function after tPA and
deferred PTCA for acute MI, 92A
Does balloon inflation duration influence the
angiographic results of coronary
angioplasty?, 58A
Does the disadvantage of incomplete
revascularization by coronary angioplasty
increase with time?, 229A
Early and late clinical outcome following
successful coronary angioplasty of total
coronary occlusions, 220A
Effect of larger balloon size on recurrence after
repeat coronary angioplasty due to
restenosis, 208A
Histopathologic phenomena at the site of
percutaneous transluminal coronary
angioplasty, 220A
Internal mammary artery graft angioplasty:
clinical and angiographic follow-up, 221A
Intravenous nitroglycerin prevents coronary
artery vasoconstriction after PTCA, 59A
Late follow-up of 781 patients undergoing
percutaneous transluminal coronary
angioplasty (PTCA) or open heart surgery
(OHS) for an isolated obstruction in the
left anterior descending (LAD) coronary
artery, l66A
Long-term (4 year) follow-up after
percutaneous transluminal coronary
angioplasty during acute myocardial
infarction, 94A
Long-term improvement of left ventricular
function after myocardial infarction with
and without thrombolytic therapy by late
PTCA of the infarct-related artery, 26A
Percutaneous cardiopulmonary bypass to
support high risk elective coronary
angioplasty, 160A
Percutaneous institution of cardiopulmonary
(bypass) support: technique and
complications, l59A
Percutaneous transluminal angioplasty of
internal mammary artery bypass grafts,
221A
Percutaneous transluminal angioplasty of left
internal mammary artery grafts using a
femoral approach, 221A
Recovery of regional myocardial function after
successful coronary angioplasty early
after non-Q-wave myocardial infarction,
7A
••Rescue" percutaneous transluminal coronary
angioplasty after failed thrombolytic
therapy, 193A
rTPA versus rTPA plus PTCA in acute
myocardial infarction: Quantitative results
of early and late coronary arteriography,
54A
Single versus multiple balloon inflations in
coronary angioplasty: late angiographic
results and recurrence, 58A
Supported angioplasty: initial experience with
high risk patients, 159A
TIMI II: a study of PTCA timing after rt-PA
thrombolysis for acute myocardial
infarction, 194A
Transesophageal 2D color-coded Doppler
echocardiography during percutaneous
transluminal coronary angioplasty, 68A
Two-year post-discharge survival after
emergency coronary angioplasty for
myocardial infarction: importance of the
timing and success of angioplasty, 193A
Vascular repair and remodeling using
radiofrequency balloon angioplasty, 228A
Verapamil as a potent cardioprotective agent
for coronary angioplasty: first clinical
experience, l54A
Angioscopy
Angioscopic endothelial macropathology in
patients with acute coronary syndromes,
14A
Angioscopy-more sensitive for identifying
thrombus, distal emboli and subintimal
dissection, 146A
Detection of intravascular thrombus by high
frequency intraluminal ultrasound
angioscopy: in vitro and in vivo studies,
5A
Intraluminal two-dimensional ultrasound
angioscopic quantitation of arterial
stenosis: comparison with external
high-frequency ultrasound imaging and
anatomy,5A
Angiotensin II
Cardiotoxic effects of angiotensin II, 2A
Cardiovascular hormones in relation to
mortality in severe heart failure, 246A
Anisotropy
Cytoplasmic and junctional components of
anisotropic internal resistance in canine
myocardium, 129A
Differential effects of amiodarone on Vmax and
conduction velocity in anisotropic
myocardium, 139A
Masking of tissue anisotropy-a computer
model of the interaction between
activation wavefront and fixed barriers,
129A
Antiarrhythmic drug therapy
See also specific agent
Does response to IA agents predict response to
IC agents in patients with sustained
ventricular tachycardia, 174A
High incidence of remission in patients with
incessant ventricular tachycardia
discontinued from antiarrhythmic drugs,
33A
Multiple morphologies of induced ventricular
tachycardia: role of antiarrhythmic drugs
and clinical implications, 20A
Outcome of empirical antiarrhythmic drug
therapy in matched cohorts of patients
with ventricular arrhythmias after
myocardial infarction, 173A
Spontaneous variability in ventricular
arrhythmias during chronic "effective"
antiarrhythmic therapy, 33A
Use-dependent prolongation of ventricular
tachycardia cycle length by type IA and
IC drugs, 21A
Antibodies
See Autoantibodies; specific antibody
Anticoagulants
See also specific agent
Patients with ST segment deviation and
unstable angina have consistent increases
in thrombin activity, 15A
Antigens
See Autoantigens; specific antigen
a 2"Antiplasmin
Selective inhibition of <l2-antiplasmin augments
the potency and specificity of
plasminogen activators, 2A
Antiplatelet antibody
Antiplatelet antibody [7E3 F(ab'hl prevents
rethrombosis after tissue-type
plasminogen activator induced coronary
artery thrombolysis in a canine model,
32A J
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Antithymocyte globulin
Prophylactic anti-rejection therapy early after
cardiac transplantation: rate versus
OKT3,62A
Antitumor agents
Low dose of antitumor agents prevents smooth
muscle cell proliferation after endothelial
injury, 252A
Aortic arch obstruction
Surgical management of aortic arch obstruction
and transposition of the great arteries,
120A
Aortic valve area
Gorlin formula for aortic valve orifice area
validated in vitro, 73A
Aortic valve disease
See also Stenosis; Surgery, valve; Valve
disease
Attenuation of early mitral flow velocity by
acute aortic insufficiency, 210A
Catheter balloon valvuloplasty of necropsy
stenotic aortic valves: etiology of aortic
stenosis is a major factor in early
"restenosis", 16A
Evaluation of aortic regurgitation by cine
magnetic resonance imaging comparing
cineangiography,20lA
Follow-up balloon aortic valvuloplasty: results
in 192 cases, 16A
Hyperlipidemic valvulopathy; aortic
regurgitation in familial
hypercholesterolemia studies by color
Doppler echocardiography, 73A
Importance of contractility in determining left
ventricular size and performance in
patients, 7lA
Isolated quadricuspid aortic valves; incidence,
description, and functional assessment,
60A
One-two year follow-up after primarily
successful valvuloplasty for calcified
aortic stenosis, 16A
Quantification of acute aortic insufficiency with
color Doppler flow mapping: in vitro
studies in a flexible model of the left
ventricle, 49A
Suppression of cardiac protein degradation
contributes to progressive hypertrophy
due to aortic regurgitation, 71A
Transesophageal echo, an improved diagnostic
technique for sub-aortic membranes, 209A
Ventricular septal defect with aortic
regurgitation: a 35 year experience, 121A
APSAC
Improvement of global and regional left
ventricular function with intravenous
APSAC in acute myocardial infarction.
Results of a multicenter double blind trial,
26A
Reduction of infarct size by intravenous
APSAC in myocardial infarction
(multicenter randomized trial vs. heparin),
95A
Arachidonic acid
Sarcolemmal phospholipid turnover: a critical
mediator of myocardial injury, 252A
Arginine vasopressin
Effect of inhibition of arginine vasopressin on
systemic and coronary hemodynamics,
I72A
Vasopressin (AVP) is elevated to pressor
levels and unopposed by atrial natriuretic
factor (ANF) following repair of
coarctation of the aorta (CoA), 136A
Arrhythmias
Determinants and outcome of early and late
arrhythmia after Fontan operation, 170A
Nonhomogenous redistribution of regional
myocardial blood flow and potassium
during reperfusion of ischemic
myocardium, 127A
Arrhythmias, atrial
Atrial natriuretic factor in atrial flutter and
fibrillation: Role of atrial rate and
cardioversion, 76A
Flecainide acetate for the treatment of
postoperative atrial arrhythmias, I64A
Flecainide for prevention of paroxysmal atrial
fibrillation and flutter. A multicenter,
double-blind, placebo-controlled
crossover study, I64A
Arrhythmias, ventricular
Comparison of antiarrhythmic efficacy and
safety of class lA, IB, and IC agents in
symptomatic and potentially malignant
ventricular arrhythmia, 163A
Delayed ventricular arrhythmias (phase IB)
resulting from midmyocardial reentry,
128A
Effect of beta-blockade on the circadian
variation of ventricular arrhythmias, 34A
Effect of myocardial revascularization on
inducible ventricular arrhythmias, 174A
Effects of combined low doses of quinidine and
metoprolol of inducible ventricular
arrhythmias in a chronic canine infarct
model,248A
Incidence of serious ventricular arrhythmias
during surgery in hypertensives with left
ventricular hypertrophy, 105A
Risk of ventricular arrhythmias according to
anatomical categories of left ventricular
hypertrophy, 105A
Short term variability of ventricular arrhythmia
and rapid assessment of drug efficacy,
140A
Spontaneous variability in ventricular
arrhythmias during chronic "effective"
antiarrhythmic therapy, 33A
Ventricular arrhythmias following orthotopic
cardiac transplantation: relationship to
acute rejection and sudden death, 211A
Ventricular arrhythmias in patients with
essential hypertension, 105A
Arterial waD still'ness
In vivo measurement of segmental arterial wall
stiffness in pigs using a real-time
ultrasonic sector imaging catheter, 218A
Arteriography
Dipyridamole-Doppler echocardiography:
comparison to thallium-201 imaging and
quantitative coronary arteriography, 159A
Is yearly coronary arteriography sufficient for
detection of coronary artery disease in
heart transplant recipients?, 242A
Arvin
Defibrinogenation reduced infarct size in a
canine model of acute myocardial
infarction, 125A
Aspirin
Antithrombolytic therapy: is the combination
of aspirin and nitroglycerin beneficial?,
145A
Aspirin but not standard heparin prevents
thrombus fibrin deposition in rabbits
treated with tissue plasminogen activator,
77A
Early intervention with low dose aspirin in first
acute transmural anterior myocardial
infarction: infarct size, clinical outcome
and follow-up, 27A
Effect of low dose aspirin on the incidence and
hematological activity of left ventricular
thrombosis in patients with anterior
myocardial infarction, 199A
Effects of aspirin on in vitro lysis with
urokinase of combined platelet and fibrin
thrombi,9lA
Myocardial infarction with minimal
atherosclerosis: a syndrome of young
women with guarded long term prognosis,
27A
Overview of bleeding risk from the TAMI
trials: two agents are better than one,
198A
Prediction and prevention of myocardial
infarction during the acute phase of
unstable angina, 192A
Preoperative aspirin is not necessary to
achieve improved vein graft patency after
coronary artery bypass surgery, 165A
rTPA versus rTPA plus PTCA in acute
myocardial infarction: quantitative results
of early and late coronary arteriography,
54A
S.T.A.I. (Study ofTiciopidine in Unstable
Angina), 238A
Thrombolytic therapy in unstable angina and
non-Q wave myocardial infarction: a
randomized trial of urokinase versus
aspirin, 15A
Tissue plasminogen activator for unstable
angina pectoris: a multicenter,
randomized, double-blind,
placebo-controlled trial, 191A
Atenolol
Antihypertensive therapy is improved by
central effects of arterial dilation and
reduced wave reflection, 244A
Differences in distribution of beta-blockers in
infarcted porcine hearts. A study with
positron emission tomography, 64A
Atherectomy
Acute outcome of atherectomy in peripheral
arterial obstructive disease, 108A
Angiographic appearance following
percutaneous coronary atherectomy, 223A
Bard rotary atherectomy system (BRAS) in
normal canine coronary arteries, 223A
Clinical follow-up :n 40 patients treated with
peripheral percutaneous atherectomy,
107A
Comparison of early and recent experience in
percutaneous coronary atherectomy, 108A
Complications: early experiences of
percutaneous coronary atherectomy, 222A
Coronary atherectomy for the treatment of
unfavorable PTCA lesions, 109A
Factors associated with restenosis following
successful peripheral atherectomy, I3A
Greater improvement in coronary flow velocity
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with atherectomy compared to
angioplasty, IOSA
Histological evaluation of "vessel biopsies"
obtained with the Simpson atherectomy
catheter, 149A
Human percutaneous coronary rotational
atherectomy: results and short follow up,
228A
Initial experience with a flexible rotational
atherectomy system designed for removal
of coronary and small peripheral artery
atheromas, 223A
Intravascular ultrasound visualization of
atheroma plaque removal by atherectomy,
222A
Percutaneous coronary atherectomy: early
experiences of multicenter trial, IOSA
Percutaneous transluminal coronary rotablation
during heart catheterization, 228A
Utility of an intravascular ultrasound imaging
device for arterial wall definition and
atherectomy guidance, 222A
Atheroma
Media thinning of severely diseased coronary
arteries: guidelines for new interventional
procedures, I94A
Atherosclerosis
See also Atherectomy; Coronary artery disease
Compensatory coronary dilatation and media
thinning: adaptive responses to
progressive atherosclerosis, 196A
Contrasting effects of acetylcholine on
coronary conductance and resistance
vessels in patients with coronary artery
disease, 133A
Contrasting effects of continuous wave and
pulsed laser imldiation on vasoreactivity
of atherosclerotic vessels in vitro, 14A
Coronary artery disease is associated with
inadequate left ventricular hypertrophy in
aortic stenosis, 81A
Coronary atherosclerosis impairs control of
shear stress, 42A
Correlation of coronary arterial with systemic
atherosclerosis, 42A
Dietary intake of saturated fat and cholesterol
in early childhood: implications for
prevention of atherosclerosis, 12A
Endothelial function influences the coronary
vasomotor response to sympathetic
stimulation in man, 202A
Evaluation of mixed atherosclerotic plaques by
quantitative ultrasonic methods, 5A
Histological evidence of coronary
atherosclerosis as a cause of myocardial
ischemia in patients with normal coronary
arteriograms, 150A
Impact of compensatory enlargement of
atherosclerotic coronary arteries on the
angiographic assessment of coronary
artery disease, 196A
In vivo photosensitizer enhanced laser
angioplasty in atherosclerotic Yucatan
miniswine, 43A
In vivo recanalization of total atherosclerotic
arterial occlusions: combined use of an
ultrasonic probe and balloon angioplasty
system, 195A
Intravascular ultrasound imaging of
atherosclerotic coronary arteries: an in
vivo validation study, 4A
Percutaneous laser angioplasty of peripheral
atherosclerotic obstructions by the
Unicorn-Cap (Tm) probe system: a
multicenter study, 14A
Preserved flow-mediated vasodilation despite
acetylcholine-induced vasoconstriction in
atherosclerotic coronary arteries in man,
I32A
Progression of coronary atherosclerosis and
enhanced thrombin-induced platelet
aggregability, 42A
Atresia
Right ventricular growth and function following
Fontan procedure for tricuspid atresia,
239A
Right ventricular size and pulmonary flow in
patients after first stage surgery for
pulmonary atresia: combined assessment
by cine magnetic resonance imaging and
color Doppler flow mapping, 240A
Atrial defects
Transcatheter umbrella closure of atrial
defects, 120A
Atrial fibrillation
Amplification of diltiazem's effects on the AV
node by rapid atrial input leads to
selective actions during atrial fibrillation,
164A
Changes in left atrial size due to chronic atrial
fibrillation, 20M
Effect of cardiac pacing mode on the long-term
development of atrial fibrillation, 217A
Flecainide for heart rate control in atrial
fibrillation, I64A
Intravenous flecainide versus intravenous
disopyramide in the reversion of atrial
fibrillation, 165A
Left atrial enlargement as a consequence of
atrial fibrillation: a prospective
echocardiographic study, 206A
Left ventricular function in atrial fibrillation: a
comparison before and after
cardioversion, 207A
Mechanism of compensatory pause in atrial
fibrillation, 173A
Mechanism of the onset of atrial fibrillation in
the Wolff-Parkinson-White syndrome:
how important is the accessory pathway?,
203A
Oral propafenone for prevention of recurrent
primary atrial fibrillation: predictive value
of the response to transesophageal atrial
stimulation, 233A
Reliability of procainamide in predicting the
shortest preexcited R-R interval during
atrial fibrillation is dose dependent, 204A
Atrial lIutter
Direct entrainment guided ablation of the slow
conduction zone (SCZ) in human type I
atrial flutter (AF), 168A
Atrial natriuretic factor
Acute and chronic antihypertensive efficacy of
atriopeptidase inhibition in rats, 76A
Acute effects of atriopeptidase inhibition on
plasma atrial natriuretic factor in chronic
heart failure, 76A
ANF blunts forearm vasoconstriction to lower
body negative pressure in essential
hypertension, 83A
Atrial natriuretic factor in atrialllutter and
fibrillation: role of atrial rate and
cardioversion, 76A
Atrial natriuretic factor in patients with right
ventricular infarction, 93A
Atrial natriuretic factor inhibition of renin
during renal hypoperfusion: role for the
macula densa, 8A
Atrial natriuretic peptide and elevated right
heart pressures in essential hypertension,
81A
Atrial natriuretic peptide from the coronary
sinus is acutely increased following
induction of paroxysmal tachycardia,
172A
Atriopeptidase inhibitors, a novel class of
drugs that raises levels of endogenous
atrial natriuretic factor-the preclinical
pharmacology of UK-69,578, 75A
Cardiovascular hormones in relation to
mortality in severe heart failure, 24M
Clinical value of measuring atrionatriuretic
factor after balloon aortic valvuloplasty,
56A
Coronary hemodynamic effects of atrial
natriuretic peptide, 132A
Direct suppression of aldosterone secretion by
endogenous atrial natriuretic peptide in
hemodynamically normal man: evidence
for physiologic role of ANP, 172A
Does ANF influence venous return?, 17lA
Does tolerance to atrial natriuretic factor
(ANF) develop during 24 hour-infusion in
patients with congestive heart failure?, 9A
Effect of atrial natriuretic factor on left
ventricular diastolic function in humans
with heart failure, 172A
Effect of combined dynamic exercise and
head-out water immersion on atrial
natriuretic peptide, 41A
Effects of different pacing modes on right atrial
pressure and atrial natriuretic peptide in
patients with atrioventricular block, 217A
In the human, expression of ventricular ANF
is independent of ventricular dilatation,
lOA
Is atrial natriuretic factor involved in the
modulation of coronary tone in man?,
IBM
Lack of inotropic effect of atrial natriuretic
factor in humans with heart failure:
demonstration by left ventricular
end-systolic pressure-volume analysis, 9A
N-terminal (1-25) atrial natriuretic factor in
humans with congestive heart failure: a
marker for endogenous secretion, 9A
Pacemaker syndrome is associated with very
high plasma concentrations of atrial
natriuretic peptide (ANP), IliA
Pharmacological elevation of endogenous atrial
natriuretic factor in man using the
atriopeptidase inhibitor (UK 69578), 76A
Preserved atrial natriuretic peptide secretory
function in denervated cardiac transplant
recipients, 243A
Prohormone atrial natriuretic peptides 1-30,
31-67, and 99-126 increase in proportion
to right ventricular pacing rate, 217A
Rapid reduction of plasma atrial natriuretic
peptide after balloon mitral valvuloplasty
in patients with mitral stenosis, 69A
Relationship of left and right atrial pressures to
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atrial natriuretic factor elaboration during
exercise in normal man, 40A
Response of atrial natriuretic factor to
percutaneous mitral valvuloplasty, 56A
Vasopressin (AVP) is elevated to pressor
levels and unopposed by atrial natriuretic
factor (ANF) following repair of
coarctation of the aorta (CoA), 136A
Ventricular levels of the atrial natriuretic factor
and of its messenger ribonucleic acid at
the time of heart transplantation, 9A
Atrial pressure
Mitral opening pressure strongly influences left
ventricular peak rapid filling rate, 130A
Relationship of left and right atrial pressures to
atrial. natriuretic factor elaboration during
exercise in normal man, 40A
Atrial septal defect
Hemodynamic results and follow-up of patients
with iatrogenic atrial septal defect
following balloon mitral valvuloplasty,
70A
Atrial size
Changes in left atrial size due to chronic atrial
fibrillation, 206A
Left atrial enlargement as a consequence of
atrial fibrillation: a prospective
echocardiographic study, 206A
Atrial stimulation
Oral propafenone for prevention of recurrent
primary atrial fibrillation: predictive value
of the response to transesophageal atrial
fibrillation, 233A
Atrioventricular junction
Catheter ablation of the atrioventricular
junction using radiofrequency energy,
169A
Atrioventricular nocle
Effect of epicardial accessory pathway ablation
or endocardial dissection for AV nodal
reentrant tachycardia on vagal innervation
to the AV node, 232A
Atropine
Abnormal QT/QSz ratio at rest and exercise in
Romano-Ward long QT patients,
normalized by beta-blocker therapy, IlA
Autonomic influence on ventricular subsidiary
pacemakers: a study of patients post AV
nodal ablation, 232A
Modulation of the fetal left ventricular function
curve by the thoracic tissue, 136A
Autoantibodies
Effect of cardiac transplantation on
anti-beta-receptor autoantibodies, 253A
Novel cardiac-specific circulating
autoantibodies in dilated cardiomyopathy,
88A
Autoantigens
Sharing of antigenic determinants between
coxsackie B3 virus and autoantigens in
viral myocarditis and dilative
cardiomyopathy, 253A
Automaticity
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purki11ie fibers
relative to effects of verapamil and class I
agents, 249A
Azathioprine
Cytomegalovirus infection in cardiac transplant
recipients predicts the incidence of
allograft atherosclerosis, 213A
Prophylactic anti-rejection therapy early after
cardiac transplantation: RATG versus
OKT3,62A
Treatment of cardiac allograft rejection with
pulsed steroids: a three year experience,
210A
B ceD antibodies
Cytotoxic B cell antibodies: insensitive
predictor of coronary disease post heart
transplantation, 42A
Barium
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil, 249A
Bayes theorem
Diagnostic strategies based on clinical and
exercise variables: liberation from
Bayes's theorem?, 182A
Bernoulli equation
Can the moclified Bernoulli equation accurately
estimate instantaneous transmitral
pressure gradients in patients with cardiac
pathology?, 234A
Beta-adrenergic activity
Enhanced ,6-adrenergic activity in
non-infarcted myocardium may cause
exercise-induced ST-segment elevation in
old myocardial infarction, 124A
Beta-adrenergic blocking agent
See also specific agent
Effect of beta-blockade on the circadian
variation of ventricular arrhythmias, 34A
Impact of medical and surgical therapy on the
cardiovascular prognosis of the Marfan
syndrome in early childhood, 119A
Majority of physicians use drug therapy for
isolated systolic hypertension, I3A
Nifedipine in unstable angina: beneficial effects
in the elderly and in patients with reduced
left ventricular function, 239A
Prior beta blocker therapy improves 28 day
post infarction survival, 12A
Beta-adrenergic receptor
Enhanced beta-adrenergic receptor function in
symptomatic mitral valve prolapse, 146A
Exercise alters guanine nucleotide binding
proteins, 40A
Portrayal of cardiac beta receptors in living
animals, 64A
Selective ,6-1 adrenergic receptor
down-regulation in experimental canine
heart failure, 181A
Bleeding
Detection of myocardial hemorrhage using IH
NMR imaging at 1.5 T, 48A
Overview of bleeding risk from the TAMI
trials: two agents are better than one,
198A
Blood ftow
See also Coronary ftow
Attenuation of early mitral flow velocity by
acute aortic insufficiency, 210A
Doppler color flow mapping of the "proximal
isovelocity surface area": a new method
for measuring volume blood flow across
an orifice, 225A
Gradual increase in left ventricular dimension
with decrease in pressure half-time of
transmitral flow following balloon mitral
valvuloplasty, 59A
Implantable and extractable sensor for intra
and postoperative monitoring of blood
flow in man, 214A
Pulsed Doppler echocardiographic mitral valve
flow patterns and left ventricular chamber
properties in patients with previous
myocardial infarction, 209A
Validation of Doppler echocardiographic
calculation of descending aortic and
umbilical flow in fetal lambs, 137A
Valve resistance in aortic stenosis: an
alternative method for assessing the
hemodynamic significance of flow
obstruction, 234A
Blood pressure
See also Hypertension
Antihypertensive therapy is improved by
central effects of arterial dilation and
reduced wave reflection, 244A
BRB-I·28
Effects of BRB-I-28 upon longitudinal and
transverse conduction in canine
myocardium, 138A
Bucindolol
Beneficial effects of longterm beta-blockade
with bucindolol in patients with idiopathic
dilated cardiomyopathy, 1l7A
Bundle branch block
Signal-averaged electrocardiogram predicts
arrhythmic events in patients with left
bundle branch block, 190A
Bypass devices
Percutaneous left atrial-femoral bypass with a
pulsatile pump: initial human experience
in cardiogenic shock, 53A
14C·deoxyglucose
Assessment of "no-reflow" phenomenon
during reperfusion with 99mTc_MIBI and
14C deoxyglucose, 30A
Caffeine
Caffeine is proarrhythmic in patients with
organic heart disease, 32A
Coffee use and acute myocardial infarction,
36A
Calcium
Blood pressure, left ventricular mass and
intracellular calcium in primary
hyperparathyroidism, 82A
Frequency response of action potentials from
human myocardium, 185A
Impaired myocardial reserve and calcium
intolerance occur prior to the congestive
heart failure stage in the cardiomyopathic
hamster, 180A
Postnatal development changes in myocardial
mitochondrial calcium transport, 137A
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents, I04A
Calcium channel blockers
See also specific agent
Myocardial infarction with minimal coronary
atherosclerosis: a syndrome of young
women with guarded long term prognosis,
27A
Calcium chloride
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
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Captopril
Captopril pretreatment and myocardial fibrosis
and stiffness in renovascular
hypertension, 82A
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Carbachol
Effect of cholinergic agonist carbachol and
cyclic guanosine monophosphate on
sudden cardiac death, 91A
Carbon dioxide
Excessive ventilatory responses to carbon
dioxide production during exercise in
patients with congestive heart failure,
242A
Importance of analyzing inspiratory gases
when calculating oxygen consumption and
carbon dioxide production during
exercise, 119A
Cardiac arrest
See also Sudden death
Effect of successful defibrillation on
subsequent defibrillation threshold in a
canine model of rapidly recurring cardiac
arrest,66A
Portable bypass does not improve survival in
cardiac arrest patients, 121 A
Cardiac catheterization
Can in-patient cardiac catheterization be
eliminated by out-patient procedures?,
47A
Fate of acute myocardial infarction patients
with successful mechanical (rescue) vs.
chemical patency of the infarct vessel at
emergency catheterization, 192A
Cardiac conduction
Antegrade and retrograde conduction occurring
over separate, adjacent accessory AV
pathways, 173A
Chronic effects of A-V nodal artery
embolization, 233A
Cocaine mediated impairment of cardiac
conduction in the conscious dog, 79A
Comparison of flecainide vs. procainamide in
depressing retrograde conduction in
atrioventricular nodal reentry tachycardia,
165A
Cytoplasmic and junctional components of
anisotropic internal resistance in canine
myocardium, 129A
Dynamic response of conduction velocity to
quinidine during pulse train stimulation in
canine Purkinje fibers, 163A
Effects of low energy direct current
countershock on atrioventricular nodal
junction in dog using suction-ablation
catheter, 176A
Epicardial mapping of rate-dependent
ventricular conduction slowing by
procainamide, 251A
Evidence for two types of sodium currents in
isolated neonatal AV nodal heart cells,
128A
Evidence that cocaine slows cardiac
conduction by an action on both AV
nodal and His-Purkinje tissue in the dog,
79A
Identification of putative intramural conduction
cells in canine left ventricle, 129A
Masking of tissue anisotropy-a computer
model of the interaction between
activation wavefront and fixed barriers,
129A
Mechanisms of electrotonic uncoupling of
myocardium induced by hypoxia, 130A
Rate-dependent slowing of intraventricular
conduction by procainamide: direct
measurement in the human heart, 250A
Retrograde conduction properties determine
rate-dependent efficacy of diltiazem for
AV reentrant tachycardia, 251A
Strength of monophasic and biphasic shocks
that cause conduction block, 67A
Sympathetic-induced changes in atrial
excitation sequences influence AV nodal
conduction, 129A
Cardiac depression
Exercise cardiac output declines with
advancing age in normal subjects, 241A
Non-invasive determination of cardiac output
during acute myocardial infarction using
electrical bioimpedance cardiography,
102A
Reversible cardiac depression caused by the
supernatant of lymphocytes cultured with
interleukin-2,207A
Cardiac resuscitation
See Resuscitation
Cardiac tamponade
Left ventricular pseudo hypertrophy in
pericardial effusion: a sign of cardiac
tamponade, 235A
Pleural effusion as a cause of right ventricular
diastolic collapse and cardiac tamponade,
236A
Cardiac transplantation
Acetylcholine is a potent vasoconstrictor in
human coronary arteries early after
cardiac transplantation, 85A
Cardiac transplantation in peripartum
cardiomyopathy,2l3A
Cardiopulmonary exercise response in
adolescents following cardiac
transplantation, 135A
Coronary artery to right ventricular fistulae in
heart transplant recipients: a complication
of endomyocardial biopsy, 243A
Cyclosporine and concomitant ketoconazole
after cardiac transplantation: intermediate
term findings and potential savings, 62A
Cytomegalovirus infection in cardiac transplant
recipients predicts the incidence of
allograft atherosclerosis, 213A
Cytotoxic B cell antibodies: intensive predictor
of coronary disease post heart transplant,
42A
Decreased rejection in older cardiac transplant
patients, 38A
Development of physiologic exercise heart rate
responses after cardiac transplantation,
184A
Diagnostic applications of lymphocyte cultures
from heart allograft biopsies, 62A
Echocardiographic features of the transplanted
heart in well patients one year post
transplantation, 243A
Effect of cardiac transplantation on anti-beta
receptor autoantibodies, 253A
Electrocardiographic changes during
dipyridamole stress as potential markers
of acute cardiac rejection, 88A
Electrophysiologic effects of adenosine
following orthotopic cardiac
transplantation: evidence of
supersensitivity, 163A
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Is atrial activation beneficial in heart transplant
recipients, IIIA
Is yearly coronary arteriography sufficient for
detection of coronary artery disease in
heart transplant recipients?, 242A
Ischemic time and graft function in human
infant cardiac transplantation, 120A
Left ventricular diastolic function-Doppler
changes in early post cardiac transplant
recipient, 99A
Magnetic resonance imaging in ischemic injury
following cardiac transplantation, 200A
One heart, two bodies: insights from the
transplanted heart's new
electrocardiogram, 243A
Positron emission tomography reveals
decreased coronary flow response to
exercise after cardiac transplantation,
242A
Prednisone withdrawal in "high risk:.' cardiac
transplant recipients, 212A
Preserved atrial natriuretic peptide secretory
function in denervated cardiac transplant
recipients, 243A
Prophylactic anti-rejection therapy early after
cardiac transplantation: RATG versus
OKT3,62A
Recovery of small and large artery
vasoconstriction in severe heart failure
following heart transplantation, 40A
Response to nitroprusside-predictor of early
post transplant mortality, 62A
Resting and supine exercise hemodynamics
improve I and 3 years after orthotopic
cardiac transplantation, lOOA
Right ventricular electrocardiographic
abnormality in orthotopic heart transplant
patients, IlA
Right ventricular restrictive/constrictive
physiology accompanies heart transplant
rejection, lOOA
Serial evaluation of cardiac transplant function:
relationship to donor heart ischemic time,
donor heart age and severe rejection
episodes,212A
T2 relaxation time as a predictor of cardiac
transplant rejection in humans, 201A
Use of enoximone in cardiac transplant
candidates: effect on J3-adrenergic
receptors, 248A
Ventricular arrhythmias following orthotopic
cardiac transplantation: relationship to
acute rejection and sudden death, 211A
Ventricular levels of the atrial natriuretic factor
and of its messenger ribonucleic acid at
the time of heart transplantation, 9A
Ventricular volume and function in infant
orthotopic heart transplantation, 239A
Cardlocytes
Endocrine conversion of ventricular
cardiocytes in ventricular aneurysm, 17lA
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Cardiomyopathy ...
See also Hypertrophy
Antibody mediat~ disturbance of myocardial
function-a model for dilated
cardiomyoM!hy.89A
Beneficial effects~f longterm beta-blockade
with bucind4l01 in patients with idiopathic
dilated cardidmyopathy. 117A
Can pre-operativ~ peak coronary flow predict
symptom atii metabolic benefit after
operative rdJ:ef of obstruction in
hypertrophi~ cardiomyopathy, 87A
Effect of cardiac transplantation on
anti-beta-receptor autoantibodies. 253A
Enhanced cardiac adrenergic response in
cardiomyopathic hamster at a
pre-congestive failure stage. 87A
Estimation of the concentration and function of
the ADP/ATP carrier in the myocardium
of patients with dilated cardiomyopathy
(DCM).25IA
Evidence for an abnormal vasodilator response
in hypertrophic cardiomyopathy. 117A
Growth factors identified in myocardium of
patients with hypertrophic
cardiomyopathy. 118A
Impaired myocardial reserve and calcium
intolerance occur prior to the congestive
heart failure stage in the cardiomyopathic
hamster. IBOA
Mechanisms of impaired vasodilation in the
coronary microvasculature of patients
with dilated cardiomyopathy. 178A
Mechanism of inducible ventricular tachycardia
in patients with idiopathic dilated
cardiomyopathy, 174A
Noninvasive discrimination in the right atrial
ectopic from sinus tachycardia in dilated
"cardiomyopathic" hearts. 137A
Novel cardiac-specific circulating
autoantibodies in dilated cardiomyopathy.
88A
31P-magnetic resonance spectroscopy and cine
IH magnetic resonance imaging of dilated
cardiomyopathy in humans. I99A
Porcine model of myocarditis leading to dilated
cardiomyopathy. 253A
Possible difference of metabolical condition in
patients with dilated cardiomyopathy and
severe coronary artery disease: evaluation
by positron emission tomography. I03A
Prevalence and direction of mitral regurgitation
in hypertrophic cardiomyopathy. 89A
Prognostic value of late potentials in
hypertrophic cardiomyopathy. 35A
Q waves in hypertrophic cardiomyopathy:
presence and localization according to the
site and extent of right and left ventricular
hypertrophy. lOA
Reducing left ventricular outflow tract
obstruction in patients with hypertrophic
cardiomyopathy by pacing-induced
intraventricular septal pre-excitation.
I17A
Relation between left ventricular hypertrophy,
filling. and perfusion in asymptomatic
hypertrophic cardiomyopathy. 80A
Relationship between the extent of muscular
hypertrophy and diastolic function in
patients with hypertrophic
cardiomyopathy without left ventricular
outflow gradients or mitral regurgitation.
89A
Sharing of antigenic determinants between
coxsackie B virus and autoantigens in
viral myocarditis and dilative
cardiomyopathy. 253A
Signal-averaged electrocardiogram predicts
arrhythmic events in patients with left
bundle branch block. I90A
Signal-averaged electrocardiographic
differences between patients with
non-myopathic left ventricular
hypertrophy and patients with
hypertrophic cardiomyopathy. 189A
Spectrum of restrictive cardiomyopathy: a
multicenter study. 116A
Survival of patients with hypertrophic
cardiomyopathy successfully resuscitated
from sudden cardiac death, 117A
T lymphocyte subsets as the noninvasive
marker of cardiomyopathy. 88A
Cardiomyoplasty
Augmentation of myocardial function with
dynamic cardiomyoplasty in a chronic
canine model. 213A
Evidence of lattissimus dorsi muscle
adaptation before cardiomyoplasty. 214A
Cardiopulmonary bypass
Cardiopulmonary bypass supported coronary
angioplasty in inoperable patients. 53A
Emergency percutaneous cardiopulmonary
(bypass) support in cardiogenic shock.
!60A
Emergency use of portable cardiopulmonary
bypass in patients with cardiac arrest,
160A
Percutaneous cardiopulmonary bypass to
support high risk elective coronary
angioplasty. 160A
Percutaneous institution of cardiopulmonary
(bypass) support: technique and
complications. 159A
Cardioverter defibrillator
Automatic implantable cardioverter
defibrillator: analysis of spontaneous
shocks.66A
Automatic implantable cardioverter-
defibrillator and patient survival: a case
study,65A
Automatic implantable cardioverter
defibrillator implantation by a
non-thoracotomy approach. 217A
Automatic implantable cardioverter
defibrillator in patients on chronic
amiodarone: effects on the defibrillation
threshold and the rate of shocks. 177A
Clinical evaluation of an implantable
cardioverter/defibrillator with
nonepicardial leads in patients with
refractory ventricular tachyarrhythmias.
215A
Does poor cardiac function preclude benefit
from an automatic implantable
cardioverter defibrillator? 65A
Operative (30-dayI mortality following
implantation of the automatic implantable
cardioverter defibrillator. 122A
Optimal catheter eiectrode dimensions for
non-thoracotomy cardioversionl
defibrillation lead system. 2l6A
Protocol for evaluation of internal defibrillation
safety margins. lilA
Carditis
See also myocarditis
Does myocardial involvement in children with
severe mitral regurgitation (MR) due to
active rheumatic carditis (ARC) influence
the outcome of mitral valve replacement
(MVR)? I46A
Catecholamines
Alterations in lymphocyte subsets and
catecholamines in congestive heart
failure, 180A
Enhanced beta-adrenergic receptorfunction in
symptomatic mitral valve prolapse. 146A
Exercise training alters catecholamine
metabolism in healthy older men. 41A
Catecholamine metabolic pathways and
exercise training: plasma and urine
catecholamines. metabolic enzymes. and
chromografin A. 182A
Catheter(s)
See also Ablation procedures; under Doppler
ultrasound: under Echocardiography;
under Valvuloplasty
Ablation of canine ventricular myocardium
with a cryogenic catheter: a new
closed-chest ablative technique?, 186A
Benefit of the "bailout" catheter for
emergency bypass surgery after failed
PTCA.155A
Endocardial isochronal patterns near the
ventricular tachycardia site of origin with
orthogonal electrode catheter array, 167A
Experience with the intrdcoronary Doppler
catheter in patients with clinical ischemic
heart disease but normal or trivially
diseased coronaries. 16lA
Histologic evaluation of "vessel-biopsies"
obtained with the Simpson atherectomy
catheter. 149A
Mechanical transluminal coronary
endarterectomy: initial clinical experience
with the Auth mechanical rotary catheter.
227A
Preservation of myocardial function by a
coronary perfusion catheter. 52A
Prolonged autoperfusion angioplasty:
immediate clinical outcome and
angiographic follow-up, 155A
Treatment of peripheral vascular disease with
the transluminal extraction catheter:
results of a multicenter trial. 227A
Use of the ACS stack perfusion dilation
catheter in PTCA to avoid coronary
artery bypass surgery, 155A
Catheterization
See Cardiac catheterization
Cholesterol
See also Hypercholesterolemia
Cardiovascular risk reduction through worksite
health promotion. 134A
Effects of cyclosporine on serum lipoproteins.
4lA
Family history predictors of high blood
cholesterol levels in 4th grade school
children. 36A
Membrane incorporation of unsaturated fatty
acids increases LDL metabolism by U937
monocytes. 32A
Risk factors and mortality in the multiple risk
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factor intervention trial after 10.5 years of
follow-up, IIA
Choline chloride
Preliminary biochemical characterization of the
canine cardiac sodium channel, 208A
Circadian patterns
Increased morning incidence of myocardial
infarction: experience in the 1515-2 trial,
I33A
Climatologic variables
Climatologic variables and acute myocardial
infarction: a time course study, 133A
Clonidine
Role of a-adrenergic receptors in syndrome X,
150A
Coarctation of the aorta
Remodeling of the aorta following successful
balloon coarctation angioplasty, 240A
Vasopressin (AVP) is elevated to pressor
levels and unopposed by atrial natriuretic
factor (ANF) following repair of
coarctation of the aorta (CoA), 136A
Cocaine
Cardiodepressant effects of cocaine, 78A
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade, 78A
Cocaine induced deleterious effects on the
canine coronary circulation, 79A
Cocaine mediated impairment of cardiac
conduction in the dog, 79A
Ergonovine testing in cocaine induced
myocardial ischemia, 79A
Evidence that cocaine shows cardiac
conduction by an action on both AV
nodal and His-Purkinje tissue in the dog,
79A
Coffee
See Caffeine
Cold
Effect of cold upon Ischemic threshold in
patients with stable angina: magnitude
and mechanism, 184A
Cold pressor test
Endothelial function influences the coronary
vasomotor response to sympathetic
stimulation in man, 202A
Collagen
Alterations in collagen cross-linking impair
myocardial contractility in vitro of the
Movbrmouse heart, 208A
Elevated right ventricular pressure increases
collagen in ventriculotomy scars in
canines, lISA
Collaterats
Bimodal time course of collateral development
in acute myocardial ischemia, 45A
Commissurotomy
Advantages of INOUE-balloon (self-positioning
balloon) in percutaneous transvenous
mitral commissurotomy (PTMC) and
aortic valvuloplasty, 18A
Early and longterm results after mitral
valvuloplasty as compared with open
commissurotomy,55A
Features of severe mitral regurgitation
following percutaneous balloon
commissurotomy,55A
Long-term follow-up of patients undergoing
closed transventricular mitral
commissurotomy, l8A
Percutaneous mitral valvuloplasty in patients
with previous surgical commissurotomy,
55A
Compliance
Concurrent compliance reduction and
increased resistance in the manifestation
of isolated systolic hypertension, 244A
Effect of receiving chamber compliance on the
spatial distribution of regurgitant jets as
imaged by color Doppler flow mapping:
an in-vitro study, 23A
Net left atrial and ventricular compliance can
be derived from transmitral velocity
curves: a hydrodynamic in vitrostudy,
198A
Noninvasive assessment of arterial compliance
in patients with systemic hypertension,
244A
Percutaneous mitral valvotomy increases left
atrial compliance without affecting its
pressure-volume curve, 70A
Ventricular and atrial compliance changes
affect pressure half time: experimental
evidence, 234A
Computed tomography
See Tomography
Conduction
See Cardiac conduction
Congenital heart defects
Bidirectional cavo-pulmonary anastomosis,
74A
Late potentials and inducible ventricular
tachycardia in surgically repaired
congenital heart disease, 170A
Occurrence of congenital heart defects in
offspring of patients with ventricular
septal defect, aortic stenosis, or
pulmonary stenosis: results of the second
natural history study of congenital heart
defects, 13M
Prevalence of congenital heart disease in
offspring of parents with Fallot's
tetralogy, 240A
Repair of complex congenital heart disease
with the use of valved conduit, 211A
Congestive heart failure
Abnormal thiiodothyronine is the strongest
short-term prognostic factor identified in
advanced heart failure, 181A
Accelerated arterial wave reflection with
dopamine but not dobutamine in
congestive heart failure, 247A
Alterations in lymphocyte subsets and
catecholamines in congestive heart
failure, l80A
Alterations in the catalyst of adenylate cyclase
and the inhibitory guanine nucleotide
regulatory protein in experimental heart
failure. l79A
Alterations in the ventilatory anaerobic
threshold after a chronic intervention
reflect changes in lactate production
during exercise in heart failure, 39A
Capillary density, fiber type and enzyme
composition of skeletal muscle in
congestive heart failure, 38A
Cardiovascular hormones in relation to
mortality in severe heart failure, 246A
Comparison of exercise protocols: evaluation
of oxygen uptake kinetics in heart failure,
242A
Decreased aerobic oxidative capacity in
skelet..1muscle in chronic heart failure,
39A
Does tolerance to atrial natriuretic factor
(ANF) develop during 24 hour-infusion in
patients with congestive heart failure?, 9A
Effects of flosequinan on metabolic and
ventilatory parameters during submaximal
exercise in cardiac failure, 181A
Excessive ventilatory responses to carbon
dioxide production during exercise in
patients with congestive heart failure,
242A
Hemodynamic correlates of increased cardiac
adrenergic drive in the intact failing
human heart, 245A
Increased exercise capacity in heart failure
patients following digoxin administration,
183A
Model for congestive heart failure: selenium
and vitamin E deficient mini pigs, 208A
N-terminal (1-25) atrial natriuretic factor in
humans with congestive heart failure: a
marker for endogenous secretion, 9A
Negative inotropic effect of nicardipine in
patients with heart failure: demonstration
by left ventricular end-systolic
pressure-volume analysis, 178A
Neurohormonal activation limits the long-term
response to the dopamine-I receptor
agonist fenoldopam in chronic heart
failure, 246A
Oral isosorbide dinitrite in chronic heart
failure: tolerance development to QID vs.
TID regimen, 17SA
Oscillatory shifts in oxygen uptake diminish
the functional relevance of gas exchange
measurements during exercise in chronic
heart failure, 241A
Prognosis of congestive heart failure (CHF)
evaluated by 1-123 meta-
iodobenzylguanidine (MIBG) myocardial
imaging, 180A
Recovery of small and large artery
vasoconstriction in severe heart failure
following heart transplantation. 40A
Skeletal muscle metabolic abnormalities in
heart failure are in part due to intrinsic
skeletal muscle changes, 39A
Temporal dissociation between invasive and
non-invasive determination in anaerobic
threshold in chronic heart failure, 39A
Conotruncal abnormalities
Noncardiac defects associated with
conotruncal abnormalities-further
implications of neural crest influence,
1I8A
Continuity equation
Estimation of effective mitral valve tissue
prosthetic area using the continuity
equation, 227A
Contractile function
Cardiac cycle-dependent variation of integrated
backscatter: an index of contractile
performance that is not distorted by
paradoxical septal motion, 52A
Effect of atrial contraction and synchroneity of
cardiac contraction on ventriculo-arterial
coupling, 20M
Endothelium-de~endent inhibition or
ergonov'ine-induced contraction is
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impaired in porcine coronary arteries with
regenerated endothelium, 31A
Left ventricular isovolumic contraction period
vanishes during intensive exercise, 102A
Contractility
Alterations in collagen cross-linking impair
myocardial contractility in vitro of the
Movbr mouse heart, 208A
Evidence of enhanced contractility in normal
infants compared to older children and
adults, I35A
Importance of contractility in determining left
ventricular size and performance in
patients with aortic regurgitation, 71A
Non-invasive assessment of improvement of
regional left ventricular contractility after
percutaneous transluminal coronary
angioplasty by QRST isoarea map in
patients with angina pectoris, I77A
Utility of left ventricular elastance for
predicting surgical outcome in patients
with mitral regurgitation, 71A
Contraction-excitation feedback
Variability of negative T wave in left
ventricular hypertrophy, the possible
result of contraction-excitation feedback,
35A
Contrast media
Nephrotoxicity of nonionic contrast media:
importance of dosage in high risk
patients, 47A
Converting enzyme inhibitors
Does age modify the hemodynamic and clinical
response to converting-enzyme inhibitors
inpatients with chronic heart failure?,
57A
Cor pulmonale
Pathological involvements of left ventricle in
chronic cor pulmonale, 151A
Coronary artery
Hypersensitivity of coronary arteries to
intracoronary ergonovine following
orthotopic cardiac transplantation, 188A
Coronary artery disease
See also Syndrome X
Acute outcome and longterm follow-up of
patients with acute myocardial infarction
and single vessel disease treated with
angioplasty without thrombolytic therapy,
94A
Acute outcome of atherectomy in peripheral
obstructive disease, 108A
Angioscopic endothelial macropathology in
patients with acute coronary syndromes,
14A
Clinical comparison between thallium-201 and
TC-99m methoxy isobutyl isonitrile
(MIBI) myocardial perfusion imaging for
detection of coronary artery disease, 30A
Comparison of exercise electrocardiography
and radionuclide angiography in the
identification of severe coronary artery
disease, 237A
Compensatory coronary dilatation and media
thinning: adaptive responses to
progressive atherosclerosis: I%A
Cytotoxic B cell antibodies: intensive predictor
of coronary disease post heart transplant,
42A
Effect of estrogen replacement and coronary
artery disease on survival in
postmenopausal women, 12A
Exercise seismocardiography for detection of
coronary artery disease: a preliminary
report, 127A
High dose dipyridamole-echocardiography test
in hypertensives: correlation with
exercise-electrocardiography test and
coronary arteriography, 103A
Impact of compensatory enlargement of
atherosclerotic coronary arteries on the
angiographic assessment of coronary
artery disease, I%A
..Laser wire" for percutaneous angioplasty
complete peripheral and coronary arterial
occlusions-initial clinical results, 60A
Late follow-up of 781 patients undergoing
percutaneous transluminal coronary
angioplasty (PTCA) or open heart surgery
(OH5) for an isolated obstruction in the
left anterior descending (LAD) coronary
artery, I66A
Left ventricular function at rest and the
prevalence of ambulatory silent ischemia
in coronary artery disease, 203A
Media thinning of severely diseased coronary
arteries: guidelines for new interventional
procedures, I94A
Pivotal role of multivessel coronary artery
disease and the remote zone in the
reperfusion era, 92A
Possible difference of metabolic condition in
patients with dilated cardiomyopathy and
severe coronary artery disease: evaluation
by positron emission tomography, 103A
Post-exercise ST segment depression in
relation to heart rate: improved
identification of coronary artery disease
by the rate-recovery loop, 236A
Relation between ischemia during exercise and
ambulatory ischemic activity in coronary
artery disease, 3A
Relation of modified fatty acid uptake to wall
motion and coronary anatomy, 29A
Three decade trends in incidence of coronary
disease and risk factors in the
Framingham study, 35A
Transthoracic two-dimensional ultrasonic high
frequency (7.5 MHZ) visualization of the
distal left anterior coronary artery, 116A
Coronary flow
Attenuation of early mitral flow velocity by
acute aortic insufficiency, 210A
Biphasic response of coronary blood flow to
intracoronary nitroglycerin in normal
subjects, 230A
Blood-velocity imaging by magnetic resonance
phase difference techniques for
quantitative measurement of stroke
volume, cardiac output and venous
return: comparison with Doppler
ultrasound, 48A
Can pre-operative peak coronary flow predict
symptom and metabolic benefit after
operative relief of obstruction in
hypertrophic cardiomyopathy, 87A
Cocaine induced deleterious effects on the
canine coronary circulation, 79A
Do Doppler flow algorithms for mapping
disturbed flow make sense?, 226A
Doppler color flow mapping of the "proximal
isovelocity surface area": a new method
for measuring volume blood flow across
an orifice, 225A
Effects of adenosine on the coronary
circulation in humans, 132A
Gradual increase in left ventricular dimension
with decrease in pressure half.·time of
transmitral flow following balloon mitral
valvuloplasty,59A
Greater improvement in coronary flow velocity
with atherectomy compared to
angioplasty, IOSA
Impedance measurement of absolute blood
flow using an angioplasty guidewire, 194A
Implantable and extractable sensor for intra
and postoperative monitoring of blood
flow in man, 214A
Increased flow velocity in the human coronary
stenosis: a simple assessment of stenosis
severity, I31A
Incremental critical coronary stenosis contracts
rather than expands myocardial vascular
volume,2lSA
Myocardial contrast echo washout curves: the
influence of ischemia and hyperemia,
1\5A
Myocardial contrast echocardiography can not
be used to assess endocardial/epidardial
blood flow ratio, \l5A
New approach to in vivo measurement of
coronary flow utilizing high-speed
coronary angiography, 7A
Nitrogen-13 ammonia myocardial uptake at
rest and with exercise in normal
volunteers: quantification of coronary
flow with dynamic positron emission
tomography, 97A
Nonhomogenous redistribution of regional
myocardial blood flow and potassium
during reperfusion of ischemic
myocardium, 127A
Positron emission tomography reveals
decreased coronary flow response to
exercise after cardiac transplantation,
242A
Pulsed Doppler echocardiographic mitral valve
flow patterns and left ventricular chamber
properties in patients with previous
myocardial infarction, 209A
Quantitative measurement of myocardial blood
flow and coronary flow reserve in patients
with CAD employing 0-15 water and
positron emission tomography (PET), 97A
Reduced myocardial blood flow with persistent
vasodilator reserve: role of adrenergic
activation, 187A
Validation of Doppler echocardiographic
calculation of descending aortic and
umbilical flow in fetal lambs, 137A
Valve resistance in aortic stenosis: an
alternative method for assessing the
hemodynamic significance of flow
obstruction, 234A
Coronary flow reserve
Aging-related decrease in vasodilatory capacity
in coronary microcirculation estimated by
coronary Doppler catheter, 57A
Details of coronary stenosis morphology
influence its hemodynamic severity and
distal flow reserve, 43A
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Effect of diltiazem on coronary flow reserve in
man,I54A
Effect of subcritical stenosis on coronary and
myocardial flow reserve in territory
supplied by other nonstenotic arteries, 7A
Effects of short- and long-term hypertensive
cardiac hypertrophy on the structural
properties of the coronary resistance
vessels, 187A
Impaired myocardial reserve and calcium
intolerance occurs prior to the congestive
heart failure stage in the cardiomyopathic
hamster, 180A
Normalization of coronary flow reserve after
successful angioplasty assessed with
positron emission tomography, 218A
Relative coronary flow reserve reflects stenosis
severity more accurately than absolute
flow reserve during changing aortic
pressure and cardiac workload. 162A
Warming up phenomenon cannot be explained
by the increase in coronary flow reserve,
237A
Coronary occlusioo
Combined laser/thermal recanalization of
peripheral artery occlusions, I3A
Consequences of occlusion during PTCA, 230A
Evaluation of left ventricular function
immediately after successful balloon
recanalization of chronic total coronary
occlusions, 229A
In vivo recanalization of total atherosclerotic
arterial occlusions, 195A
Quantitation of critically ischemic myocardial
mass during acute coronary occlusion in
vivo: measurement with positron emission
tomography, 64A
Radiofrequency thermal angioplasty for the
treatment of peripheral vascular occlusive
disease: preliminary results of a clinical
trial, 14A
Regional electrophysiological effects of stellate
stimulation on infarcted myocardium,
128A
Seismocardiography for detection of coronary
artery occlusion during coronary
angioplasty: a preliminary report, 43A
Coronary perfusioo
See also Echoperfusion; Coronary reperfusion
Dipyridamole-induced malperfusion may not
indicate ischemic ventricular dysfunction.
126A
Impact of abnormal myocardial perfusion on
ventricular function in patients with
unstable angina, 239A
Tomographic myocardial perfusion imaging
with technetium-99m 2-methoxy isobutyl
isonitrile (MIBI) and thallium-201: the
sensitivity and reproducibility of
semiquantitative assessments of
myocardial perfusion and regional systolic
function, 30A
Coronary reocdusion
J::~rly thrombotic reocclusion after successful
coronary thrombolysis is predictable from
an increased thrombin release two hours
after onset of therapy, 152A
Coronary reperfusion
Assessment of "no reflow" phenomenon
during reperfusion with 99mTc-MIBI and
14C-deoxyglucose, 30A
Coronary occlusion-reperfusion attenuates
endothelium-mediated vascular response
to leukotriene 04and acetylcholine, 143A
Detection of hydroxyl radicals in the
reperfused isolated monkey heart, IlOA
Early histopathology of reperfusion therapy for
myocardial ischemia: study of 29
autopsied cases, 193A
Early reperfusion after treatment with
intravenous pro-urokinase when
compared to intravenous streptokinase,
152A
Effect of reperfusion on post-myocardial
infarction aneurysm formation at one
week, llOA
Enhanced phosphoinositide metabolism during
reperfusion of ischemic rat heart: a novel
mechanism ofreperfusion injury, 252A
Observer variability in TIMI flow grading:
comparison to a new computer method
for measurement of reperfusion kinetics,
91A
Overriding heightened risk, prior angina
denoted a favorable response to
myocardial reperfusion. 95A
Pivotal role of multivessel coronary artery
disease and the remote zone in the
reperfusion era, 92A
Preservation of myocardial function and
topography by late reperfusion and
long-acting superoxide dismutase therapy.
I09A
Serial changes in myocardial perfusion using
tomographic technetium-99m methoxy
isobutyl isonitrile (Tc-MIBI), 30A
Time course of reperfusion induced reversal of
early myocardial expansion. I09A
Tomographic assessment of myocardial
reperfusion during acute myocardial
infarction using Tc-99m methoxy isobutyl
isonitrile (MIBI), 153A
Coronary tone
Is atrial natriuretic factor involved in the
modulation of coronary tone in man?
IBM
Cost etrectiveness
Cost-benefit advantage of primary scintigraphic
evaluation after uncomplicated acute
inferior wall myocardial infarction, 162A
Countershock
Effects of low energy direct current
countershock on atrioventricular nodal
junction in dog using suction-ablation
catheter. 176A
Cycle length alternans
Mechanism of significance of cycle length
a1ternan:; during supraventricular
tachycardia. 185A
Cyclosporine, eyclosporine A
Cyclosporine and concomitant ketoconazole
after cardiac transplantation: intermediate
lerm findings and potential savings, 62A
Cyclosporine in aviremic coxsackievirus B3
myocarditis in mice, 254A
Cyclosporin therapy impairs
endothelium-dependent relaxations in the
renal circulation. 83A
Cytomegalovirus infection in cardiac transplant
recipients predicts the incidence of
allograft atherosclerosis. 213A
Effects of cyclosporine on serum lipoproteins.
4lA
Influence of antihypertensive therapy on
plasma hormones in cardiac transplant
recipients: measurements at rest and
during exercise, 81A
Prophylactic anti-rejection therapy early after
cardiac transplantation: RATG versus
OKT3,62A
Treatment of cardiac allograft rejection with
pulsed steroids: a three year experience,
210A
Death
See also Sudden death
Low maximum acceleration measured using
aortic Doppler identified patients at risk
of cardiac death following acute
myocardial infarction, 157A
Risk of death after nonfatal myocardial
infarction in the VA cooperative study of
coronary artery bypass surgery, 166A
Debridement
High frequency (ultrasonic) mechanical
debridement in the treatment of calcific
aortic stenosis: an echocardiographic
studY,214A
Is ultrasonic debridement of aortic stenosis a
reliable alternative to valve replacement?,
123A
Defect reversibility
Frequency of late defect reversibility in
SPECT TL-201 stress redistribution
studies, 28A
De6briUation
Comparison of single and double capacitor
biphasic waveforms for internal
defibrillation, 67A
Direct excitation of relatively refractory tissue
by monophasic and biphasic shocks, 215A
Does electrode polarity influence defibrillation
efficacy for thoracotomy and
non-thoracotomy internal defibrillation,
67A
Effect of pericardial effusion on energy
requirements for defibrillation using
extrapericardial patch electrodes, 112A
Effect of successful defibrillation on
subsequent defibrillation threshold in a
canine model of rapidly recurring cardiac
arrest,66A
Increased defibrillation threshold and cardiac
hypertrophy in a rapid pacing model of
congestive heart failure in the dog, 67A
Relationship between stimulation threshold
variability of isolated cardiomyocytes and
separated defibrillation shocks delivered
in orthogonal directions, 177A
Relationship of interpulse separation and
defibrillation efficacy for biphasic
waveforms.216A
Sequential pulse defibrillation in man: effects
of lidocaine and verapamil, 21M
Strength of monophasic and biphasic shocks
that cause conduction block, 67A
Triphasic waveforms increase defibrillation
efficacy over biphasic waveforms with
catheter/subcutaneous patch electrodes,
21SA
Ventricular fibrfilation waveform
charact~ristics associated with successful
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defibrillation using fixed low energy DC
shock,2l6A
Defibrillator
See also Cardioverter defibrillator
Flexible and effective 3 electrode
non-thoracotomy defibrillation system in
man,65A
Initial clinical experience: Endotak-implantable
transvenous defibrillator system, 65A
Pacemaker/implantable defibrillator
interactions: are they of clinical
importance?,66A
Use of gradient maps to create an electrode
configuration with a more even
defibrillation field, 66A
Defibrinogenation
Defibrinogenation reduces infarct size in a
canine model of acute myocardial
infarction, l25A
2·Deoxy·D.gIucose
Validation of a tracer analogue method for the
assessment of glucose metabolism in
isolated working rat hearts, 103A
Diabetes
Painless myocardial ischemia in diabetic
patients with coronary artery disease, 4A
Diastolic collapse
Long term characterization of left ventricular
diastolic collapse dynamics post
infarction, 48A
Diastolic function
Altered left ventricular diastolic filling due to
acute right ventricular volume overload
following tricuspid valvectomy. A pulsed
Doppler echocardiographic study, 72A
Are Doppler indices of diastolic filling affected
by left ventricular hypertrophy, 209A
Are Doppler indices more load sensitive than
other measures of diastolic function?,
197A
Diastolic abnormalities in hypertension are not
explained by LVH alone, 59A
Diltiazem improves diastolic function during
hypoxia in hypertrophied rat hearts, l3lA
Effect of atrial natriuretic on left ventricular
diastolic function in humans with heart
failure, 172A
Effect of early diastolic loading on myocardial
relaxation in the intact canine left
ventricle, l30A
Effects of exercise-induced ischemia in
pressure-volume relations and filling
dynamics in the conscious dog, l8lA
Enhanced recovery of diastolic function after
global myocardial ischemia in the intact
animal, l30A
Evidence for an early increase in cardiac
sympathetic stimulation in patients with
diastolic dysfunction, 246A
Improved diastolic function after aortic valve
replacement assessed by ultrafast
computed tomography, 47A
Improvement of relaxation velocity by calcium
blocker in aging rabbit myocardium, 57A
Left ventricular diastolic function-Doppler
changes in early post cardiac transplant
recipients, 99A
Left ventricular diastolic function in
pheochromocytoma: relation to plasma
catecholamines, 82A
Load dependence of reduced early diastolic
filling in left ventricular hypertrophy.
2l0A
Persistence of increased diastolic stiffness late
following aortic valve replacement, l4SA
Regional diastolic mechanics of ischemic and
nonischemic areas in the pig heart, l3lA
Relationship between the extent of muscular
hypertrophy and diastolic function in
patients with hypertrophic
cardiomyopathy without left ventricular
outflow gradients or mitral regurgitation,
89A
Respiratory influence on RV and LV diastolic
filling in normal children, 205A
Shift of the left ventricular diastolic
pressure-volume curve with ischemia:
importance of volume and the
pericardium, 207A
Stunned myocardium; evidence that diastolic
ventricular dysfunction persists even after
resolution of systolic dysfunction-
experimental Doppler echocardiographic
studies, 197A
Systolic shortening determines diastolic
distensibility of ischemic myocardium
during pacing induced angina and
transluminal coronary occlusion, 80A
Ventricular diastolic interaction in intact dogs
assessed by conductance catheters, l3lA
Diatrizoate
Randomized trial of ionic versus non-ionic
contrast for cardiac angiography: effect on
complications and costs, 46A
Dibenzepin
Electrophysiologic effects of a chemical
defibrillatory agent: dibenzepin, 250A
Diet
Telephone-mail mediated dietary intervention
for hypercholesterolemia, l34A
Digitalis
Lack of correlation of ouabain binding sites
and inotropic response to digitalis in
experimental heart failure, 24SA
Digoxin
F1ecainide acetate for the treatment of
postoperative atrial arrhythmias, l64A
Flecainide for heart rate control in atrial
fibrillation, l64A
Increased exercise capacity in heart failure
patients following digoxin administration,
l83A
Dilevalol
Antihypertensive therapy is improved by
central effects of arterial dilation and
reduced wave reflection, 244A
Diltiazem
Age-related risk factors and mechanism of
death following myocardial infarction.
Experience from the multicenter diltiazem
postinfarction trial, 27A
Amplification of diltiazem's effects on the AV
node by rapid atrial input leads to
selective actions during atrial fibrillation,
164A
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade, 78A
Coronary spasm induced by stent implantation,
194A
Diltiazem improves diastolic function during
hypoxia in hyperthyroid rat hearts, l31A
Effect of diltiazem on coronary flow reserve in
man,154A
Exercise training versus exercise training with
diltiazem or pr.opranolol: effects on lipids
10 men With mIld hypertension, 241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
maximal oxygen uptake and exercise
duration in men with mild hypertension,
241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
resting blood pressure in men with mild
hypertension, I06A
Favorable effect of diltiazem on late mortality
and reinfarction after non-Q wave
myocardial infarction: Multicenter
Diltiazem Post-Infarction Trial (MDPIT),
6A
Intracoronary diltiazem limits infarct size
during prolonged angioplasty balloon
inflation, 195A
Retrograde conduction properties determine
rate-dependent efficacy of diltiazem for
AV reentrant tachycardia, 251A
Role of electrocardiographic location of
diltiazem treatment effect in non-Q wave
myocardial infarction: Multicenter
Diltiazem Post-Infarction Trial (MDPlT),
6A
Dipyridamole
Detection of coronary stenoses by high speed
NMR imaging: the utility of
dysprosium-DTPA,48A
Dipyridamole-Doppler echocardiography:
comparison to thallium-201 imaging and
quantitative coronary arteriography, 159A
Dipyridamole-induced malperfusion may not
indicate ischemic ventricular dysfunction,
l26A
Electrocardiographic changes during
dipyridamole stress as potential markers
of acute cardiac rejection, 88A
Experience with the intracoronary Doppler
catheter in patients with clinical ischemic
heart disease but normal or trivially
diseased coronaries, 161A
High dose dipyridamole-echocardiography test
in hypertensives: correlation with
exercise-electrocardiography test in
coronary arteriography, 103A
High dose dipyridamole-echocardiography test:
large scale clinical trial, l58A
Insensitivity of thallium 201 imaging after oral
dipyridamole for detection of reversible
myocardial ischemia, 182A
Iodine-123, phenylpentadecanoid acid
tomography following dipyridamole
infusion for the detection of coronary
artery disease, 99A
Is there an improvement in coronary
vasodilator capacity after aortic valve
replacement?,147A
Normalization of coronary flow reserve after
successful angioplasty assessed with
positron emission tomography and H/sO,
2lSA
Prognostic value of intravenous dipyridamole
thallium imaging in asymptomatic patients
with coronary disease and no previous
myocardial infarction, 126A
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Role of intravenous dipyridamole thallium
imaging in preoperative cardiac risk
assessment before renal transplantation,
161A
Dtiopyramide
Combination of class IA and IB antiarrhythmic
drugs markedly depresses Vmax with
little change in the action potential
duration in canine Purkinje fibers, 248A
Disopyramide induces uterine contractions in
pregnancy, 141A
Intravenous f1ecainide versus intravenous
disopyramide in the reversion of atrial
fibrillation, 165A
Safety, efficacy and predictive value of drug
termination of ventricular tachycardia,
162A
Short term variability of ventricular arrhythmia
and rapid assessment of drug efficacy,
I40A
Synergistic actions of disopyramide and
lidocaine on Vmax of action potentials in
guinea pig papillary muscles, 139A
Imsection
Coronary angioplasty dissection: in-hospital
outcome, 221A
Determinants of arterial dissection during
PTCA: lesion type versus inflation rate,
229A
Effect of epicardial accessory pathway ablation
or endocardial dissection for AV nodal
reentrant tachycardia on vagal innervation
to the AV node, 232A
Diuretics
See also specific agent
Majority of physicians use drug therapy for
isolated systolic hypertension, 13A
Dobutamlne
Accelerated arterial wave reflection with
dopamine not dobutamine in congestive
heart failure, 247A
Demonstration of viable myocardium after
acute infarction submitted to
thrombolysis: comparison between
positron emission tomography and
dobutamine echocardiography, InA
Dopamine
Accelerated arterial wave reflection with
dopamine but not dobutamine in
congestive heart failure, 247A
l3-adrenergic agonists in nonfailing, failing, and
transplanted human hearts, 143A
Dopamine-l receptor agonist
Neurohormonal activation limits the long-term
response to the dopamine-I receptor
agonist, fendoldopam, in chronic heart
failure, 246A
Dopexamine
l3-adrenergic agonists in nonfailing, failing, and
transplanted hearts, 143A
Tachyphylaxis associated with dopexamine
administration in severe heart failure,
247A
Doppler color 801'1' imaging
Can color Doppler/two dimensional
echocardiography identify the need for
tricuspid valve repair?, 24A
Consistency of color flow Doppler estimation
of regurgitant flow rate across varying
size orifices and multiple orifice
communcations using flow convergence
concepts, 22A
Demonstration of jet entrainment-an
interaction which causes parallel jets to
merge and cross: in-vitro experiments
using color Doppler flow mapping and
optical visualization, 25A
Diagnosis of left ventricular pseudoaneurysm
by color Doppler flow mapping, 24A
Do Doppler flow algorithms for mapping
disturbed flow make sense?, 226A
Does color Doppler echocardiography detect
additional small muscular defects in
infants with a large ventricular septal
defect?, 20M
Doppler color flow mapping of the "proximal
isovelocity surface area": a new method
for measuring volume blood flow across
an orifice, 225A
Evaluation of ventricular septal defect
complicating acute myocardial infarction:
identification, localization and
differentiation from mitral regurgitation by
Doppler color flow imaging, 209A
Limitations of color Doppler in analysis of
valvular regurgitation, 22A
Overestimation of regurgitant jet area by
transesophageal as compared to
transthoracic color Doppler, 68A
Quantification of acute aortic insufficiency with
color Doppler flow mapping: in vitro
studies in a flexible model of the left
ventricle, 49A
Quantitative evaluation of ventricular septal
defect by color Doppler flow imaging,
24A
Transesophageal 2D color-coded
echocardiography during percutaneous
transluminal coronary angioplasty, 68A
Two dimensional/color Doppler assessment of
ventricular septal defect, 24A
Validation of a method to estimate regurgitant
fractions using the power mode in a dog
model,23A
Value and limitations of transesophageal color
Doppler echocardiography for the
recognition of transvalvular regurgitation
in the normally functioning St. Jude
valve,2lOA
Doppler ultrasound
Are Doppler indices more load sensitive than
other measures of left ventricular
function?, 197A
Are Doppler indices of diastolic filling affected
by left ventricular hypertrophy?, 209A
Differential effects of right ventricular pressure
and volume loading on left ventricular
filling assessed by Doppler
echocardiography, 19M
Dipyridamole-Doppler echocardiography:
comparison to thallium-201 imaging and
quantitative coronary arteriography, 159A
Doppler harmonic spectral signals
("STRIPES"): in vivo and in vitro
evidence of an artifact due to leaflet
reverberations, 49A
Evaluation of prosthetic valve performance by
assessing the response to exercise using
Doppler echocardiography, 233A
Experience with the intracoronary Doppler
catheter in patients with clinical ischemic
heart disease but normal or trivially
diseased coronaries, 161A
Profile of a regurgitant color jet is independent
of orifice shape, 23A
Progression of aortic stenosis as assessed by
echocardiography, 233A
Pulsed Doppler echocardiographic mitral valve
flow patterns and left ventricular chamber
properties in patients with previous
myocardial infarction, 209A
Reduction of left ventricular preload produced
by lower body negative pressures alters
Doppler transmitral filling patterns, 197A
Use of Doppler echocardiography in
determination of left ventricular DplDt
MAX,60A
Droperldol
Randomized controlled trial of
neuroleptanalgesia infusion in the early
treatment of acute myocardial infarction,
91A
Dyspr05ium-DTPA
Detection of coronary stenosis by high-speed
NMR imaging: the utility of
dysprosium-DTPA,48A
Ebstelu's anomaly
Ebstein's anomaly of the fetus and neonate;
anatomic details of prognostic
importance, I35A
Echocardiography
See also Doppler color flow imaging; Doppler
ultrasound; Ultrasound
Assessing infarct expansion in an
echocardiographic wall motion index
improved prediction of outcome after
myocardial infarction, 27A
Echocardiographic computed tomography of
the heart: preliminary results, 224A
Echocardiographic features of the transplanted
heart in well patients one year post
transplantation, 243A
High dose dipyridamole-echocardiography test:
large scale clinical trial, 158A
Impact of intraoperative echocardiography: the
first 1,000 patients, 23A
Two to five year echocardiographic follow-up
of patients with mitral valve prolapse: is
apical four-chamber view displacement a
precursor of abnormality, 22M
Ecbocardlography. contrast
Myocardial contrast echo washout curves: the
influence of ischemia and hyperemia,
115A
Myocardial contrast echocardiography can not
be used to assess endocardial/epicardial
blood flow ratio, 115A
Reproducibility of washout curves derived
from myocardial contrast echo, 115A
Echocardiography. exercUc
Echocardiographic assessment of mental stress
induced wall motion abnormalities:
comparison with exercise, 158A
Exercise echocardiographic detection of
coronary artery disease in women, 158A
Physiologic significance of coronary lesions
assessed by exercise echocardiography
and quantitative coronary angiography.
158A
Echoeardlography,'three dimensional
New three-dimensional echocardiographic
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method for quantitating mitral valve
prolapse, 227A
Three-dimensional echocardiography: a
feasible, non-invasive method to measure
cardiac volume, 50A
Transesophageal echo computer tomography: a
new method for dynamic 3-D imaging of
the heart, 68A
Echocardiography, transesophageal
Contribution of transesophageal
echocardiography in the ultrasound
assessment of percutaneous mitral
valvuloplasty, 51A
Detection of pulmonary artery thrombi by
transesophageal echocardiography in
patients with suspected pulmonary
embolism, 224A
Impact of transesophageal echocardiographic
examinations: comparison between
transthoracic and transesophageal
approach,51A
Mitral prosthesis malfunction: utility of
transesophageal echocardiography, 69A
Safety of transesophageal echocardiography in
awake patients: experience with 400
procedures, 225A
Transesophageal echo, an improved diagnostic
technique for sub-aortic membranes, 209A
Transesophageal echo computer tomography: a
new method for dynamic 3-D imaging of
the heart, 68A
Transesophageal echo in mitral prosthetic
dysfunction: echo-surgical correlation,
69A
Transthoracic versus transesophageal
two-dimensional echolDoppler flow
imaging in surgical patients with mitral
regurgitation, 68A
Utility of transesophageal echocardiography in
patients undergoing cardiac valve surgery,
123A
Echocardiography, two-dimensional
Can color Doppler/two dimensional
echocardiography identify the need for
tricuspid valve repair, 24A
Can hemodynamically significant RV infarction
be identified by two-dimensional
echocardiography?, 157A
Intravascular real-time, high resolution
two-dimensional echocardiography, 4A
Progression of aortic stenosis as assessed by
echocardiography, 233A
Transthoracic two-dimensional ultrasonic high
frequency (7.5 MHZ) visualization of the
distal left anterior coronary artery, 116A
Transthoracic versus transesophageal
two-dimensional echolDoppler flow
imaging in surgical patients with mitral
regurgitation, 68A
Two-dimensional echocardiography can reduce
hospital admissions for acute myocardial
infarction by more than one-third: results
of a prospective study performed in the
emergency room, 159A
Echoperfusion, contrast
Current myocardial perfusion echo
methodology precludes an accurate
assessment of coronary vascular reserve,
11M
Ectopic activity
Increased ventricular ectopic activity during
ischemic episodes in ambulatory patients,
33A
Microprocessor based ECG analyzer and tone
generator which permits immediate
recognition and categorization of ectopic
rhythms by sound, 18SA
Edema
Rapid-onset pulmonary edema in patients with
left ventricular systolic dysfunction: a
syndrome related to ventricular function,
179A
Survival among patients with flash pulmonary
edema: a retrospective review of surgical
and medical management, 46A
Ejection fraction
Ambulatory left ventricular function
monitoring: are the ejection fraction
measurements reproducible?, 96A
Augmentation of ejection fraction during
ambulatory monitoring in thrombolysis
patients with concomitant silent
ventricular dysfunction: mechanistic
implications, 96A
Evidence against a "myocardial factor" in
rheumatic mitral stenosis, 147A
Improvement in left ventricular ejection
fraction during the first post-infarction
year in patients with inferior and non-Q
wave infarcts, 81A
Natural history of left ventricular function
changes after myocardial infarction, 25A
Right and left ventricular response early and
late after surgical relief of mitral
regurgitation, 71A
Elderly
See also Age factors
Aortic stenosis in the elderly: aortic balloon
valvuloplasty vs. aortic valve
replacement, 38A
Cardiovascular risk of hypertension in the old
old: the Bronx Longitudinal Aging Study,
37A
Decreased rejection in older cardiac transplant
patients, 38A
Exercise training alters catecholamine
metabolism in healthy older men, 41A
Risk factors for coronary mortality in elderly
survivors of myocardial infarction: the
Framingham Study, 37A
Silent coronary artery disease in elderly men:
low exercise tolerance is strongly
associated with multivessel disease, 37A
Electrocardiography
See also specific wave; specific interval
Absence of late potentials in patients with
repetitive monomorphic and
exercise-facilitated ventricular tachycardia
and no apparent heart disease, 177A
Complementary role of signal-averaged ECG
and exercise testing in predicting cardiac
events after myocardial infarction, 190A
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Effect of exercise induced ischemia on signal
averaged electrocardiogram, 191A
Effect of thrombolysis on late potentials
incidence after acute myocardial
infarction, 178A
Enhancing prediction of induced ventricular
tachycardia in patients with non-sustained
runs by the signal averaged
electrocardiogram, 34A
Late potential and noise level variability
caused by bandpass versus high-pass
filtering, and type of signal-averaging
equipment, 188A
Microprocessor based ECG analyzer and tone
generator which permits immediate
recognition and categorization of ectopic
rhythms by sound, 188A
One heart, two bodies: insights, from the
transplanted heart's new
electrocardiogram, 243A
Reproducibility of the signal-averaged ECG in
the acute phase of myocardial infarction
and at long term follow-up, 190A
Right ventricular electrocardiographic
abnormality in orthotopic heart transplant
patients, IIA
Role of electrocardiographic location on
diltiazem treatment in non-Q wave
myocardial infarction: multicenter
diltiazem post-infarction trial (MDPIT),
6A
Signal-averaged electrocardiogram predicts
arrhythmic events in patients with left
bundle branch block, 190A
Signal-averaged electrocardiographic
abnormalities in non-affected first degree
relatives of patients with hypertrophic
cardiomyopathy, 190A
Signal-averaged electrocardiographic
differences between patients with
non-myopathic left ventricular
hypertrophy and patients with
hypertrophic cardiomyopathy, 189A
Time-dependent electrophysiologic changes
after experimental myocardial infarction:
parallel changes in inducibility of
ventricular arrhythmias and the
signal-averaged electrocardiogram, 22A
Electrocardiography, ambulatory
Does three channel ambulatory
electrocardiographic monitoring increase
detection of ischemia?, 189A
Holter monitoring in the diagnosis of sleep
apnea syndrome, 189A
Silent ischemia on ambulatory ECG monitoring
provides additional prognostic information
in patients with stable angina and a
positive exercise treadmill test, 202A
ST analysis: intragroup versus intrapatient
variability of Holter results, 189A
Electromechanical dissociation
Stunned myocardium: a form fruste of
electromechanical dissociation, 90A
Electrophysiologic studies
Accelerated arterial wave reflection with
dopamine but not dobutamine
incongestive heart failure, 247A
AV nodal reentry incorperating His bundle:
verapamil sensitivity in retrograde fast
pathway conduction, 173A
Comparison of electrophysiologic responses to
isoproterenol in the failing and nonfailing
heart, 180A
Delayed ventricular arrhythmias (phase IB)
resulting from midmyocardial reentry,
128A
Electrophysiologic testing in patients with
asymptomatic nonsustained ventricular
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tachycardia predicts risk of sudden death
or sustained ventricular tachycardia
within the first year but not thereafter,
19A
Mechanism and significance of cycle length
alternans during supraventricular
tachycardia, 185A
Mechanism of compensatory pause in atrial
fibrillation, 173A
New quantitative method of sinoatrial nodal
cells in sick sinus syndrome, 184A
Periodicity of transmural and epicardial
electrograms during sinus rhythm in
patients with ventricular tachycardia,
191A
Rate-dependent cellular uncoupling contributes
to the conduction changes in acute
ischemia and is prevented by verapamil,
127A
Regional electrophysiological effects of stellate
stimulation on infarcted myocardium,
128A
Relation of inducibility of ventricular
arrhythmias to symptoms in patients with
hypertrophic cardiomyopathy-relevance
of induced polymorphic ventricular
tachycardia, 19A
Role of electrophysiologic testing in patients
with asymptomatic nonsustained
ventricular tachycardia: relationship to
ventricular function and its presence or
absence of coronary artery disease, 19A
Should the induction of nonsustained
ventricular tachycardia during baseline
electrophysiologic testing constitute a
positive study?, 20A
Sustained reentrant activation orients around
arcs of abrupt functional conduction block
in the canine post-infarction heart, 128A
Emboli
Acoustic filtration of gas microemboli in blood,
212A
Deleterious effects of volume loading after
acute pulmonary emboli, 86A
Potential role of transesophageal echo in the
definition of intracardiac sources of
emboli in transient ischemic attacks, 38A
Embolization
Chronic effects of A-V nodal artery
embolization, 233A
Enalapril
Cardiovascular hormones in relation to
mortality in severe heart failure, 246A
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Influence of antihypertensive therapy on
plasma hormones in cardiac
transplantation recipients: measurements
at rest and during exercise, 81A
Encainide
Combined therapy with Type IC and type IB
agents: is it effective for ventricular
tachycardia?, 141A
Comparison of antiarrhythmic efficacy and
safety of class la, Ib, and IC agents in
symptomatic and potentially malignant
ventricular arrhythmia, 163A
Endarterectomy
Mechanical transluminal coronary
endarterectomy: initial clinical experience
with the Auth mechanical rotary catheter,
227A
Endocarditis
Prediction of risk for complications in patients
with left sided infectious endocarditis,
72A
Endothelin
Effects of endothelin, a novel vasoconstrictor
peptide, on the isolated human mesenteric
arteries, 85A
Endothelin constricts the systemic and
coronary circulations and depresses
ventricular function in vivo, 179A
Endothelin is a potent constrictor of forearm
resistance vessels and veins in man, 84A
Endothelin is a potent constrictor of human
coronary arteries in vitro, 85A
Intracoronary endothelin infusion induces
transmural myocardial ischemia in the
dog,84A
Potent pressor effects of endothelin in
spontaneously hypertensive rats and
Wistar Kyoto rats, 83A
Endothelium
Endothelial function influences the coronary
vasomotor response to sympathetic
stimulation in man, 202A
Endothelium-dependent inhibition or
ergonovine-induced contraction is
impaired in porcine coronary arteries with
regenerated endothelium, 31A
Endothelium protects against contractions
induced by histamine and serotinin in
arterial, but not in venous coronary
bypass grafts, 166A
Persistent endothelial dysfunction following
experimental angioplasty, 195A
Enoximone
Acute and chronic response to oral enoximone
in severe congestive heart failure:
sustained hemodynamic improvement and
preferential effect on right ventricular
systolic performance, lOlA
Enoximone improves maximal and submaximal
exertion in patients with chronic heart
failure: a double-blind, placebo controlled
trial,247A
Use of enoximone in cardiac transplant
candidates: effect on f3 adrenergic
receptors, 248A
Entrainment
Surface ECG and intracardiac findings with the
onset of entrainment in a pacing model of
pseudoentry ventricular tachycardia, 185A
Epinephrine
Exercise training alters catecholamine
metabolism in healthy older men, 41A
Prevention of halothane-epinephrine-induced
cardiac arrhythmias with fructose 1-6
diphosphate, 139A
Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
Ergonovine
Comparison of acetylcholine and ergonovine in
the provocation of coronary vasospasm,
132A
Endothelium-dependent inhibition or
ergonovine-induced contraction is
impaired in porcine coronary arteries with
regenerated endothelium, 31A
Ergonovine testing in cocaine induced
myocardial ischemia, 79A
Hypersensitivity of coronary arteries to
intracoronary ergonovine following
orthotopic cardiac transplantation, 188A
Esmolol
Abnormal QT/QS2 ratio at rest and exercise in
Romano-Ward long QT patients,
normalized by beta-blocker therapy, llA
Estrogen
Effect of estrogen replacement and coronary
artery disease on survival in
postmenopausal women, 12A
Exercise
Comparison of exercise protocols: evaluation
of oxygen uptake kinetics in heart failure,
242A
Excessive ventilatory responses to carbon
dioxide production during exercise in
patients with congestive heart failure,
242A
Oscillatory shifts in oxygen uptake diminish
the functional relevance of gas exchange
measurements during exercise in chronic
heart failure, 241A
Exercise testing
See also Echocardiography, exercise;
Seismocardiography
Abnormal tissue glycogen depletion patterns
during submaximal exercise in rats with a
chronic myocardial infarction and heart
failure, 40A
Comparison of effects of prolonged exercise on
the right and left ventricles, 182A
Complementary role of signal-averaged ECG
and exercise testing in predicting cardiac
events after myocardial infarction, 190A
Computer analysis reduces incidence of false
positive exercise tests in middle aged
women,126A
Detection of restenosis after elective coronary
angioplasty using the exercise treadmill
test,236A
Development of physiologic exercise heart rate
responses after cardiac transplantation,
184A
Diagnostic strategies based on clinical and
exercise variables: liberation from
Bayes's theorem?, 182A
Does ambulatory ST segment monitoring
confer added information to that of
exercise testing in the investigation of
patients with coronary artery disease-a
study of 227 patients, 34A
Effect of cold upon ischemic threshold in
patients with stable angina: magnitude
and mechanism, 184A
Effect of combined dynamic exercise and
head-out water immersion on atrial
natriuretic peptide, 41A
Effects of exercise induced ischemia on the
signal averaged electrocardiogram, 191A
Enoximone improves maximal and submaximal
exertion in patients with chronic heart
failure: a double-blind placebo controlled
trial,247A
Exercise test results predict silent ischemia on
ambulatory monitoring, 3A
Importance"of analyzing inspiratory gases
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when calculating oxygen consumption and
carbon dioxide production during
exercise. 119A
Increased exercise capacity in heart failure
patients following digoxin administration,
183A
Initial clinical experience with a dual chamber
rate modulated pacemaker, 112A
Insensitivity of thallium-201 imaging after oral
dipyridamole for detection of reversible
myocardial ischemia. 182A
Left ventricular isovolumic contraction period
vanishes during intense exercise. 102A
Patterns and determinants of exercise
performance in Fontan patients. 135A
Prognostic implications of nuclear exercise
tests in an unselected outpatient
population.97A
Reduced exercise capacity of chronic
obstructive pulmonary disease patients
exercising with noseclip/mouthpiece:
decreased right heart preload? 183A
Relation between ischemia during exercise and
ambulatory ischemic activity in coronary
artery disease, 3A
Resting and supine exercise hemodynamics
improve I and 2 years after orthotopic
cardiac transplantation, lOOA
Risk assessment after myocardial infarction
ruled out. 184A
Use of the exercise test to predict prognosis
after coronary artery bypass surgery.
183A
Exercise training
Catecholamine metabolic pathways and
exercise training: plasma and urine
catecholamines, metabolic enzymes, and
chromogranin A, 182A
Exercise training alters catecholamine
metabolism in healthy older men. 41A
Exercise training versus exercise training with
diltiazem or propranolol: effects on lipids
in men with mild hypertension, 241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
maximal oxygen uptake and exercise
duration in men with mild hypertension,
241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
resting blood pressure in men with mild
hypertension, 10M
Training level comparison study: factors
influencing exercise capacity, 183A
F-18 deoxyglucose
Significance of exercise ST-segment elevation
in patients with Qwave anterior
myocardial infarction: evaluation by
positron emission tomography. 203A
F·18 metaraminol
F-18 metaraminol uptake as marker for
neuronal function in post-ischemic canine
myocardium. 64A
Fallot's tetralogy
See Tetralogy of Fallot
Fatty acid
Impaired fatty acid metabolism in postischemic
canine myocardium: a time course study
with positron emission tomography, 63A
Membrane incorporation of unsaturated fatty
acids increased LDL metabolism by U937
monocytes, 32A
Relation of modified fatty acid uptake to wall
motion and coronary anatomy, 29A
Felodipine
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents, I04A
Fenoldopam
Neurohormonal activation limits the long-term
response to the dopamine-I receptor
agonist, fenoldopam. in chronic heart
failure, 246A
Fentanyl
Randomized controlled trial of
neuroleptanalgesia infusion in the early
treatment of acute myocardial infarction,
91A
Fibrin
Aspirin but not standard heparin prevents
thrombus deposition in rabbits treated
with tissue plasminogen activator, 77A
Fibrinylitic activity
Comparison of the effect of upright posture
and platelet aggregability and fibrinolytic
activity. 93A
Fibrinolytic therapy
See also Thrombolytic therapy
Dose response relationship of RT-PA infusion
to induction of systemic fibrin (ogen)
olysis of the NHLBI thrombolysis in
myocardial infarction (TIMI-Il) trial. 198A
Patients with ST segment deviation and
unstable angina have consistent increases
in thrombin activity, 15A
Fibrinopeptide A
Serial urinary fibrinopeptide A levels in
unstable ischemic heart disease, 238A
Fibroblast growth factors
Growth factors identified in myocardium of
patients with hypertrophic
cardiomyopathy, 118A
Fibrosis
Myocardial stiffness and reparative fibrosis
following coronary embolization in the
rat. IA
Filtration
Acoustic filtration of gas microemboli in blood.
212A
Fish oil
Absorption and effect on platelet function from
single dose concentrated fish oil compared
with tunafish. 12A
Dietary supplementation with fish oil prevents
coronary occlusion by thrombus
formation, 195A
Regression of atherosclerosis in cholesterol fed
rabbits: effects of fish oil and verapamil,
196A
Fistulae
Coronary artery to right ventricular fistulae in
heart transplant recipients: a complication
of endomyocardial biopsy, 243A
F1agyl
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Flecainide, ftecainide acetate
Combined therapy with Type IC and IB
agents: is it effective for ventricular
tachycardia?, 141A
Comparison of f1ecainide vs procainamide in
depressing retrograde conduction in
atrioventricular nodal reentry tachycardia,
165A
Effects of f1ecainide on action potential
duration of human atrial fibers, 140A
Flecainide acetate for the treatment of
postoperative atrial arrhythmias, 164A
Flecainide for heart rate control in atrial
fibrillation, I64A
Flecainide for prevention of paroxysmal atrial
fibrillation and flutter. A multicenter,
double-blind, placebo-controlled
crossover study. 164A
Intravenous f1ecainide versus intravenous
disopyramide in the reversion of atrial
fibrillation, 165A
Plasma and heart tissue levels of f1ecainide
after single versus multiple doses: is there
a rationale for intermittent use?, 144A
Safety, efficacy and predictive value of drug
termination of ventricular tachycardia,
162A
Safety and efficacy of oral f1ecainide therapy in
patients with the Wolff-Parkinson-White
syndrome,204A
Short term variability of ventricular arrhythmia
and rapid assessment of drug efficacy,
140A
Use-dependent prolongation of ventricular
tachycardia cycle length by type IA and
IC drugs, 21A
Ftosequinan
Effects of f10sequinan on metabolic and
ventilatory parameters during submaximal
exercise in cardiac failure. 181A
2·Ftuoro-2-deoxy·D glucose
Validation of a tracer analogue method for the
assessment of glucose metabolism in
isolated working rat heart, 103A
Fructose 1-6 diphosphate
Prevention of halothane-epinephrine-induced
cardiac arrhythmias with fructose 1-6
diphosphate, 139A
Furosemide
Influence of antihypertensive therapy on
plasma hormones in cardiac transplant
recipients: measurements at rest and
during exercise, 81A
Gadolinium·DTPA
Improved assessment of acute myocardial
infarction by magnetic resonance imaging
and gadolinium-DTPA. 49A
Magnetic resonance imaging in ischemic injury
following cardiac transplant in rats, 200A
Magnetic resonance imaging with
gadolinium·DTPA in man for detection of
acute myocardial infarction with occluded
and reperfused vessels. 20lA
Gene expression
Delayed switch of myosin heavy chain gene
expression in the right ventricle after
experimental infarction in the rat, 125A
Glucose
Hypoxia and glucose deprivation
independently induce uncoupling of Q,
adrenergic signal transduction in cultured
myocardial cells, 252A
Independent effects of hypoxia and glucose
deprivation on the {j-adrenoceptor-cyclase
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system in cultured neonatal rat ventricular
myocytes. 142A
Quantitative positron tomography
demonstrates accelerated glucose
utilization relative to flow in ischemic
human myocardium, 63A
Validation of a tracer analogue method for the
assessment of glucose metabolism in
isolated working rat hearts, I03A
Glutaraldehyde
Long term prevention of bioprosthetic heart
valve calcification: Al +++ pretreatment,
136A
Glutathione
Model for congestive heart failure: selenium
and vitamin E deficient mini pigs. 208A
Protective effects of glutathione on compliance
and coronary resistance, 90A
Glyburide
Effects of glyburide on ischemia-induced
changes in extracellular potassium and
local myocardial activation: a novel
antiarrhythmic mechanism, 142A
Glycogen
Abnormal tissue glycogen depletion patterns
during submaximal exercise in rats with a
chronic myocardial infarction and heart
failure, 40A
Gorlin formula
Gorlin formula for aortic valve orifice area
validated in vitro, 73A
Gorlin formula: is the traditional method of
calculating the pressure gradient
accurate?, 73A
Grafts
See also Surgery, coronary artery bypass
Comparison of the Gorlin, Cannon, Angel and
Hakki equations for the determination of
pathologic stenosis in porcine xenografts,
123A
Direct argon laser irradiation of high-grade
stenosis and total occlusions in native
human coronary arteries and bypass
grafts: initial clinical experience, 60A
Endothelium protects against contractions
induced by histamine and serotinin in
arterial, but not in venous coronary
bypass grafts, l66A
Internal mammary artery graft angioplasty:
clinical and angiographic follow-up, 22lA
Oxidative metabolism during cardiac allograft
rejection studied by NADH laser
fluorimetry, I02A
Percutaneous transluminal angioplasty of
internal mammary artery bypass grafts,
221A
Percutaneous transluminal angioplasty of left
internal mammary artery grafts using a
femoral approach, 221A
Preoperative aspirin is not necessary to
achieve improved vein graft patency after
coronary artery bypass surgery, 165A
Repair of complex congenital heart disease
with the use of valved conduit, 21lA
Stent implantation for the treatment of
coronary artery bypass graft stenosis,
I07A
Treatment of cardiac allograft rejection with
pulsed steroids: a three year experience,
210A
Granulocytes
Granulocyte activation augments
hypoxia-induced pulmonary hypertension
in vivo, 15lA
Guanine nucleotide binding proteins
Exercise alters guanine nucleotide binding
proteins, 40A
Guanine nucleotide regulatory protein
Alterations in the catalyst of adenylate cyclase
and the inhibitory guanine nucleotide
regulatory protein in experimental heart
failure, l79A
Guanosine monophosphate
Antithrombotic action of nitroglycerin: cyclic
GMP as a potential mediator, 231A
Effect of cholinergic carbachol and cyclic
guanosine monophosphate on sudden
cardiac death: protection from ventricular
fibrillation, 91A
HA-t077
New intracellular calcium antagonist, HA-1077,
an isoquinoline derivative, inhibits
quiescent bovine arterial smooth muscle
cell proliferation, 153A
Halothane
Prevention of halothane-epinephrine-induced
cardiac arrhythmias with fructose 1-6
diphosphate, l39A
Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
Heart block
Effects of different pacing modes on right atrial
pressure and atrial natriuretic peptide in
patients with atrioventricular block, 217A
Is complete heart block in inferior myocardial
infarction a benign phenomenon following
reperfusion therapy?, 26A
Heart failure
See Congestive heart failure
Helicopter transport
See Air transport
Hemodynamics
Do hemodynamics overestimate the results of
balloon mitral valvuloplasty?, 114A
Effect of inhibition of arginine vasopressin on
systemic and coronary hemodynamics,
172A
Relationship of ventriculo-arterial coupling to
neurohumoral mechanisms in heart
failure, 245A
Hemopump
See Ventricular assist device
Hemorrhage
See Bleeding
Heparin
Aspirin but not standard heparin prevents
thrombin fibrin deposition in patients
treated with tissue plasminogen activator,
77A
Coronary thrombolysis with urokinase
preactivated intravenous pro-urokinase,
193A
Dose response relationship of RT-PA infusion
to induction of systemic fibrin (ogen)
olysis in the NHLBI thrombolysis in
myocardial infarction (TlMI)-Il) trial,
198A
Effect of low dose aspirin on the incidence and
hematological activity of left ventricular
thrombosis in patients with anterior
myocardial infarction, 199A
Effects of urokinase and heparin on lesion
geometry in unstable angina, l5A
Growth factors identified in myocardium of
patients with hypertrophic
cardiomyopathy, 1I8A
Heparin protentiates the thrombolytic efficacy
of pro-urokinase, 198A
Improvement of global and regional left
ventricular function with intravenous
APSAC in acute myocardial infarction.
Results of a multicenter double blind trial,
26A
Overview of bleeding risk from the TAMI
trials: two agents are better than one,
198A
Prediction and prevention of myocardial
infarction during the acute phase of
unstable angina, 192A
Prevention of thrombosis by recombinant
hirudin during arterial angioplasty in pigs:
comparison with heparin, 77A
Reduction of infarct size by intravenous
APSAC in myocardial infarction
(multicenter randomized trial vs. heparin),
95A
Thrombin inhibition by hirudin decreases
platelet thrombus growth on arc;as of
severe vessel wall injury, 145A
Tissue plasminogen activator for unstable
angina pectoris: a multicenter,
randomized, double-blind,
placebo-controlled trial, 19lA
Hibernation
Endocardial trabeculation: a marker for
hibernating myocardium, 80A
Time course of improved function following
postinfarction angioplasty: evidence for
"hibernation" even in "infarcted"
myocardium, 25A
Hibernation induction trigger
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Hirudin
Prevention of thrombosis by recombinant
hirudin during arterial angioplasty in pigs:
comparison with heparin, 77A
Thrombin inhibition by hirudin decreases
platelet thrombus growth on areas of
severe vessel wall iQiury, 145A
His-Purkinje system
His-PurkiQie activation during ventricular
tachycardia: a determinant of QRS
duration, 21A
Histamine
Endothelium protects against contractions
induced by histamine and serotonin in
arterial, but not venous coronary bypass
grafts, 166A
Genetically-induced atherosclerosis attenuates
endothelial mediated relaxation, 32A
Ionic mechanisms underlying positive
chronotropic effects of histamine on the
rabbit atrioventricular node, l43A
Holter monitoring
See Electrocardiography, ambulatory
Hormones
Influence of antihypertensive therapy on
plasma' hormones in cardiac transplant
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recipients: measurements at rest and
during exercise, 81A
Hydralazine
Does acute pharmacologic stimulation of
stunned myocardium have chronic
deleterious effects?, 219A
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Hypercholesterolemia
Hyperlipidemic valvulopathy: aortic
regurgitation in familial
hypercholesterolemia studied by color
Doppler echocardiography, 73A
Platelet deposition in areas of stenosis is
stimulated by high plasma cholesterol
levels, l45A
Telephone-mail mediated dietary intervention
for hypercholesterolemia, 134A
Hyperconstriction
Angiographic demonstration of
hyperconstriction induced by serotonin
and aggregating platelets in porcine
coronary arteries with regenerated
endothelium,31A
Hyperkinesis
Beta adrenergic blockade blunts compensatory
hyperkinesis during acute infarction, lOOA
Hyperparathyroidism
Blood pressure, left ventricular mass and
intracellular calcium in primary
hyperparathyroidism, 82A
Hypertension
ANF blunts forearm vasoconstriction to lower
body negative pressure in essential
hypertensive patients, 83A
Atrial natriuretic peptide and elevated right
heart pressures in essential hypertension,
81A
Captopril pretreatment and myocardial fibrosis
and stiffness in renovascular
hypertension, 82A
Cardiovascular risk of hypertension in the old
old: the Bronx Longitudinal Aging Study.
37A
Cardiovascular risk reduction through worksite
health promotion, 134A
Comparison of pharmacological and
nonpharmacologic treatment of
hypertension. A randomized placebo
controlled study, I04A
Concentric remodeling of the left ventricule in
hypertensive patients with normal
ventricular mass, 245A
Concurrent compliance reduction and
increased resistance in the manifestation
of isolated systolic hypertension, 244A
Coupling of left ventricular load and
hypertrophy in hypertension, I04A
Decreased adrenergic response in hypertensive
patients without left ventricular
hypertrophy, 82A
Diastolic abnormalities in hypertension. are not
explained by LVH alone. 59A
EcholDoppler and catheterization correlated of
survival in primary pulmonary
hypertension. 151A
Exercise training versus exercise training with
diltiazem or propranolol: effects on lipids
in men with mild hypertension, 241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
maximum oxygen uptake and exercise
duration in men with mild hypertension.
241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
resting blood pressure in men with mild
hypertension. I06A
Granulocyte activation augments
hypoxia-induced pulmonary hypertension
in vivo. 15lA
High dose dipyridamole-echocardiography test
in hypertensives: correlation with
exercise-electrocardiography test and
coronary arteriography. I03A
Incidence of serious ventricular arrhythmias
during surgery in hypertensives with left
ventricular hypertrophy. 105A
Is digital vasoconstriction a marker for
reversible pulmonary vasoconstriction in
patients with pulmonary hypertension,
151A
Is lung transplantation feasible in patients with
pulmonary hypertension? 21lA
Late electrophysiologic sequelae of
experimental right ventriculotomy with
right ventricular hypertension, 170A
Left ventricular diastolic function in
pheochromocytoma: relation to plasma
catecholamines. 82A
Majority of physicians use drug therapy for
isolated systolic hypertension. 13A
Microproteinemia-an early marker for target
orgfan damage in essential hypertension.
I05A
Noninvasive assessment of arterial compliance
in patients with systemic hypertension,
244A
Potent pressor effects of endothelin in
spontaneously hypertensive rate and
Wistar Kyoto rats. 83A
Prognosis of obesity-related hypertension:
Framingham Study. I04A
Relationship between left ventricular mass
regression and improved left ventricular
filing in severe hypertension. 244A
Relationship of ventriculo-arterial coupling to
neurohumoral mechanisms in heart
failure. 245A
Spontaneous progression and regression of
concentric hypertrophy in patients with
borderline (BOH) or mild hypertension
(MIH).245A
Transient myocardial ischemia In hypertensive
coronary microangiopathy. 84A
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents. I04A
Ventricular arrhythmias in patients with
essential hypertension. I05A
Hyperthyroidism
Left ventricular systolic pressure-volume area
and oxygen consumption of hyper- and
hypothyroid rats. 87A
Hypertrophy
See also Cardiomyopathy
Are Doppler indices of diastolic filling affected
by left ventricular hypertrophy? 209A
Coronary artery disease is associated with
inadequate left ventricular hypertrophy in
aortic stenosis. 81A
Coupling of left ventricular load and
hypertrophy in hypertension, I04A
Effect of decreased afterload on Doppler
indices of left ventricular filling in
pressure overload hypertrophy, 51 A
Effects of short- and long-term hypertensive
cardiac hypertrophy on the structural
properties of the coronary resistance
vessels, 187A
Incidence of serious ventricular arrhythmias
during surgery in hypertensives with left
ventricular hypertrophy, 105A
Increased defibrillation threshold and cardiac
hypertrophy in a rapid pacing model of
congestive heart failure, 67A
Is there an improvement in coronary
vasodilator capacity after aortic valve
replacement?, 147A
Left ventricular pseudo hypertrophy in
pericardial effusion: a sign of cardiac
tamponade, 235A
Load dependence of reduced early diastolic
filling in left ventricular hypertrophy,
210A
Oxygen consumption during exercise in the
pressure-overloaded hypertrophied heart,
l87A
Reperfusion associated ventricular fibrillation:
potentiation by left ventricular
hypertrophy despite lidocaine
pretreatment, l27A
Risk of ventricular arrhythmias according to
anatomic categories of left ventricular
hypertrophy, 105A
Signal-averaged electrocardiographic
differences between patients with
non-myopathic left ventricular
hypertrophy and patients with
hypertrophic cardiomyopathy, 189A
Spontaneous progression and regression of
concentric hypertrophy in patients with
borderline (BOH) or mild hypertension.
245A
Suppression of cardiac protein degradation
contributes to progressive hypertrophy
due to aortic regurgitation, 7lA
Variability of negative T wave in left
ventricular hypertrophy. the possible
result of contraction-excitation feedback,
35A
Hypothyroidism
Left ventricular systolic pressure-volume area
and oxygen consumption of hyper- and
hypothyroid rabbits, 87A
Hypoxia
Diltiazem improves diastolic function during
hypoxia in hypertrophied rat hearts, I3IA
Independent effects of hypoxia and glucose
deprivation on the ~adrenorreceptor­
adenylate cyclase system in cultured rat
ventricular myocytes. 142A
Mechanisms of electrotonic uncoupling of
myocardium induced by hypoxia, 130A
Quinidine myocardial pharmacokinetics and
pharmacodynamics: influence of hypoxia.
138A
1-123 meta-iodobenzylguanidine
Prognosis of congestive heart failure (CHF)
evaluated by 1-123 meta-
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iodobenzylguanidine (MIBG) myocardial
imaging, 180A
125-1 iodocyanopinodol
Portrayal of cardiac beta-receptors in living
animals, 64A
Imipramine
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Immunoglobulins
Myocardial IgA deposition: a possible marker
for alcohol related myocardial disease,
254A
Indium-HI
Predictive value of In-Ill antimyosin uptake
for improvement of left ventricular wall
motion after thrombolysis in acute
myocardial infarction, 97A
Indomethacin
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Infection
See also Sepsis
Cytomegalovirus infection in cardiac transplant
recipients predicts the incidence of
allograft atherosclerosis, 213A
Predictors of deep sternal wound infections
after cardiac surgery, 122A
Inosine
Improvement of post-ischemic myocardial
metabolism and function by inosine in
3IP-MRS study, 103A
Insulin
Hibernation induction triggers extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Interleukin-2
Reversible cardiac depression caused by the
supernatant of lymphocytes cultured with
interleukin-2, 207A
Internal mammary artery
See also under Grafts
Implantation of the internal mammary artery as
a means of myocardial revascularization
in a canine model of myocardial ischemia:
a reassessment, 187A
Noninvasive evaluation of the internal
mammary artery by ultrasonic
duplex-scanning, 116A
lodamidol
Randomized trial of ionic versus non-ionic
contrast for cardiac angiography: effect on
complications and costs, 46A
lodine-I23 phenylpentadecanoic acid
Iodine-123 phenylpentadecanoic acid
tomography following dipyridamole
infusion for the detection of coronary
artery disease, 99A
Indopindolol
Enhanced beta-adrenergic receptor function in
symptomatic mitral valve prolapse, l46A
lohexol
Nephrotoxicity of nonionic contrast media:
importance of dosage in high risk
patients, 47A
Ischemia
See also Myocardial ischemia; Silent defects
Analysis of the ischemia related coronary
artery and its predictive value in unstable
angina, 238A
Assessment of ischemia during occlusion and
reperfusion using methoxy-isobutyl
isonitrile, 29A
Differences in distribution of beta-blockers in
infarcted porcine hearts. A study with
positron emission tomography (PET), 64A
Dipyridamole-induced malperfusion may not
indicate ischemic ventricular dysfunction,
126A
Discordance between radionuclide, Doppler
echo, angiographic and ambulatory
markers of ischemia, 2A
Does ambulatory ST segment monitoring
confer added information to that of
exercise testing in the investigation of
patients with coronary artery disease, 34A
Does three channel ambulatory
electrocardiographic monitoring increase
detection of ischemia?, l89A
Effect of cold upon ischemic threshold in
patients with stable angina: magnitude
and mechanism, 184A
Effects of exercise-induced ischemia in
pressure volume relations and filling
dynamics in the conscious dog, 181A
Effects of glyburide on ischemia-induced
changes in extracellular potassium and
local myocardial activation: a novel
antiarrhythmic mechanism, 142A
Improvement of post-ischemic myocardial
metabolism and function by inosine in
3IP-MRS study, 103A
Increased ventricular ectopic activity during
ischemic episodes in ambulatory patients,
33A
Independent effects of hypoxia and glucose
deprivation on the ,B-adrenoreceptor-
adenylate glycase system in cultured
neonatal rat ventricular myocytes, 142A
Ischemic threshold varies in response to
different types of exercise in patients with
chronic stable angina, 237A
Ischemic ventricular fibrillation is distinguished
by preserved histamine-stimulated adenyl
cyclase activity, 90A
Magnetic resonance imaging in ischemic injury
following cardiac transplant in rats, 200A
Post-ischemic oxygen radical production
detected by chemiluminescence varies
with duration of ischemia, 109A
Preservation of ventricular performance with
reduced ischemic dysfunction by
intravenous nisoldipine during rapid atrial
pacing,46A
Rate-dependent cellular uncoupling contributes
to the conduction changes in acute
ischemia and is prevented by verapamil,
127A
Regional diastolic mechanics of ischemic and
nonischemic areas in the pig heart, 131 A
Relation between ischemia during exercise and
ambulatory ischemic activity in coronary
artery disease, 3A
Serial urinary fibrinopeptide A levels in
unstable ischemic heart disease, 238A
Shift of the left ventricular diastolic
pressure-volume curve with ischemia:
importance of volume and the
pericardium, 207A
Time-averaged phosphorus-31 NMR
spectroscopy of the metabolic response to
hemodynamically equivalent
pacing-induced and flow-limited ischemia
in the conscious dog, 219A
Isobutyl-I-methylxanthine
Genetically-induced atherosclerosis attentuates
endothelially mediated relaxation, 32A
Isoproterenol
Autonomic influence on ventricular subsidiary
pacemakers: a study of patients post AV
nodal ablation, 232A
,B-adrenergic agonists in nonfailing, failing, and
transplanted human hearts, 143A
Comparison of electrophysiologic responses to
isoproterenol in the failing and nonfailing
heart, 180A
Decreased adrenergic response in hypertensive
patients without left ventricular
hypertrophy, 82A
Enhanced beta-adrenergic receptor function in
symptomatic mitral valve prolapse, 146A
Enhanced cardiac adrenergic response in
cardiomyopathic hamster at a
pre-congestive failure stage, 87A
Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
Isosorbide dinitrate
Effects of nitrates on coronary hemodynamics
and anginal threshold in syndrome X,
155A,201A
Newly developed nitroglycerin patch with
"phased released", 231A
Oral isosorbide dinitrite in chronic heart
failure: tolerance development to QID vs
TID regimen, 178A
Isosorbide·5-mononitrate
Evidence for antithrombotic properties of
nitrate-vasodilators in vivo but not in
vitro, 231A
Jets
Demonstration of jet entrainment-an
interaction which causes parallel jets to
merge and cross: in-vitro experiments
using color Doppler flow mapping and
optical visualization, 25A
Effect of receiving chamber compliance on the
spatial distribution of regurgitant jets as
imaged by color Doppler flow mapping:
an in-vitro study, 23A
How turbulent is a turbulent jet? An in vitro
color flow Doppler study, 22A
Profile of a regurgitant color jet is independent
of orifice shape, 23A
Validation in physiologic pulsatile flow of a
new method for noninvasive
quantification of valvular regurgitation
based on conservation of momentum, 73A
Kawasaki disease
Coronary blood flow and hemodynamics during
exercise after the coronary artery bypass
grafting with the internal mammary artery
for Kawasaki disease, 74A
Ketanserin
Ketanserin prevents acute occlusion but not
restenosis after PTCA, 44A
Ketoconazole
Cyclosporine and concomitant ketoconazole
after sardiac transplantation: intermediate
term findings and potential savings, 62A
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Labetolol
Anithypertensive therapy is improved by
central effects of arterial dilation and
reduced wave reflection. 244A
Lactate
Alterations in th.e ventilatory anaerobic
threshold after a chronic intervention
reflect changes in lactate production
during exercise in heart failure, 39A
Temporal dissociation between invasive and
non-invasive determination of anaerobic
threshold in chronic heart failure, 39A
Lasers
Arterial color flow duplex sonography of the
lower extremities before and after
excimer laser angiography. 149A
Characteristics of patients requiring epicardial
vs endocardial Nd:YAG laser
photoablation for ventricular
tachycardia-three year study, l21A
Combined laser/thermal recanalization of
peripheral artery occlusions, 13A
Comparative effects of radiofrequency and
laser ablation in normal and diseased
ventricular myocardium, 175A
Contrasting effects of continuous wave pulsed
laser irradiation on vasoreactivity of
atherosclerotic vessels in vitro. 14A
Direct argon laser irradiation of high-grade
stenosis and total occlusions in native
human coronary arteries and bypass
grafts: initial clinical experience, 60A
Early clinical experience with percutaneous
transluminal argon laser coronary
angioplasty. 61 A
Electrophysiologic effects of argon laser
irradiation during intraoperative
atrioventricular node or accessory
pathway ablation in man, 169A
Enhanced recognition of plaque composition in
vivo using laser excited fluorescence
spectroscopy. 54A
Excimer laser irradiation induces
endothelium-independent relaxation of
vascular smooth muscle. l41A
Guided percutaneous pulsed laser angioplasty:
results and follow-up. 13A
Human percutaneous laser-assisted coronary
angioplasty: efforts to reduce spasm and
thrombosis, 61A
In-vitro comparison of excimer laser and an
argon laser heated probe, 53A
In vivo photosensitizer enhanced laser
angioplasty in atherosclerotic Yucatan
miniswine, 43A
"Laser wire" for percutaneous angioplasty
complete peripheral and coronary arterial
occlusions-initial clinical results, 60A
Mechanism responsible for laser-induced
photorelaxation of vascular smooth
muscle is limited to ultraviolet and visible
wavelengths. 142A
Percutaneous coronary excimer laser
angioplasty in animals and humans. 61A
Percutaneous coronary laser balloon
angioplasty: preliminary results of a
multicenter trial. 61A
Percutaneous laser angioplasty of peripheral
atherosclerotic obstructions by the
Unicorn-Cap (Tm) probe system: a
multicenter study 14A
Late potentials
Late potentials and noise level variability
caused by bandpass versus high-pass
filtering. and type of signal-averaging
equipment. 188A
Prognostic value of late potentials in
hypertrophic cardiomyopathy. 35A
Latissimus dorsi muscle
Evidence of lattissimus dorsi muscle
adaptation before cardiomyoplasty, 214A
Leukocytes
Vascular responses to leukocyte products in
atherosclerotic primates, 2A
Leukotrienes
Coronary occlusion-reperfusion attenuated
endothelium-mediated vascular response
to leukotriene D4 and acetylcholine. 143A
Lidocaine
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents. 249A
Combination of class IA and IB antiarrhythmic
drugs markedly depresses Vmax with little
change in the action potential duration in
canine Purkinje fibers, 248A
Developmental changes in lidocaine action
occur at neutral but not acidic pH, 250A
Reperfusion associated ventricular fibrillation:
potentiation by left ventricular
hypertrophy despite lidocaine
pretreatment, 127A
Safety, efficacy and predictive value of drug
termination of ventricular tachycardia.
162A
Sequential pulse defibrillation in man: effects
of lidocaine and verapamil. 2l6A
Short term variability of ventricular arrhythmia
and rapid assessment of drug efficacy,
140A
Synergistic actions of disopyramide and
lidocaine on Vmax of action potentials in
guinea pig papillary muscles. 139A
Lipids
See also Phospholipid
Exercise training versus exercise training with
diltiazem or propranolol: effects on lipids
in men with mild hypertension. 241A
Induction by LDL of growth related
metabolism in vascular smooth muscle
cells,84A
NMR lipid imaging: a new strategy for
assessing the myocardial ischemic insult.
200A
Lipoproteins
Effects of cyclosporine on serum lipoproteins,
41A
Loading conditions
Altered left ventricular diastolic filling due to
acute right ventricular volume overload
following tricuspid valvulectomy. A
pulsed Doppler echocardiographic study,
72A
Brachial artery pressure measurements
underestimate beneficial effects of
nitroglycerin on left ventricular afterload.
231A
Coupling of left ventricular load and
hypertrophy in hypertension, 104A
Deleterious effects of volume loading after
acute pulmonary embolism, 86A
Effect of decreased afterload on Doppler
indices of left ventricular filling in
pressure overload hypertrophy. 51A
Heterogeneity of regional motion and shape in
response to altered load. lOlA
Insignificance of "load dependence" on left
ventricular relaxation and filling. 220A
Lack of inotropic effect on atrial natriuretic
factor in humans with heart failure:
demonstration by left ventricular
end-systolic-pressure volume analysis. 9A
Load dependence of reduced early diastolic
filling in left ventricular hypertrophy,
210A
Percent wall thickening is preload dependent at
low but not high levels of afterload, 2l9A
Percutaneous left atrial-femoral artery bypass
with a pulsatile pump: initial experience
in cardiogenic shock, 53A
Reduced exercise capacity of chronic
obstructive pulmonary disease patients
exercising with noseclip/mouthpiece:
decreased right heart preload. 183A
Reduction of left ventricular preload produced
by lower body negative pressure alters
Doppler transmitral filling patterns. 197A
Lung transplantation
Is lung transplantation feasible in patients with
pulmonary hypertension. 211A
Lymphocytes
Alterations in lymphocyte subsets and
catecholamines in congestive heart
failure. 180A
Diagnostic applications of lymphocyte cultures
from heart allograft biopsies. 62A
Reversible cardiac depression caused by the
supernatant of lymphocytes cultured with
interleukin-2. 207A
T lymphocyte subsets as the noninvasive
marker of hypertrophy. 88A
Mahaim fibers
Further support of the atrio-ventricular
localization of so-called "mahaim fibers."
232A
Mannitol
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Mapping procedures
Activation pattern during induction and
maintenance of ventricular tachycardia in
patients with coronary artery disease.
167A
Endocardial isochronal patterns near the
ventricular tachycardia site of origin with
orthogonal electrode catheter array. 167A
Epicardial mapping of rate-dependent
ventricular conduction slowing by
procainamide, 251 A
Fatal and non fatal recurrences after
endocardial resection: role of the
underlying etiology. 212A
Non-invasive assessment of improvement of
regional left ventricular contractility after
percutaneous transluminal coronary
angioplasty by QRST isoarea map in
patients with angina pectoris, 177A
Transmural ventricular activation during
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consecutive cycles of sustained
ventricular tachycardia, 167A
Use of gradient maps to create an electrode
configuration with a more even
defibrillation field, 66A
Marfan syndrome
Impact of medical and surgical therapy on the
cardiovascular prognosis of the Marfan
syndrome in early childhood, 119A
Media
See also Culture media
Compensatory coronary dilatation and media
thinning: adaptive responses to
progressive atherosclerosis, 196A
Media thinning of severely diseased coronary
arteries: guidelines for new interventional
procedures, 194A
Menopause
Effect of estrogen replacement and coronary
artery disease on survival in
postmenopausal women, 12A
Meperidine
Randomized controlled trial of
neuroleptanalgesia infusion in the early
treatment of acute myocardial infarction,
91A
Metabolism
Glucose metabolism in stunned reperfused
myocardium, 102A
Identification of transient regional myocardial
metabolic abnormalities in patients with
chronic stable angina using positron
emission tomography (PET), 45A
Improvement of post-ischemic myocardial
metabolism and function by inosine in
3IP-MRS study, 103A
Induction by LDL of growth related
metabolism in vascular smooth muscle
cells,84A
Oxidative metabolism during cardiac allograft
rejection studied by NADH laser
fluorimetry, 102A
Possible difference of metabolical condition in
patients with dilated cardiomyopathy and
severe coronary artery disease: evaluation
of positron emission tomography, 103A
Recovery of myocardial metabolism by PET
precedes improvement of ischemic wall
motion after PTCA, 28A
Methionine
Methionine reverses tolerance to transdermal
nitroglycerin, 230A
Methoxy-isobutyl isonitrile
Assessment of ischemia during occlusion and
reperfusion using methoxy-isobutyl
isonitrile, 29A
Metoprolol
Beta adrenergic blockade blunts compensatory
hyperkinesis during acute infarction, IOOA
Differences in distribution of beta-blockers in
infarcted porcine hearts. A study with
positron emission tomography, 64A
Effects of combined low doses of quinidine and
metoprolol on inducible ventricular
arrhythmias in a chronic canine infarct
model,248A
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents, I04A
Mexiletine
Combination of class IA and IB antiarrhythmic
drugs markedly depresses Vmax with
little change in the action potential
duration in canine Purkinje fibers, 248A
Comparison of antiarrhythmic efficacy and
safety of class lA, IB, and IC agents in
symptomatic and potentially malignant
ventricular arrhythmias, 163A
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Prodysrhythmia of O-demethyl encainide:
suppression by combination with
mexiletine, 140A
Microprocessors
Microprocessor based on ECG analyzer and
tone generator which permits immediate
recognition and categorization of ectopic
rhythms by sound, 188A
Microproteinemia
Microproteinemia-an early marker for target
organ damage in essential hypertension,
105A
Mitochondrial function
Post-hypoperfusion reperfusion: orchestrated
recovery from myocardial supply/demand
imbalance maximizes heart function, 90A
Mitral valve area
Gorlin formula: is the traditional method of
calculating the pressure gradient
accurate?, 73A
Systemic errors in the Doppler pressure
half-time formula for mitral orifice area,
234A
Mitral valve disease
See also Stenosis
Comparison of long-term hemodynamic
evaluation between percutaneous mitral
valvuloplasty and mitral valvular
replacement for severe mitral stenosis,
19A
Direct imaging of the papillary muscles during
ischemia: implications for ischemic mitral
regurgitation, 156A
Does myocardial involvement in children with
severe mitral regurgitation (MR) due to
active rheumatic carditis (ARC) influence
the outcome of mitral valve replacement
(MVR)?, l46A
Enhanced beta-adrenergic receptor function in
symptomatic mitral valve prolapse, l46A
Features of severe mitral regurgitation
following percutaneous balloon
commissurotomy, 55A
New three-dimensional echocardiographic
method for quantitating mitral valve
prolapse, 227A
Pathogenesis of systolic anterior motion of the
mitral valve-can the papillary-mitral
apparatus playa primary role clinically?,
88A
Percutaneous mitral valvotomy using the
double balloon technique: determinant
factors of mitral regurgitation, 69A
Prevalence and direction of mitral regurgitation
in hypertrophic cardiomyopathy, 89A
Right and left ventricular response early and
late after surgical relief of mitral
regurgitation, 71A
Serial assessment of mitral regurgitation in
patients undergoing aortic valvuloplasty,
50A
Six month follow-up of mitral balloon
valvuloplasty, 17A
Surgical fate of mitral regurgitation associated
with severe aortic stenosis: an
intraoperative echo study, 72A
Transthoracic versus transesophageal
two-dimensional echo/Doppler flow
imaging in surgical patients with mitral
regurgitation, 68A
Two to five year echocardiographic follow-up
of patients with mitral valve prolapse: is
apical four-chamber view displacement a
precursor of abnormality?, 226A
Utility of left ventricular elastance for
predicting surgical outcome in patients
with mitral regurgitation, 71A
Variability in mitral regurgitant jet area size
during systole and its relation to mitral
regurgitation severity, 50A
Molsidomine
Evidence for antithrombotic properties of
nitrate-vasodilators in vivo but not in
vitro, 231A
Morphologic studies
Quantitative analysis of coronary artery
morphology using intracoronary high
frequency ultrasound: validation by
histology and quantitative coronary
arteriography, 228A
Murmur
Cystic medical necrosis of the aorta: natural
history and long-term follow-up, l22A
Myocardial disease
See also specific disease
Myocardial IgA deposition: a possible marker
for alcohol related myocardial disease,
254A
Myocardial energetics
Myocardial metabolic to mechanical energy
transfer characteristics from single vena
caval occlusions in conscious dogs, 87A
Myocardial factor
Evidence against a "myocardial factor" in
rheumatic mitral stenosis, 147A
Myocardial function
Depressed myocardial function and ventricular
wall stress in neural crest ablated chick
embryos, 1I8A
Preservation of myocardial function and
topography by late reperfusion and
long-acting superoxide dismutase therapy,
109A
Preservation of myocardial function by a
coronary perfusion catheter, 52A
Recovery of regional myocardial function after
successful coronary angioplasty early
after a non-Q-wave myocardial infarction,
7A
Superoxide dismutase (SOD) prevents
reperfusion-induced deterioration in
coronary vasodilator reserve (CVR) and
regional myocardial function, 1I0A
Myocardial hibernation
See Hibernation
Myocardial infarction
See also Coronary occlusion
Abnormal Doppler left ventricular filling
following acute myocardial infarction and
changes during early recovery, 157A
Acute outcome <ll1d long term follow-up of
patients 'with acute myocardial infarction
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and single vessel disease treated with
angioplasty without thrombolytic therapy,
94A
Age-related risk factors and mechanism of
death following myocardial infarction.
Experience from the multicenter diltiazem
postinfarction trial, 27A
Assessing infarct expansion in an
echocardiographic wall motion index
improves prediction of outcome after
myocardial infarction, 27A
Atrial natriuretic factor in patients with right
ventricular infarction, 93A
Bimodal time course of collateral development
in acute myocardial infarction, 45A
Chronic reduction of left ventricular volumes
at rest and exercise in patients treated
with nitroglycerin following anterior MI,
25A
Climatologic variables and acute myocardial
infarction: a time course study, 133A
Coffee use and acute myocardial infarction,
36A
Coronary anatomy preceding non-Q wave
myocardial infarction, 6A
Delayed switch of myosin heavy chain
expression in the right ventricle after
experimental infarction in the rat, 125A
Early intervention with low dose aspirin in first
acute transmural myocardial infarction:
infarct size, clinical outcome and
follow-up,27A
Economic advantage of a conservative strategy
for AMI management: rt-PA without
obligatory PTCA, 152A
Effect of thrombolysis on late potentials
incidence after acute myocardial
infarction, 178A
Evaluation of ventricular septal defect
complicating acute myocardial infarction:
identification, localization and
differentiation from mitral regurgitation by
color Doppler flow imaging, 209A
Fate of acute myocardial infarction patients
with successful mechanical (rescue) vs.
chemical patency of the infarct vessel at
emergency catheterization, 192A
Favorable effect of diltiazem on late mortality
and reinfarction after non-Q wave
myocardial infarction: Multicenter
Diltiazem Post-Infarction Trial (MDPITl,
6A
Functional left ventricular aneurysm after
anterior Q-wave myocardial infarction:
incidence, contributing factors and natural
history, 45A
Improved assessment of acute myocardial
infarction by magnetic resonance imaging
and gadolinium-DTPA, 49A
Improvement in left ventricular ejection
fraction during the first post-infarction
year in patients with inferior and non-Q
wave infarcts, 8lA
Increased morning incidence of myocardial
infarction: experience in the ISIS-2 trial,
l33A
Is complete heart block in inferior infarction a
benign phenomenon following reperfusion
therapy?, 26A
Lack of association between early
administration of thrombolytic therapy
and the development of non-Q wave
myocardial infarction, 6A
Long term characterization of left ventricular
diastolic collapse dynamics post
infarction, 48A
Long-term (4 year) follow-up after
percutaneous transluminal coronary
angioplasty during acute myocardial
infarction, 94A
Mechanism of myocardial infarction in patients
with prior coronary bypass surgery:
therapeutic implications, 93A
Morphometric mapping of regional differences
in myocyte diameters after healing of
myocardial infarction, l25A
Myocardial infarction complicating elective
coronary bypass surgery, 166A
Myocardial infarction with minimal coronary
atherosclerosis: a syndrome of young
women with guarded long term prognosis,
27A
Natural history of left ventricular function
changes after myocardial infarction, 25A
Non-invasive determination of cardiac output
during acute myocardial infarction using
electrical bioimpedence cardiography,
102A
Non-invasive identification of viable versus
infarcted myocardium by automated
three-dimensional cardiac positron
emission tomography with generator
produced rubidiium-82, 29A
Nuclear magnetic imaging with
gadolinium-DTPA in man for detection of
acute myocardial infarction with occluded
and reperfused vessels, 20lA
Observer variability in T!MI flow grading:
comparison to a new computer method
for measurement of reperfusion kinetics,
91A
Prediction and prevention of myocardial
infarction during the acute phase of
unstable angina, I92A
Prehospital thrombolytic therapy-MIT!
project report on phase I: feasibility,
characteristics of patients, 152A
Prior beta blocker therapy improves 28 day
post infarction survival. 12A
Prognostic significance of first myocardial
infarction type (Q-wave vs non Q-wave),
5A
Randomized controlled trial of
neuroleptanalgesia infusion in the early
treatment of acute myocardial infarction,
91A
Recent exposure to cigarette smoke increases
myocardial infarct size, 124A
Reduction of infarct size by intravenous
APSAC in myocardial infarction
(multicenter randomized trial vs heparin),
95A
Regional electrophysiological effects of stellate
stimulation on infarcted myocardium,
128A
Reproducibility of the signal-averaged ECG in
the acute phase of myocardial infarction
and at long term follow-up, I90A
Reverse redistribution following myocardial
infarction is related to severity of
coronary stenosis, 99A
Risk factors for coronary mortality in elderly
survivors of myocardial infarction: the
Framingham study, 37A
Risk of death after nonfatal myocardial
infarction in the VA cooperative study of
coronary artery bypass surgery, 166A
Role of electrocardiographic location on
diltiazem treatment effect in non-Q wave
myocardial infarction: Multicenter
Diltiazem Post-Infarction Trial (MDPIT),
6A
Selective neurohumoral activation in the
recovery phase of anterior myocardial
infarction in man, 92A
Significance of exercise-induced ST segment
elevation in patients with Q wave anterior
myocardial infarction: evaluation by
positron emission tomography, 203A
Thrombolysis-induced limitation of infarct size
in relation to time of pain onset and
infarct localization: results from the
I.S.A.M. study, 95A
Thrombolytic therapy in unstable angina and
non Q wave myocardial infarction: a
randomized trial of urokinase versus
aspirin, 15A
Time course of reperfusion induced reversal of
early myocardial expansion, I09A
Time of onset of acute myocardial infarction
(AMI) after awakening, 133A
Two-dimensional echocardiography can reduce
hospital admissions for acute myocardial
infarction by more than one-third: results
of a prospective study performed in the
emergency room, l59A
Two-year post-discharge survival after
emergency coronary angioplasty for
myocardial infarction: importance of the
timing and success of angioplasty, 193A
Myocardial ischemia
Chronic amiodarone administration protects
against global myocardial ischemia in the
rat, 250A
Clinical application of ultrasonic backscatter in
transesophageal echo to detect ischemic
myocardium, 226A
Direct administration of recombinant
superoxide dismutase significantly
preserves myocardial function and
mitochondrial structures after 30 minutes
normothermic global ischemia, 63A
Early histopathology of reperfusion therapy for
myocardial ischemia: study of 29
autopsied cases, 193A
Ergonovine testing in cocaine induced
myocardial ischemia, 79A
Experience with the intracoronary Doppler
catheter in patients with clinical ischemic
heart disease but normal or trivially
diseased coronaries, 161A
Extent of jeopardized myocardium: importance
of location, severity and extent of
coronary stenosis, 44A
F-18 metaraminol uptake as marker for
neuronal function in post-ischemic canine
myocardium, 64A
Histological evidence of coronary
atherosclerosis as a cause of myocardial
ischemia in patients with normal coronary
arteriograms, 150A
Identification of transient regional myocardial
metabolic abnormalities in patients with
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chronic stable angina using positron
emission tomography (PETl. 45A
Impaired fatty acid metabolism in postischemic
canine myocardium: a time course with
positron emission tomography. 63A
Insensitivity of thallium 201 imaging after oral
dipyridamole for detection of reversible
myocardial ischemia. 182A
Intracoronary endothelium infusion induces
transmural myocardial ischemia in the
dog.84A
Long-term follow-up and variability of markers
of myocardial ischemia in syndrome X.
150A
Modification of myocardial ischemia and
dysfunction by nifedipine and
nitroglycerin during coronary occlusion.
154A
Neutrophil function in ischemic heart disease.
44A
Oxidation of sultbydryl groups of serum
albumin in coronary artery diseases. 44A
Painless myocardial ischemia in diabetic
patients with coronary artery disease. 4A
Quantitation of critically ischemic myocardial
mass during acute coronary occlusion in
vivo: measurement with positron emission
tomography. 64A
Quantitative positron tomography
demonstrates accelerated glucose
utilization relative to flow in ischemic
human myocardium. 63A
Rand S wave amplitude changes with acute
transmural ischemia. lOB
Sarcolemmal phospholipid turnover: a critical
mediator of myocardial injury. 252A
Simultaneous cardiac mechanics and
myocardial phosphorus-3l NMR
energetics during global ischemia &
reperfusion in the closed-chest conscious
dog.200A
Systolic shortening determines diastolic
distensibility of ischemic myocardium
during pacing induced angina and
transluminal coronary occlusion. 80A
Therapy of painful and painless ischemia in 348
patients: results of the nifedipine total
ischemia awareness program. 3A
Transient myocardial ischemia in hypertensive
coronary microangiopathy. 84A
Transmurally localized 31 MRS: metabolic
heterogeneity during regional ischemia.
199A
Myocardial metabolism
See Metabolism
Myocardial relaxation
See Relaxation
Myocardial rupture
Myocardial rupture complicating tissue
plasminogen activator therapy of acute
myocardial infarction. 94A
Myocardial salvage
Assessment of myocardial viability with
technetium-99m 2-methoxy isobutyl
isonitrile (MIBl) and gated tomography in
patients with coronary artery disease. 3lA
Early post-thrombolysis assessment of necrosis
and viability with rest-redistribution
thallium scintigraphy: correlation with
positron emission tomography (PETl. 28A
Increase in myocardial salvage by combining
coronary sinus occlusion and
retroperfusion. 53A
Non-invasive identification of viable versus
infarcted myocardium by automated
three-dimensional cardiac positron
emission tomography with generator
produced rubidium-82. 29A
Myocarditis
Cyclosporine in aviremic coxsackievirus B3
myocarditis in mice. 254A
Insensitivity of right ventricular
endomyocardial biopsy in the diagnosis of
myocarditis: whither the gold standard?
253A
Porcine model of myocarditis leading to dilated
cardiomyopathy. 253A
Sharing of antigenic determinants between
coxsackie B3 virus and autoantigens in
viral myocarditis and dilative
cardiomyopathy. 253A
Myocardium, immature
Electrophysiologic and histopathologic
comparison between apical and
transepicardial septal ventricular pacing in
the immature canine myocardium:
evaluation of a new method. llOA
Myocardium, stilI
Myocardial stiffness and reparative fibrosis
following coronary embolization. lA
Myocardium, stunned
Demonstration of viable myocardium after an
acute infarction submitted to
thrombolysis: comparison between
positron emission tomography and
dobutamine echocardiography. 192A
Does acute pharmacologic stimulation of
stunned myocardium have chronic
deleterious effects? 219A
Effect of a-tocopherol (vitamin El on regional
function in stunned myocardium. l44A
Glucose metabolism in stunned reperfused
myocardium. I02A
Stunned myocardium: a form fruste of
electromechanical dissociation. 90A
Stunned myocardium: evidence that diastolic
ventricular dysfunction persists after
resolution of systolic dysfunction-
experimental Doppler echocardiographic
studies. 197A
Myocytes
Morphometric mapping of regional differences
in myocyte diameters after healing of
myocardial infarction. l25A
Relationship between stimulation threshold
variability of isolated cardiomyocytes and
separated defibrillation shocks delivered
in orthogonal directions. 177A
Myosin heavy chain
Delayed switch of myosin heavy chain gene
expression in the right ventricle after
experimental infarction in the rat. l25A
Myosin light chains
Biphasic release of myosin light chains in
patients with successful thrombolysis in
acute myocardial infarction. 95A
Myotonic dystrophy
Prevalence of cardiac abnormalities in a large
kindred with myotonic dystrophy. 89A
N-acetylcysteine
N-acetylcysteine potentiates IV nitroglycerin in
inhibiting periodic platelet thrombus
formation in stenosed dog coronary
arteries. 145A
Necrosis
Cystic medial necrosis of the aorta: natural
history and long-term follow-up. l22A
Neural crest
Noncardiac defects associated with
conotruncal abnormalities-further
implications of neural crest influence.
ll8A
Neurohumoral activation
Selective neurohumoral activation in the
recovery phase of anterior myocardial
infarction in man. 92A
Neuroleptanalgesia
Randomized controlled trial of
neuroleptanalgesia infusion in the early
treatment of acute myocardial infarction.
9lA
Neuronal function
F-18 metaraminol uptake as marker for
neuronal function in post-ischemic canine
myocardium. 64A
Neutrophil function
Neutrophil function in ischemic heart disease.
44A
Nicardipine
Negative inotropic effect of nicardipine in
patients with heart failure: den1onstration
by left ventricular end-systolic
pressure-volume analysis. 178A
Nifedipine
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade. 78A
Coronary spasm induced by stent implantation.
194A
Effects of low dose nifedipine administrated
through the coronary sinus in ischemic
heart disease. 153A
Improvement of relaxation velocity by calcium
blocker in aging rabbit myocardium. 57A
Modification of myocardial ischemia and
dysfunction by nifedipine and
nitroglycerin during coronary occlusion.
154A
Nifedipine does not alter the venodilatory
response to nitroglycerine. 154A
Nifedipine in unstable angina: beneficial effects
in the elderly and in patients with reduced
left ventricular function. 239A
Therapy of painful and painless myocardial
ischemia in 348 patients: results of the
nifedipine total ischemia awareness
program.3A
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents. 104A
Nisoldipine
Improvement of relaxation velocity by calcium
blocker in aging rabbit myocardium. 57A
Preservation of ventricular performance with
reduced ischemic dysfunction by
ventricular nisoldipine during rapid atrial
pacing.46A
Nitrates
Evidence for antithromnbotic properties of
nitrate-vasodilators in vivo but not in
vitro. 231A
Myocardial iJlfa'rction with minimal coronary
atherosclerosis: a syndrome of young
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women with guarded long term prognosis,
27A
Nifedipine in unstable angina: beneficial effects
in the elderly and in patients with reduced
left ventricular function, 239A
Nitric oxide
Evidence for antithrombotic properties of
nitrate-vasodilators in vivo but not in
vitro, 231A
Preserved flow-mediated vasodilation despite
acetylcholine-induced vasoconstriction in
atherosclerotic coronary arteries in man,
132A
Nitrogen·13 ammonia
Nitrogen-13 ammonia myocardial uptake at
rest with exercise in normal volunteers:
quantification of coronary flow with
dynamic positron emission tomography,
97A
Significance of exercise-induced ST-segment
elevation in patients with Q wave anterior
myocardial infarction: evaluation by
positron emission tomography, 203A
Nitroglycerin
Antithrombotic action of nitroglycerin: cyclic
GMP as a potential mediator, 231A
Antithrombotic therapy: is the combination of
aspirin and nitroglycerin beneficial?, 145A
Biphasic response of coronary blood flow to
intracoronary nitroglycerin in normal
subjects, 230A
Brachial artery pressure measurements
underestimate beneficial effects of
nitroglycerin on left ventricular overload,
231A
Chronic reduction of left ventricular volumes
at rest and exercise in patients treated
with nitroglycerin following anterior MI,
25A
Coronary spasm induced by stent implantation,
194A
Intravenous nitroglycerin prevents coronary
artery vasoconstriction after PICA, 59A
Methionine reversed tolerance to transdermal
nitroglycerin, 230A
Modification of myocardial ischemia and
dysfunction by nifedipine and
nitroglycerin curing coronary occlusion,
154A
N-acetylcysteine potentiates IV nitroglycerin in
inhibiting periodic platelet thrombus
formation in stenosed dog coronary
arteries, 145A
Newly developed nitroglycerin patch with
'phased release,' 23lA
Nifedipine does not alter the venodilatory
response to nitroglycerin, l54A
Nitroprusside
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Evidence for antithrombotic properties of
nitrate-vasodilators in vivo but not in
vitro, 23lA
Persistent endothelial dysfunction following
experimental angioplasty, 195A
Response to nitroprusside-predictor of early
post transplant mortality, 62A
Noradrenaline
Cardiovascular hormones in relation to
mortality in severe heart failure, 246A
Genetically-induced atherosclerosis attenuates
endothelially mediated relaxation, 32A
Norepinephrine
Differences in neurohumoral activation in
patients with left ventricular dysfunction
with and without heart failure, 246A
Exercise training alters catecholamine
metabolism in healthy older men, 4lA
F-18 metaraminol uptake as marker for
neuronal function in post-ischemic canine
myocardium, 64A
Independent effects of hypoxia and glucose
deprivation on the /3-adrenoreceptor-
adenylate cyclase system in cultured
neonatal rat ventricular myocytes, l42A
Persistent endothelial dysfunction following
experimental angioplasty, 195A
Nuclear magnetic resonance imaging
See also Spectroscopy
Detection of myocardial hemorrhage using IH
NMR imaging at I.5T, 48A
Evaluation of aortic regurgitation by cine
magnetic resonance imaging comparing
cineangiography, 20lA
Improved assessment of acute myocardial
infarction by magnetic resonance imaging
and gadolinium DTPA, 49A
Magnetic resonance imaging in ischemic injury
following cardiac transplantation, 200A
Magnetic resonance imaging with
gadolinium-DTPA in man for detection of
acute myocardial infarction with occluded
and reperfused vessels, 20lA
NMR lipid imaging: a new strategy for
assessing the myocardial ischemic insult,
200A
Simultaneous cardiac mechanics and
myocardial phosphorus-31 NMR
energetics during global ischemia &
reperfusion in the closed-chest conscious
dog,200A
O·demethyl encainide
Prodysrhythmia of O-demethyl encainide:
suppression by combination with
mexiletine, 140A
Obesity
Prognosis of obesity-related hypertension:
Framingham Study, I04A
OKT3
Prophylactic anti-rejection therapy early after
cardiac transplantation, 62A
Ouabain
Lack of correlation of ouabain binding sites
and inotropic response to digitalis in
experimental heart failure, 248A
Oxfenicine
Glucose metabolism in stunned reperfused
myocardium, I02A
Oxygen consumption
Importance of analyzing inspiratory gases
when calculating oxygen consumption and
carbon dioxide production during
exercise, 119A
In vivo assessment of the independent effects
of heart rate, contractility and systolic
loading conditions on myocardial oxygen
consumption, lOlA
Left ventricular systolic pressure-volume area
and oxygen consumption of hyper-and
hypothyroid rabbits, 87A
Oxygen consumption during exercise in the
pressure-overloaded hypertrophied heart,
187A
Oxygen radical
Detection of hydroxyl radicals in the
reperfused isolated monkey heart, llOA
Post-ischemic oxygen radical production
detected by chemiluminescence varies
with duration of ischemia, 109A
Oxygen saturation
Acute clinical testing and follow-up of a
rate-variable pacemaker controlled by
central venous oxygen saturation, 112A
Oxygen uptake
Comparison of exercise protocols: evaluation
of oxygen uptake kinetics in heart failure,
242A
Oscillatory shifts in oxygen uptake diminish
the functional relevance of gas exchange
measurements during exercise in chronic
heart failure, 241A
Oxygenation
In vivo near infrared monitoring of myocardial
oxygenation during ischemia and
reperfusion, 251A
Oxygenators
Cardiac resuscitation by extracorporeal pump
oxygenator (ECPO) after failure of
precordial compression, 220A
Pacemaker
Acute clinical testing and follow-up of a
rate-variable pacemaker controlled by
central venous oxygen saturation, 112A
Autonomic influence on ventricular subsidiary
pacemakers: a study of patients post AV
nodal ablation, 232A
Double blind cross-over study on the
symptomatology and quality of life in
patients with rate responsive pacemakers,
I13A
Impaired activity rate responsiveness of atrial
Actrivitax II pacemakers, 215A
Initial clinical experience with a dual chamber
rate modulation pacemaker, 112A
Initial experience with automatic slope settings
for Meta MV and Rhythmyx rate
responsive pacemakers, 113A
Investigation of a new activity sensing rate
responsive dual chamber pacemaker,
I12A
Pacemaker/implantable defibrillator
interactions: are they of clinical
importance?,66A
Response of rate-adaptive pacemakers to
physiological stimuli other than isotonic
exercise: comparison of six different
sensors, 215A
Unique upper rate behaviors in dual chamber.
rate modulated pacemakers, II3A
Pacemaker syndrome
Pacemaker syndrome is associated with very
high plasma concentrations of atrial
natriuretic peptide (ANP), IlIA
Pacing
Effect of atrial contraction and synchroneity of
cardiac contraction on ventriculo-arterial
coupling, 206A
Effect of cardiac pacing mode on the long-term
development of atrial fibrillation, 217A
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Effects of different pacing modes on right atrial
pressure and atrial natriuretic peptide in
patients with atrioventricular block. 217A
Electrophysiologic and histopathologic
comparison between apical and
transepicardial septal ventricular pacing in
the immature canine myocardium:
evaluation of a new method. llOA
Is atrial activation beneficial in heart transplant
recipients? lIlA
Prohormone atrial natriuretic peptides 1-30.
31-67. and 99-126 increase in proportion
to right ventricular pacing rate, 217A
Spontaneous changes in ventricular
tachycardia cycle length: relevance to
antitachycardia device development. IliA
Palmitate oxidation
Mechanical function and palmitate oxidation in
the neonatal piglet heart during
normothermic ischemia and reperfusion.
1I9A
Papaverin
Preserved flow-mediated vasodilation despite
acetylcholine-induced vasoconstriction in
atherosclerotic coronary arteries in man.
132A
Papillary muscle
Direct tracing of the papillary muscle during
ischemia: implications for ischemic mitral
regurgitation. 156A
Parasympathectomy
"Up-regulation" of GTP binding proteins
following cardiac parasympathectomy-
quantitation by immunoblot method. 143A
Parasympathetic cardiac control
Chronic impairment of parasympathetic cardiac
control in heavy smokers. 36A
Pediatric cardiology
See also Congenital heart defects: specific
disease; Surgery. pediatric
Cardiopulmonary exercise response in
adolescents following cardiac
transplantation. 135A
Characterization of the phasic responses of the
neonatal sinus and atrioventricular node
to brief vagal stimulation. 138A
Does myocardial involvement in children with
severe mitra! regurgitation (MR) due to
active rheumatic carditis (ARC) influence
the outcome of mitral valve replacement
(MVR)? 146A
Early experience with pulmonary autograft use
for aortic valve replacement in pediatric
patients. 120A
Effects of position and exercise on the QT
interval in children, 171A
Evidence of enhanced contractility in normal
infants compared to older children and
adults. 135A
Experimental animal investigations of the
potential for new approaches to diagnostic
cardiac imaging in infants and small
premature infants from intracardiac and
transesophageal approaches using a
20MHz real time ultrasound imaging
catheter. 137A
Family history predictors of high blood
cholesterol levels in 4th grade school
children. 36A
Fate of the neoaortic valve after arterial repair
of transposition of the great arteries, 240A
Ischemic time and graft function in human
infant cardiac transplantation, 120A
Linear growth in pediatric cardiac transplant
patients, l34A
Long-term follow-up of amiodarone in the
young: continued efficacy. unimpaired
growth. moderate side effects. 171A
Mechanical function and palmitate oxidation in
the neonatal piglet heart during
normothermic ischemia and reperfusion.
119A
Modulation of the fetal left ventricular function
curve by thoracic tissue. 136A
Noncardiac defects associated with
conotruncal abnormalities-further
implications of neural crest influence.
lISA
Noninvasive discrimination of right atrial
ectopic from sinus tachycardia in dilated
"cardiomyopathic" hearts, 137A
Poor prognosis for fetuses with prenatally
diagnosed tricuspid valve abnormalities.
205A
Postnatal developmental changes in myocardial
mitochondrial calcium transport. 137A
Remodeling of the aorta following successful
balloon coarctation angioplasty. 240A
Respiratory influence on RV and LV diastolic
filling in normal children. 205A
Time course of pulmonary arterial pressure
change in the early postnatal period-
noninvasive color Doppler and continuous
wave Doppler echocardiographic study.
225A
Transcatheter umbrella closure of atrial
defects. 120A
Use of balloon-expandable stents to treat
experimental peripheral pulmonary artery
and superior vena caval stenosis:
preliminary experience. 119A
Validation of Doppler echocardiographic
calculation of descending aortic umbilical
flow in fetal lambs. 137A
Ventricular septal defect with aortic
regurgitation: a 35 year experience. 121A
Ventricular volume and function in infant
orthotopic heart transplantation. 239A
Penicillin
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation. 63A
Pericardial abnormalities
Diagnosis of pericardial abnormalities by
two-dimensional echo: a pathology-echo
correlation in 85 patients. 235A
Pericardia! effusion
Effect of pericardial effusion on energy
requirements for defibrillation using
extrapericardial patch electrodes. 112A
Effectiveness of pericardioscopy for etiological
diagnosis in 18 patients with suspected
malignant pericardial effusion. 235A
Left ventricular pseudo hypertrophy in
pericardial effusion: a sign of cardiac
tamponade. 235A
Pericardial sac
Geometric view of cardiac "efficiency." 86A
Pericardioscopy
Effectiveness of pericardioscopy for etiological
diagnosis in 18 patients with suspected
malignant pericardial effusion, 235A
Pericarditis
Pericarditis in the face of thrombolytic
intervention denotes severe myocardial
damage. 236A
Pericardium
Influence of the pericardium on dynamic right
and left ventricular filling. 207A
Regional deformation of the pericardium during
the cardiac cycle. 219A
Peripheral vascular disease
Treatment of peripheral vascular disease with
the transluminal extraction catheter:
results of a multicenter study, 227A
pH
Developmental changes in lidocaine action
occur at neutral but not acidic pH. 250A
Phenoxybenzamine
Reduced myocardial blood flow with persistent
vasodilator reserve: role of adrenergic
activation, 187A
Phentolamine
Cocaine-induced contraction of vascular
smooth muscle in inhibited by calcium
channel blockade, 78A
Phenylephrine
Enhanced cardiac adrenergic response in
cardiomyopathic hamster at a
pre-congestive failure stage. 87A
Increased contractility induced by alpha
adrenergic stimulation in septic rat hearts.
144A
Role of a-adrenergic receptors in syndrome X,
150A
Pheochromocytoma
Left ventricular diastolic function in
pheochromocytoma: relation to plasma
catecholamines. 82A
Phosphates
Simultaneous cardiac mechanics and
myocardial phosphorus-31 NMR
energetics during global ischemia &
reperfusion in the closed-chest conscious
dog.200A
Time-averaged phosphorus-31 NMR
spectroscopy of the metabolic response to
hemodynamically equivalent
pacing-induced and flow-limited ischemia
in the conscious dog. 219A
Phosphatidylinositol
Hypoxia and glucose deprivation
independently induce uncoupling of
a)-adrenergic signal transduction in
cultured myocardial cells. 252A
Phosphoinositide
Enhanced phosphoinositide metabolism during
reperfusion of ischemic rat heart: a novel
mechanism ofreperfusion injury. 252A
Phospholipid
Sarcolemmal phospholipid turnover: a critical
mediator of myocardial injury. 252A
Plaque
Enhanced recognition of plaque composition in
vivo using laser excited fluorescence
~ spectroscopy, 54A
Plasminogen activator, tissue
Antiplatelet antibody [7E3 F(ab)] prevents
rethrombosis after tissue-type
plasminogen activator induced coronary
artery thrombolysis in a canine model,
32A '
Aspirin but riot standard heparin prevents
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thrombus deposition in rabbits treated
with tissue plasminogen activator. 77A
Bleeding complications after double-chain tPA:
influence of dose and duration of infusion,
77A
Comparison of the effect of upright posture
and exercise on platelet aggregability and
fibrinolytic activity, 93A
Determinants of improved global left
ventricular function after tPA and
deferred PTCA for acute MI, 92A
Dose response relationship of rt-PA infusion to
induction of systemic fibrin (ogen) olysis
in the NHLBI thrombolysis in myocardial
infarction (TIMI-II) trial, 198A
Echocardiographic evaluation of segmental
wall motion early and late after
thrombolytic therapy in acute myocardial
infarction. l56A
Economic advantage of a conservative strategy
for AMI management: rt-PA without
obligatory PTCA, 152A
Effect of the length of tissue plasminogen
activator administration on lysis of fresh
and old thrombi, 78A
Effect ofTPA on myocardial cells. the
no-reflow phenomenon and
intramyocardial hemorrhage, l24A
Is delivery of rt-PA by helicopter transport
teams safe and time-effective?, 192A
Lack of association between early
administration of thrombolytic therapy
and the development of non-Q wave
myocardial infarction, 6A
Myocardial infarction with minimal coronary
atherosclerosis: a syndrome of young
women with guarded long term prognosis,
27A
Myocardial rupture complicating tissue
plasminogen activator therapy of acute
myocardial infarction, 94A
No difference in long term ventricular function
after streptokinase and tissue plasminogen
activator therapy in acute myocardial
infarction, %A
Pericarditis in the face of thrombolytic
intervention denotes severe myocardial
damage, 236A
Prehospital thrombolytic therapy-mini project
report on Phase I: feasibility,
characteristics of patients, 152A
Risk factors for hemorrhagic and ischemic
stroke in myocardial infarct patients
treated with tissue plasminogen activator.
153A
rtPA versus rtPA plus PTCA in acute
myocardial infarction: quantitative results
of early and late coronary arteriography.
54A
Selective inhibition of a2-antiplasmin augments
the potency and specificity of
plasminogen activators, 2A
TIMI II a new study of PTCA timing after
rt-PA thrombolysis for acute myocardial
infarction (AMI), 194A
Tissue plasminogen activator for unstable
angina pectoris: a multicenter,
randomized. double-blind,
placebo-controlled trial, 191A
Western Washington tissue plasminogen
activator emergency room study, 94A
Plasminogen activator inhibitor
Platelet plasminogen activator inhibitor:
purification and characterization of
interaction with plasminogen activators
and activated Protein C. IA
Platelet(s)
Angiographic demonstration of
hyperconstriction induced by serotonin
and aggregating platelets in porcine
coronary arteries with regenerated
endothelium,3lA
Platelet-activating factor
Cardiovascular effects of platelet-activating
factor in conscious dogs, l44A
Platelet aggregation
Comparison of the effect of upright posture
and exercise on platelet aggregability and
fibrinolytic activity, 93A
Progression of coronary atherosclerosis and
enhanced thrombin·induced platelet
aggregability, 42A
Treatment of hypertension alters the
relationship between platelet calcium and
sensitivity to aggregatory agents, I04A
Platelet deposition
Platelet deposition in areas of stenosis is
stimulated by high plasma cholesterol
levels, 145A
Platelet function
Absorption and effect on platelet function from
single dose concentrated fish oil compared
with tunafish, l2A
Pleural elJusion
Pleural effusion as a cause of right ventricular
diastolic collapse and cardiac tamponade,
236A
Posture
Effects of upright posture on atrioventricular
accessory pathway conduction, 205A
Potassium
Effects of glyburide on ischemia-induced
changes in extracellular potassium and
local myocardial activation: a novel
antiarrhythmic mechanism, 142A
Nonhomogenous redistribution of regional
myocardial blood flow and potassium
during reperfusion of ischemic
myocardium, 127A
Potassium cbloride
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
PR interval
Site of age-related PR interval prolongation in
normal subjects, 57A
Prazosin
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade, 78A
Increased contractility induced by alpha
adrenergic stimulation in septic rat hearts.
I44A
Role of a-adrenergic receptors in syndrome X,
150A
Prednisolone, Prednisone
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Prednisone withdrawal in "high risk cardiac
transplant recipients," 2l2A
Prophylactic anti-rejection therapy early after
cardiac transplantation: RATG versus
OPKT3, 62A
Treatment of cardiac allograft rejection with
pulsed steroids: a three year experience,
210A
Preexcitation
100% specificity in localizing ventricular
preexcitation site in WPW syndrome with
ECG, lOA
Pregnancy
Disopyramide induces uterine contractions in
pregnancy, l4lA
Preload
See Loading conditions
Pressure gradients
Can the modified Bernoulli equation accurately
estimate instantaneous transmitral
pressure gradients in patients with cardiac
pathology?, 234A
Pressure half-time
Systemic errors in the Doppler pressure
half-time formula for mitral orifice area,
234A
Ventricular and atrial compliance changes
affect pressure half-time: experimental
evidence, 234A
Preventive cardiology
Housestaff practice of preventive cardiology:
who's not doing what?, 37A
Procainamide
Comparison of antiarrhythmic efficacy and
safety of class lA, IB, and IC agents in
symptomatic and potentially malignant
ventricular arrhythmia, 163A
Comparison of flecainide vs procainamide in
depressing retrograde conduction in
atrioventricular nodal reentry tachycardia,
l65A
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Epicardial mapping of rate-dependent
ventricular conduction slowing by
procainamide, 25lA
Rate-dependent slowing of intraventricular
conduction by procainamide: direct
measurement in the human heart, 250A
Reliability of procainamide in predicting the
shortest preexcited R-R interval during
atrial fibrillation is dose dependent, 204A
Use-dependent prolongation of ventricular
tachycardia cycle length by type IA and
IC drugs, 21A
Propafeoooe
Combined therapy with type IC and IB agents:
is it effective for ventricular tachycardia?,
141A
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Intravenous propafenone for conversion of
atrial flutter or fibrillation of recent onset,
140A
Oral propafenone for prevention of recurrent
atrial fibrillation: predictive value of the
response to transesophageal atrial
stimulation, 233A
Short term variability of ventricular arrhythmia
and rapid assessment of drug efficacy,
140A
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Propranolol
Beta-blockers in syndrome X, 150A
Comparison of pharmacological and
nonpharmacological treatment of
hypertension. A randomized placebo
controlled study, I04A
Electrophysiologic effects of a chemical
defibrillatory agent: dibenzepin, 250A
Enhanced cardiac adrenergic response in
cardiomyopathic hamster at a
pre-congestive failure stage, 87A
Exercise training versus exercise training with
diltiazem or propranolol: effects on lipids
in men with mild hypertension, 241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
maximal oxygen uptake and exercise
duration in men with mild hypertension,
241A
Exercise training versus exercise training with
diltiazem or propranolol: effects on
resting blood pressure in men with mild
hypertension, 10M
Increased contractility induced by alpha
adrenergic stimulation in septic rat hearts,
144A
Modulation of the fetal left ventricular function
curve by the throacic tissue, 136A
'Torsade de pointes' with quinidine and
propranolol in conscious dogs with A-V
block,249A
Protein
Suppression of cardiac protein degredation
contributes to progressive hypertrophy
due to aortic regurgitation, 71A
"Up regulation" of GTP binding proteins
following cardiac parasympathectomy-
quantitation by immunoblot method, 143A
Protein C
Platelet plasminogen activator inhibitor:
purification and characterization of
interaction with plasminogen activators
and activated protein C, IA
Pro-urokinase
Acute thrombotic reocclusion after
percutaneous transluminal coronary
angioplasty-should thrombolysis be
attempted?, 58A
Coronary thrombolysis with urokinase
preactivated intravenous pro-urokinase,
193A
Early reperfusion after treatment with
intravenous pro-urokinase when
compared to intravenous streptokinase,
152A
Heparin potentiates the thrombolytic efficacy
of natural pro-urokinase, 198A
Pseudoaneurysm
Diagnosis of left ventricular pseudoaneurysm
by colour Doppler flow mapping, 24A
Pulmonary artery pre&'iure
Estimation of pulmonary pressure in
ventricular septal defect: Doppler and
color flow application, 52A
Non-invasive computer reconstruction of the
pulmonary artery pressure waveform
using Doppler echocardiography, 225A
Time course of pulmonary arterial pressure
change in the early postnatal period-
noninvasive color Doppler and continuous
wave Doppler echocardiographic study,
225A
Pulmonary capillary wedge pressure
Use of pulmonary capillary wedge pressure to
assess the severity of mitral stenosis: is a
true left atrial pressure needed in these
patients?, 14M
Pulmonary disease
Reduced exercise capacity of chronic
obstructive pulmonary disease patients
exercising with noseclip/mouthpiece:
decreased right heart preload?, 183A
Pulmonary venous flow velocities
Effect of age on pulmonary venous flow
velocities in normal subjects, 50A
Pulsation
Improved hemodynamic and left ventricular
unloading during acute ischemia using the
hemopump left ventricular assist device
compared to intra aortic balloon counter
pulsation, 160A
Q waves
Q waves in hypertrophic cardiomyopathy:
presence and localization according to the
site and extent of right and left ventricular
hypertrophy, lOA
QRS interval
His-Purkinje activation during ventricular
tachycardia: a determinant of QRS
duration, 21A
QT interval
Abnormal QT/QS2 ratio at rest and exercise in
Romano-Ward long QT patients,
normalized by beta-blocker therapy, IIC
Effects of position and exercise on the QT
interval in children, 171A
Etiology of polymorphic ventricular
tachycardia in the absence of prolonged
QT,2IA
Improved electrocardiographic identification of
patients with the long QT syndrome
(LQTS),llA
Long QT syndrome international prospective
registry, 20A
Quantitative regional curvature analysis
Quantitative regional curvature analysis:
determination of abnormal systolic and
diastolic function by assessing shape
throughout the cardiac cycle, lOOA
Quinidine
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents, 249A
Dynamic response of conduction velocity to
quinidine during pulse train stimulation in
canine Purkinje fibers, 163A
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Effects of combined low doses of quinidine and
metoprolol on inducible ventricular
arrhythmias in a chronic canine infarct
model,248A
Is the proarrhythmic effect of quinidine a
chaotic phenomenon?, 186A
Quinidine myocardial pharmacokinetics and
pharmacodynamics: influence on hypoxia,
138A
'Torsade de pointes' with quinidine and
propranolol in conscious dogs with A-V
block,249A
Radionuclide studies
See Angiography, radionuclide;
Ventriculography, radionuclide
Recanalization
Combined laser/thermal recanalization of
peripheral artery occlusions, 13A
Reentry
Incidence and substrate of sustained bundle
branch reentry as a mechanism of
ventricular tachycardia, 174A
Refractorine&'i
Factors that influence the reproducibility of
ventricular refractoriness, 45A
Regurgitant fractions
Validation of a method to estimate regurgitant
fractions using the power mode in a dog
model,23A
Relaxation
See also Ventricular relaxation
Effect of oral administration of
antihypertensive agents on endothelium
dependent and endothelium independent
vascular relaxation, 83A
Genetically-induced atherosclerosis attenuates
endothelially mediated relaxation, 32A
Relaxation time
T2 relaxation time as a predictor of Qardiac
transplant rejection in humans, 20lA
Relaxing factor
Evaluation of endothelial dependent relaxation
in human saphenous veins, 165A
Renal circulation
Cyclosporin therapy impairs
endothelium-dependent relaxation in the
renal circulation, 83A
Renal transplantation
Role of intravenous dipyridamole thallium
imaging in preoperative cardiac risk
assessment before renal transplantation,
161A
Renin
Atrial natriuretic factor inhibition of renin
during renal hypertension: role for the
macula densa, 8A
Differences in neurohumoral activation in
patients with left ventricular dysfunction
with and without heart failure, 246A
Respiration
Respiratory influence on RV and LV diastolic
filling in normal children, 205A
Restenosis
Consequences of early restenosis after
coronary angioplasty, 229A
Detection of restenosis after elective coronary
angioplasty using the exercise treadmill
test, 23M
Dual balloon aortic valvuloplasty, despite
augmenting acute hemodynamic
improvement, fails to prevent
post-valvuloplasty restenosis, 148A
Effect of larger balloon size on recurrence after
-repeat coronary angioplasty due to
restenosis, 208A
Factors associated with restenosis following
successful peripheral atherectomy, 13A
Histologic evaluation of "vessel-biopsies"
obtained with the Simpson atherectomy
catheter, 149A
Low dose dfantitumor agents prevents smooth
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muscle cell proliferation after endothelial
injury, 252A
Pathologic findings after in vivo placement of
percutaneous balloon expandable
tantalum stents, 224A
Restenosis within coronary stents: possible
effect of previous angioplasty, 107A
Second dilatation for restenosis following
successful balloon aortic valvuloplasty:
results, pathology and mechanism, 17A
Superiority of tomographic thallium imaging
for the detection of restenosis after
percutaneous transluminal coronary
angioplasty, 161A
Vascular repair and remodeling using
radiofrequency balloon angioplasty, 228A
Resuscitation
Cardiac resuscitation by extracorporeal pump
oxygenator (ECPO) after failure of
precordial compression, 220A
Revascularization
Effect of myocardial revascularization on
inducible ventricular arrhythmias, 174A
Implantation of the internal mammary artery as
a means of myocardial revascularization
in a canine model of myocardial ischemia:
a reassessment, 187A
Ribonucleic acid
Ventricular levels of the atrial natriuretic factor
and of its messenger ribonucleic acid at
the time of heart transplantation, 9A
Ribose
Ribose infusion post-ischemia alters
thallium-20l myocardial clearance in
patients with coronary disease, 29A
Risk factors
Cardiovascular risk reduction through worksite
health promotion, 134A
Risk assessment after myocardial infarction
ruled out, 184A
Risk factors and mortality in the multiple risk
factor intervention trial after 10.5 years of
follow-up, llA
Rotablation
Percutaneous transluminal coronary rotablation
during heart catheterization, 228A
R·R interval
Reliability of procainamide in predicting the
shortest preexcited R-R interval during
atrial fibrillation is dose dependent, 204A
Rubidium·82
Non-invasive identification of viable versus
infarcted myocardium by automated
three-dimensional cardiac positron
emission tomography with generator
produced rubidium-82, 29A
Saline
Does acute pharmacologic stimulation of
stunned myocardium have chronic
deleterious effects?, 219A
Saxitoxin
Preliminary biochemical characterization of the
canine cardiac sodium channel, 208A
Scintigraphy
See Thallium-201
Seismocardiography
Exercise radionuclide angiography yields
prognostic information equivalent to
cardiac catheterization, 126A
Seismocardiography for detection of coronary
artery occlusion during coronary
angioplasty: a preliminary report, 43A
Selenium
Model for congestive heart failure: selenium
and vitamin E deficient mini pigs, 208A
Sensors
Implantable and extractable sensor for intra
and postoperative monitoring of blood
flow in man, 2l4A
Sepsis
See also Infection
Increased contractility induced by alpha
adrenergic stimulation in septic rat hearts,
144A
Serotonin
Angiographic demonstration of
hyperconstriction induced by serotonin
and aggregating platelets in porcine
coronary arteries with regenerated
endothelium, 31A
Endothelium protects against contractions
induced by histamine and serotonin in
arterial, but not in venous coronary
bypass grafts, 166A
Shock, cardiogenic
Emergency percutaneous cardiopulmonary
(bypass) support in cardiogenic shock,
160A
Sick sinus syndrome
New quantitative method of sinoatrial nodal
cells in sick sinus syndrome, 184A
Silent defects
Augmentation of ejection fraction during
ambulatory monitoring in thrombolysis
patients with concomitant silent
ventricular dysfunction: mechanistic
implications, 96A
Exercise-induced silent ischemia: effect of type
A behavior on frequency and prognosis,
237A
Exercise test results predict silent ischemia on
ambulatory monitoring, 3A
Incidence and prognostic significance of early
postoperative silent ischemia in peripheral
vascular surgery patients, 149A
Left ventricular function at rest and the
prevalence of ambulatory silent ischemia
in coronary artery disease, 203A
Silent coronary artery disease in elderly men:
low exercise tolerance is strongly
associated with multivessel disease, 37A
Silent ischemia on ambulatory ECG monitoring
provides additional prognostic information
in patients with stable angina and a
positive exercise treadmill test, 202A
Silent ischemia during daily life is an
independent predictor of survival in stable
angina,3A
Sinus node
Duration of sinus node depolarization can
indicate the degree of sinus node
dysfunction, 232A
Skeletal muscle
Capillary density, fiber type and enzyme
composition of skeletal muscle in
congestive heart failure, 38D
Decreased aerobic oxidative capacity in
skeletal muscle in chronic heart failure,
39A
Skeletal muscle metabolic abnormalities in
heart failure are in part due to intrinsic
skeletal muscle changes, 39A
Sleep apnea syndrome
Holter monitoring in the diagnosis of sleep
apnea syndrome, 189A
Smoking
Chronic impairment of parasympathetic cardiac
control in heavy smokers, 36A
Recent exposure to cigarette smoke increases
myocardial size infarct. 124A
Smoking cessation post myocardial infarction:
effects of a nurse-directed intervention
l34A •
Survival and quality of life in cigarette smokers
versus quitters randomized to medicine or
CABG in the coronary artery surgery
study (CASS): 10 year follow-up. 36A
Smooth muscle
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade. 78A
Excimer laser irradiation induces
endothelium-independent relaxation of
vascular smooth muscle, 141A
Mechanism responsible for laser-induced
photorelaxation of vascular smooth
muscle is limited to ultraviolet and visible
wavelengths. 142A
Sodium channel
Preliminary biochemical characterization of the
canine cardiac sodium channel, 20SA
Sodium currents
Evidence for two types of sodium currents
inisolated neonatal AV nodal heart cells
128D •
Sodium nitroprusside
See Nitroprusside
Sotalol
Effect of antiarrhythmic drugs on
frequency-domain parameters of
signal-averaged ECG, 191A
Safety, efficacy and predictive value of drug
termination of ventricular tachycardia,
l62A
Soyacal
Hibernation induction trigger extended
effective organ preservation time in a new
autoperfusion multiorgan preparation, 63A
Spasm
Coronary spasm induced by stent implantation,
194A
Human percutaneous laser-assisted coronary
angioplasty: efforts to reduce spasm and
thrombosis, 61A
Spectroscopy
In vivo near infrared monitoring of myocardial
oxygenation during ischemia and
reperfusion, 251A
In vivo 31P spectroscopy from turtle heart
during anoxia and recovery, 199A
Myocardial protection with verapamil during
ischemia and reperfusion: assessment by
magnetic resonance spectroscopy, 200A
Time-averaged phosphorus-3l NMR
spectroscopy of the metabolic response to
hemodynamically equivilant
pacing-induced and flow-limited ischemia
in the conscious dog, 219A
3lP-magnetic resonance spectroscopy and cine
1H magnetic resonance imaging of dilated
cardiomyopathy in humans, 199A
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Transmurally localized 31P MRS: metabolic
heterogeneity during myocardial ischemia,
199A
Spinal stimulatioo
Epidural spinal stimulation in patients suffering
from intractable angina, 46A
SQ30217
Kinetics of the new Tc-99m labeled blood flow
marker (SQ30217) in canine myocardium,
98A
Planar and tomographic myocardial imaging
with SQ 30217, a new technetium labeled
agent,98A
ST segment
Enhanced ,B-adrenergic activity in
non-infarcted myocardium may cause
exercise-induced St-segment elevation in
old myocardial infarction, 124A
Importance of assessing ST elevation by
Holter monitoring in unstable angina,
203A
In-hospital angina with transient ECG changes
predict poor one-year survival only in
patients with ST depression, 93A
Initial validation of a new patient-borne
miniature device for continuous
monitoring of left ventricular function and
ST-segment,96A
Post-exercise ST segment depression in
relation to heart rate: improved
identification of coronary artery disease
by the rate-recovery loop, 236A
Significance of exercise-induced ST segment
elevation in patients with Q wave anterior
myocardial infarction: evaluation by
positron emission tomography, 203A
ST analysis: intragroup versus intrapatient
variability of Holter results, 189A
Stenosis
Antithrombotic effect of aspirin is independent
of stenosis severity, 77A
Aortic stenosis in the elderly: aortic balloon
valvuloplasty vs. aortic valve
replacement, 38A
Balloon mitral valvuloplasty: a multicentre
study,70A
Comparison of the Gorlin, Cannon, Angel and
Hakki equations for the determination of
pathologic stenosis in porcine xenografts,
123A
Coronary anatomy preceding non-Q wave
myocardial infarction, 6A
Details of coronary stenosis morphology
influence its hemodynamic severity and
distal flow reserve, 43A
Detection of coronary stenoses by high speed
NMR imaging: the utility of
dysprosium-DTPA,48A
Different immediate and long-term outcome
after percutaneous balloon valvuloplasty
for severe aortic stenosis, contingent
upon the type of valve, 54A
Doppler-echo evaluation of aortic stenosis
severity pre-and post-balloon aortic
valvuloplasty, ll4A
Doppler-echo evaluation of mitral stenosis
pre-and post-balloon valvuloplasty, 1I4A
Effect of subcritical stenosis on coronary and
myocardial flow reserve in territory
supplied by other non-stenotic arteries,
7A
Evidence against a "myocardial factor" in
rheumatic mitral stenosis, 147A
Extent ofjeopardized myocardium: importance
of location, severity and extent of
coronary stenosis, 44A
High frequency (ultrasonic) mechanical
debridement in the treatment of calcific
aortic stenosis: an angiographic study,
214A
Increased flow velocity in the human coronary
stenosis: a simple assessment of stenosis
severity, 131 A
Incremental critical coronary stenosis contracts
rather than expands myocardial vascular
volume,218A
Intraluminal two-dimensional ultrasound
angioscopic quantitation of arterial
stenosis: comparison with external
high-frequency ultrasound imaging and
anatomy,5A
Intravascular ultrasound imaging catheter
accurately measures area of aortic valves
in vitro, 49A
Is balloon valvuloplasty beneficial in patients
with calculated critical aortic stenosis but
low ejection fraction and pressure
gradient, 156A
Left ventricular relaxation in mitral stenosis
before and after valvuloplasty, 55A
Mechanical resistance in aortic stenosis: an
index of functional change after
valvuloplasty, 147A
Myocardial infarction with minimal coronary
atherosclerosis: a syndrome of young
women with guarded long term prognosis,
27A
Natural history of adults with asymptomatic,
severe aortic stenosis, 147A
One-year clinical and Doppler
echocardiographic follow-up of patients
having double-balloon catheter balloon
valvuloplasty for mitral stenosis, 115A
Platelet deposition in areas of stenosisis
stimulated by high plasma cholesterol
levels, 145A
Progression of aortic stenosis as assessed by
echocardiography, 233A
Propagation of turbulence in aortic stenosis,
lOlA
Rapid reduction of plasma atrial natriuretic
peptide after balloon mitral valvuloplasty
in patients with mitral stenosis, 69A
Regression of infundibular pulmonary stenosis
after successful balloon pulmonary
valvuloplasty in adults, 56A
Relative coronary flow reserve reflects stenosis
severity more accurately than absolute
flow reserve during changing aortic
pressure and cardiac workload, 162A
Reverse redistribution following myocardial
infarction is related to severity of
coronary stenosis, 99A
Superiority of Tc-99m methoxyisobutyl
isonitrile compared to thallium-201 for the
tomographic assessment of coronary
artery stenosis, 98A
Surgical fate of mitral regurgitation associated
with severe aortic stenosis: an
interoperative echo study, 72A
Use of balloon-expandable stents to treat
experimental peripheral pulmonary artery
and superior vena caval stenosis:
preliminary experience, 119A
Use of pulmonary capillary wedge pressure to
assess the severity of mitral stenosis: is a
true left atrial pressure needed in these
patients?, 146A
Valve resistance in aortic stenosis: an
alternative method for assessing the
hemodynamic significance of flow
obstruction, 234A
Stenls
Additional improvement in vessel lumen in the
first 24 hours after stent implantation due
to radial dilating force, 224A
Balloon expandable intravascular stents (BEIS)
in human coronary arteries: a follow-up
report, 106A
Chronic endovascular responses after stent
implantation in vein grafts, I06A
Coronary spasm induced by stent implantation,
194A
Evaluation of aortic implantation and redilation
of balloon expandable intravascular stents
in juvenile minipigs, 223A
Implantation of 100 coronary artery stents:
learning curve incidence for the acute
early complications, 107A
Pathologic findings after in vivo placement of
percutaneous balloon expandable
tantalum stents, 224A
Restenosis within coronary stents: possible
effect of previous angioplasty, 107A
Self-expanding parallel wire metallic stent,
I06A
Stent implantation for the treatment of
coronary artery bypass graft stenosis,
107A
Use of balloon-expandable stents to treat
experimental peripheral pulmonary artery
and superior vena cavalstenosis:
preliminary experience, 119a
Steroids
Cytomegalovirus infection in cardiac transplant
recipients predicts the incidence of
allograft atherosclerosis, 213A
Influence of antihypertensive therapy on
plasma hormones in cardiac transplant
recipients: measurements at rest and
during exercise, 81 A
Linear growth in pediatric cardiac transplant
recipients. 134A
Streptokinase
Defibrinogenation reduces infarct size in a
canine model of acute myocardial
infarction, 125A
Demonstration of viable myocardium after an
acute infarction submitted to
thrombolysis: comparison between
positron emission tomography and
dobutamine echocardiography, I92A
Early reperfusion after treatment with
intravenous pro-urokinase when
compared to intravenous streptokinase,
152A
Effect of thrombolysis on late potentials
incidence after acute myocardial
infarction, 178A
No difference in long term left ventricular
function after streptokinase and tissue
plasminogen activator therapy in acute
myocardial infarction, %A
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Streptokinase inhibits platelet thrombus
formation in stenosed dog coronary
arteries: possible mechanisms, 78A
Sustained left ventricular function benefit one
year after thrombolytic therapy, 26A
Thrombolysis-induced limitation of infarct size
in relation to time from pain onset and
infarct localization: results from I.S.A.M
study,95A
Stress, mental
Echocardiographic assessment of mental stress
induced wall motion abnormalities:
comparison with exercise, 158A
Stress, shear
Coronary atherosclerosis impairs control of
shear stress, 42A
Stroke
Risk factors for hemorrhagic and ischemic
stroke in myocardial infarct patients
treated with tissue plasminogen activator,
153A
Sudden death
Evidence for an abnormal vasodilator response
in hypertrophic cardiomyopathy, 117A
Factors predicting survival from prehospital
cardiac arrest, 35A
Survival of patients with hypertrophic
cardiomyopathy successfully resuscitated
from sudden cardiac arrest, 117A
Ventricular tachycardia is not the predominant
cause of monitored sudden death in heart
failure, 179A
Sufentanil
Cocaine induced deleterious effects on the
canine coronary circulation, 79A
Sulfhydryl groups
Oxidation of sulfuydryl groups of serum
albumin in coronary artery diseases, 44A
Sullinpyrazone
S.T.A.I. (study of ticlopidine in unstable
angina), 238A
S·Sulfo·phenyltheophyliine
Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
SUN·1165
Electrophysiologic and hemodynamic effects of
SUN-I 165: a new antiarrhythmic drug,
163A
Superoxide dismutase
Direct administration of recombinant
superoxide dismutase significantly
preserves myocardial function and
mitochondrial structures after 30 minutes
normothermic global ischemia, 63A
Preservation of myocardial function and
topography by late reperfusion and
long-active superoxide dismutase, 109A
Superoxide dismutase (SOD) (SOD) prevents
reperfusion-induced deterioration in
coronary vasodilator reserve (CVR) and
regional myocardial function, IIOA
Surgery, ablation
His bundle cryosurgical ablation using a closed
heart epicardial approach, 175A
Junctional tachycardia-anatomic substrate
and its significance in ablative procedures,
175A
Surgery, cardiac
See also specific procedure
Late follow-up of 781 patients undergoing
percutaneous transluminal coronary
angioplasty (PTCA) or open heart surgery
for an isolated obstruction in the left
ascending (LAD) coronary artery, l66A
Postoperative monitoring of regional left
ventricular function in man, 80A
Predictors of deep sternal wound infections
after cardiac surgery, 122A
Surgery, coronary artery bypass
See also Cardiopulmonary bypass
Benefit of the "bailout" catheter for
emergency bypass surgery after failed
PTCA,155A
Central neurological complications after
coronary artery bypass: influence of
multiple aortic cross-clamping, 122A
Comparison of socio-economics and outcome
after multivessel coronary angioplasty or
bypass surgery, 230A
Coronary blood flow and hemodynamics during
exercise after the coronary artery bypass
grafting with the internal mammary artery
for Kawasaki disease, 74A
Effects of coronary revascularization on
regional wall motion: an intraoperative
echo study, 211A
Mechanism of myocardial infarction in patients
with prior coronary bypass surgery, 93A
Myocardial infarction complicating elective
coronary bypass surgery, 166A
Portable bypass does not improve survival in
cardiac arrest patients, 121A
Risk of death after nonfatal myocardial
infarction in the VA cooperative study of
coronary artery bypass surgery, 166A
Role of radionuclide angiography in selecting
patients for coronary bypass surgery,
213A
Use of the exercise test to predict prognosis
after coronary artery bypass surgery,
183A
Surgery, pediatric
Determinants and outcome of early and late
arrhythmia after Fontan operation, 170A
Experience with the Fontan procedure, 75A
Impact of coexisting heart disease on outcome
of surgery for Wolff-Parkinson-White
syndrome in children, 138A
Impact of medical and surgical therapy on the
cardiovascular prognosis of the Marfan
syndrome, 119A
Neonatal repair of Fallot's tetralogy with and
without pulmonary atresia, 74A
Patterns and determinants of exercise
performance in Fontan patients, 135A
Right ventricular size and pulmonary flow in
patients after first stage surgery for
pulmonary atresia: combined assessment
by cine magnetic resonance imaging and
color Doppler flow mapping, 240A
Right ventricular growth and function following
Fontan procedure for tricuspid atresia,
239A
Surgical management of aortic arch obstruction
and transposition of the great arteries,
120A
Surgery, valve
Altered left ventricular diastolic filling due to
acute left ventricular volume overload
following tricuspid valvulectomy. A
pulsed Doppler echocardiographic study,
72A
Can color Doppler/two dimensional
echocardiography identify the need for
tricuspid valve repair?, 24A
Doppler-echocardiographic evaluation of the
results of surgical ultrasonic
decalcification of the aortic valve, 113A
Echo evaluation of immediate and late failed
mitral valve repair, 114A
Echo-Doppler vs cardiac catheterization in the
decision to operate on mitral valves, 72A
Utility of transesophageal echocardiography in
patients undergoing cardiac valve surgery,
123A
Surgery, vascular
Comparison of exercise testing, dipyridamole
thallium imaging and gated blood pool
scanning for the prediction of cardiac
complications following vascular surgery,
149A
Incidence and prognostic significance of early
postoperative silent ischemia in peripheral
vascular surgery patients, 149A
Sympathetic drive
Evidence for an early increase in cardiac
sympathetic stimulation in patients with
diastolic dysfunction, 246A
Sympathetic nervous system
Alterations in lymphocyte subsets and
catecholamines in congestive heart
failure, 180A
Syncope
Combined ambulatory EEG and ECG
monitoring for evaluation of syncope, 33A
Syndrome X
Beta-blockers in syndrome X, 150A
Effects of nitrates on coronary hemodynamics
and anginal threshold in syndrome X,
155A,20lA
Exercise capacity after acute aminophylline
administration in patients with syndrome
X,202A
Long-term follow-up and variability of markers
of myocardial ischemia in syndrome X,
150A
Role of a-adrenergic receptors in syndrome X,
150A
Syndrome X: a primary metabolic disease?,
202A
Systolic function
Acute and chronic response to oral enoximone
in severe congestive heart failure:
sustained hemodynamic improvement and
preferential effect on right ventricular
systolic performance, lOlA
Relationship between left ventricular mass
regression and improved left ventricular
filling in severe hypertension, 244A
Systolic thickening
Percent wall thickening is preload dependent at
low but not at high levels of afterload,
219A
T lymphocytes
See Lymphocytes
Twave
Variability of negative T wave in left
ventricular hypertrophy, the possible
result of contraction-excitation feedback,
35A
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Tachyarrhythmias
See also Ventricular tachyarrhythmias
Autonomic influence on ventricular subsidiary
pacemakers: a study of patients post AV
nodal ablation, 232A
Tachycardia
See also Ventricular tachycardia
Catheter modification of AV nodal conduction
in drug resistant AV nodal reentrant
tachycardia (AVNRT), 176A
Catheter modification of the atrioventricular
node:.a potential cure for atrioventricular
nodal reentrant tachycardia, I68A
Comparison of flecainide vs. procainamide in
depressing retrograde conduction in
atrioventricular nodal reentry tachycardia,
165A
Effect of epicardial accessory pathway ablation
or endocardial dissection for AV nodal
reentrant tachycardia, 232A
Junctional tachycardia-anatomic substrate
and its significance in ablative procedures,
175A
New criterion for diagnosis of sustained bundle
branch reentry tachycardia, 21A
Retrograde conduction properties determine
rate-dependent efficacy of diltiazem for
AV reentrant tachycardia, 251A
Retrograde pathway in atrioventricular nodal
tachycardia: nodal tissue or extranodal
accessory pathway?, 175A
Sustained preexcited tachycardia: AV nodal
rather than true antidromic reentry as the
main mechanism, 204A
Tachyphylaxis
Absence of tachyphylaxis following chronic
therapy with xamoterol in heart failure,
247A
Tachyphylaxis associated with dopexamine
administration in severe heart failure,
247A
Tamponade
See Cardiac tamponade
Technetium
Assessment of myocardial viability with
technetium-99m 2 methoxy isobutyl
isonitrile (MIBI) and gated tomography in
patients with coronary artery disease, 31A
Assessment of "no reflow" phenomenon
during reperfusion with 99mTc-MIBI and
14C-deoxyglucose, 30A
Clinical comparison between thallium-201 and
Tc-99m methoxy isobutyl isonitrile (MIBI)
myocardial perfusion imaging for
detection of coronary artery disease, 30A
Quantitative analysis of stress TC-99m
methoxy isobutyl isonitrile (MIBI)
SPECT: preliminary development and
validation of an optimized computerized
method,98A
Serial changes in myocardial perfusion using
tomographic technetium-99m methoxy
isobutyl isonitrile (Tc-MIBI) following
reperfusion therapy of myocardial
infarction, 30A
Superiority of Tc-99m methoxyisobutyl
isonitrile compared to thallium-201 for the
tomographic assessment of coronary
artery stenosis, 98A
Tomographic assessment of myocardial
reperfusion during acute myocardial
infarction using Tc-99m methoxy isobutyl
isonitrile (MIBI), 153A
Tomographic myocardial perfusion imaging
with technetium-99m 2-methoxy isobutyl
isonitrile (MIBI) and thallium-201: the
sensitivity and reproducibility of
semi-quantitative assessments of
myocardial perfusion and regional systolic
function, 30A
Tetralogy of Fallot
Elevated right ventricular pressure increases
collagen in ventricular scars in canines,
118A
Neonatal repair of Fallot's tetralogy with and
without pulmonary atresia, 74A
Prevalence of congenital heart disease in
offspring of parents with Fallot's
tetralogy, 240A
Tetrodotoxin
Preliminary biochemical characterization of the
canine cardiac sodium channel, 208A
Thallium-201
See also Dipyridamole
Adenosine thallium-201 scintigraphy:
feasibility, safety, and initial results in
man,16lA
Characterization of patients with abnormal
stress redistribution TL-201 SPECT and
normal coronary arteries, 99A
Clinical comparison between thallium-201 and
Tc-99m methoxy isobutyl isonitrile (MIBI)
myocardial perfusion for detection of
coronary artery disease, 30A
Cost-benefit advantage of primary scintigraphic
evaluation after uncomplicated acute
inferior wall myocardial infarction, 162A
Dipyridamole-Doppler echocardiography:
comparison to thallium-201 imaging and
quantitative coronary arteriography, 159A
Early post-thrombolysis assessment of necrosis
and viability with rest-redistribution
thallium scintigraphy: correlation with
positron emission tomography (PET), 28A
Frequency of late defect reversibility in
SPECT TL-201 stress redistribution
studies, 28A
Insensitivity of thallium-201 imaging after oral
dipyridamole for detection of reversible
myocardial ischemia, 182A
Limitations of exercise thallium single photon
tomography early after myocardial
infarction, 125A
Reverse redistribution following myocardial
infarction is related to severity of
coronary stenosis, 99A
Ribose infusion post-ischemia alters
thallium-201 myocardial clearance in
patients with coronary disease, 29A
Superiority of Tc-99m methoxyisobutyl
isonitrile compared to thallium-201 for the
tomographic assessment of coronary
artery stenosis, 98A
Superiority of tomographic thallium imaging
for the detection of restenosis after
percutaneous transluminal coronary
angioplasty, 161A
Tomographic myocardial perfusion imaging
with technetium-99m 2-methoxy isobutyl
isonitrile (MIBI) and thallium-201: the
sensitivity and reproducibility of
semi-quantitative assessments of
myocardial perfusion and regional systolic
function, 30A
Thrombi
Detection of intravascular thrombus by high
frequency intraluminal ultrasound
angioscopy: in vitro and in vivo studies,
5A
Detection of pulmonary artery thrombi by
transesophageal echocardiography in
patients with suspected pulmonary
embolism, 224A
Effects of aspirin on in vitro lysis with
urokinase of combined platelet and fibrin
thrombi, 91A
Identification of acute experimental left
ventricular thrombi using a real-time
backscatter imaging system, 59A
N-acetylcysteine potentiates IV nitroglycerin in
inhibiting periodic platelet thrombus
formation in stenosed dog coronary
arteries, 145A
Streptokinase inhibits platelet thrombus
formation in stenosed dog coronary
arteries: possible mechanisms, 78A
Thrombin
Early thrombotic reocclusion after successful
coronary thrombolysis is predictable from
an increased thrombin release two hours
after onset of therapy, 152A
Progression of coronary atherosclerosis and
enhanced thrombin-induced platelet
aggregability, 42A
Thrombin inhibition by hirudin decreases
platelet thrombus growth on areas of
severe vessel wall injury, 145A
Thrombolytic therapy
See also specific agent
Antecedent angina: a clinical marker for
patients at high risk following
thrombolytic therapy, 27A
Augmentation of ejection fraction during
ambulatory monitoring in thrombolysis
patients with concomitant silent
ventricular dysfunction: mechanistic
implications, 96A
Biphasic release of cardiac myosin light chains
in patients with successful thrombolysis in
acute myocardial infarction, 95A
Early intervention with low dose aspirin in first
acute transmural anterior myocardial
infarction: infarct size, clinical outcome
and follow-up, 27A
Early post-thrombolysis assessment of necrosis
and viability with rest-redistribution
thallium scintigraphy: correlation with
positron emission tomography (PET), 28A
Intracoronary thrombolytic therapy in patients
with refractory thrombus after
intravenous treatment, 92A
Limitations of exercise thallium single photon
tomography early after myocardial
infarction, 125A
Long-term improvement of left ventricular
function after myocardial infarction with
and without thrombolytic therapy by late
PTCA of the infarct-related artery, 26A
Observer variability in TIMI flow grading:
comparison to a new computer method
for measurement of reperfusion kinetics,
91A '
Serial changes in left ventricular systolic and
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diastolic function following successful
thrombolytic therapy of myocardial
infarction: assessment by Doppler
echocardiography, l57A
Thrombosis
Acute thrombotic reocclusion after
percutaneous transluminal coronary
angioplasty-should thrombolysis be
attempted?,58A
Antiplatelet antibody lyE3 F(ab')2) prevents
rethrombosis after tissue-type
plasminogen activator induced coronary
artery thrombolysis in a canine model,
32A
Human percutaneous laser-assisted coronary
angioplasty: efforts to reduce spasm and
thrombosis,6lA
Inability of thrombosis related markers to
distinguish between unstable and stable
angina pectoris, l5A
Patients with ST segment deviation and
unstable angina have consistent increases
in thrombin activity, l5A
Prevention of thrombosis by recombinant
hirudin during arterial angioplasty in pigs:
comparison with heparin, 77A
Ticlopidine
S.T.A.!. (study of ticlopidine in unstable
angina), 238A
Tocainide
Therapeutic levels of tocainide produce
deletetious hemodynamic and clinical
effects in severe heart failure, 142A
Tomography
Echocardiographic computed tomography of
the heart: preliminary results, 224A
Improved diastolic function after aortic valve
replacement assessed by ultrafast
computed tomography (UFCT), 47A
Iodine-123 phenylpentadecanoic acid
tomography following dipyridamole
infusion for the detection of coronary
artery disease, 99A
Right ventricular mass can be accurately
assessed by ultrafast computed
tomography, 8A
Surgically resectable left ventricular aneurysm:
specific characteristics by ultrafast
computerized tomography, 47A
Transesophageal echo computer tomography: a
new method for dynamic 3-D imaging of
the heart, 68A
Tomography, positron emission,
Early post-thrombolysis assessment of necrosis
and viability with rest-redistribution
thallium scintigraphy: correlation with
positron emission tommography (PET),
28A
Nitrogen-13 ammonia myocardial uptake at
rest and with exercise in normal
volunteers: quantification of coronary
flow with dynamic positron emission
tomography, 97A
Quantitative measurement of myocardial blood
flow and coronary flow reserve in patients
with CAD employing 0-15 water and
positron emission tomography (PET), 97A
Tomosynthesis
Digital flashing tomosynthesis (DFTS}-an
alternative to cine technique in coronary
angiography, 8A
Torsade de pointes
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents, 249A
'Torsade de pointes' with quinidine and
propranolol in conscious dogs with A-V
block,249A
Total heart volume
Geometric view of cardiac "efficiency", 86A
Trabeculation
Endocardial trabeculation: a marker for
hibernating myocardium, 80A
Transesophageal echocardlography
See Echocardiography, transesophageal
Transient ischemic attack
Potential role of transesophageal echo in the
definition of intracardiac sources of
emboli in transient ischemic attacks, 38A
Transposition of the great arteries
Fate of the neoaortic valve after arterial repair
of transposition of the great arteries, 24llA
Surgical management of aortic arch obstruction
and transposition of the great arteries,
120A
Triiodothyronine
Abnormal triiodothyronine is the strongest
short-term prognostic factor identified in
advanced heart failure, 181A
Truncus arteriosus
Depressed myocardial function and ventricular
wall stress in neuralcrest ablated chick
embryos, 118A
Tumor necrosis factor
Immunohistochemical detection and
localization of tumor necrosis factor in
human vasculature, 31A
Turbulence
Propogation of turbulence in aortic stenosis,
lOlA
UK-69,578
Acute and chronic antihypertensive efficacy of
atriopeptidase inhibition in rats, 76A
Acute effects of atriopeptidase inhibition on
plasma atrial natriuretic factor in chronic
heart failure, 76A
Atriopeptidase inhibitors, a novel class of drug
that raises levels of endogenous atrial
natriuretic factor-the preclinical
pharmacology of UK-69,578, 75A
Effect of UK-69,578, an atriopeptidase
inhibitor, in a conscious dog model of
cardiac insufficiency, 75A
Pharmacologic elevation of endogenous atrial
natriuretic factor in man using the
atriiopeptidase inhibitor (UK 69578), 76A
Uk-66914
Selectivity of a novel class III antiarrhythmic
agent,162A
Ultrasound
See also Doppler ultrasound;
Echocardiography Doppler color flow
imaging; Echocardiography
Arterial color flow duplex sonography of the
lower extremities before and after
excimer laser angioplasty, 149A
Detection of intravascular thrombus by high
frequency intraluminal ultrasound
angioscopy: in vitro and in vivo studies,
5A
Doppler-echocardiographic evaluation of the
results of surgical ultrasonic
decalcification of the aortic valve, II3A
Evaluation of mixed atherosclerotic plaques by
quantitative ultrasonic methods, 5A
Experimental animal investigations of the
potential for new approaches to diagnostic
cardiac imaging in infants and small
premature infants from intracardiac and
transesophageal approaches using 20MHz
realtime ultrasound imaging catheter,
137A
Intraluminal two-dimensional ultrasound
angioscopic quantitation of arterial
stenosis: comparison with external
high-frequency ultrasound imaging and
anatomY,5A
Intravascular ultrasound imaging catheter
accurately measures area of stenotic
aortic valves in vitro, 49A
Intravascular ultrasound imaging of
atherosclerotic coronary arteries: an in
vitro validation study, 4A
Intravascular ultrasound visualization of
atheroma plaque removal by atherectomy,
222A
Noninvasive evaluation of the internal
mammary artery by ultrasonic
duplex-scanning, ll6A
Ultrasonic angioplasty using a new flexible
wire system, 4A
Utility of an intravascular ultrasound imaging
device for arterial wall definition and
atherectomy guidance, 222A
Ultrasound backscatter
Cardiac cycle-dependent variation of integrated
backscatter: an index of contractile
performance that is not distorted by
paradoxical septal motion, 52A
Clinical application of ultrasonic backscatter in
transesophageal echo to detect ischemic
myocardium, 226A
Cyclic variation of ultrasound backscatter in
normal myocardium is view dependent:
clinical studies using a real-time
backscatter imaging system, 226A
Identification of acute experimental left
ventricular thrombi using a real-time
backscatter imaging system, 59A
Umbrellas
Transcatheter umbrella closure of atrial
defects, 120A
Urokinase
See also Pro-urokinase
Acute thrombotic reocclusion after
percutaneous transluminal coronary
angioplasty-should thrombolysis be
attempted?, 58A
Coronary thrombolysis with urokinase
preactivated intravenous pro-urokinase,
193A
Effects of aspirin on in vitro lysis with
urokinase of combined platelet and fibrin
thrombi, 91A
Effects of urokinase and heparin on lesion
geometry in unstable angina, 15A
Intermittent urokinase therapy as a new
strategy concept in untractable angina
pectoris, 16A
Myocardial infarction with minimal coronary
atherosclerosis: a syndrome of young
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women with guarded long term prognosis,
27A
Overview of bleeding risk from the TAMI
trials: two agents are better than one,
198A
Pericarditis in the face of thrombolytic
intervention denotes severe myocardial
damage, 236A
Platelet plasminogen activator inhibitor:
purification and characterization of
interaction with plasminogen activators
and protein C, lA
Thrombolytic therapy in unstable angina and
non Q-wave myocardial infarction: a
randomized trial of urokinase versus
aspirin, l5A
Vagal stimulation
Characterization of the phasic responses to the
neonatal sinus and atrioventricular node
to brief vagal stimulation, 138A
Vagal tone
Effect of cholinergic agonist carbachol and
cyclic guanosine monophosphate on
sudden cardiac death: protection from
ventricular fibrillation, 9lA
Valve disease
Consistency of color flow Doppler estimation
of regurgitant flow rate across varying
size orifice and multiple orifice
communications using flow convergence
concepts: studies in an "in-vitro" model,
22A
How turbulent is a turbulent jet? An in vitro
color flow Doppler study, 22A
Limitations of color Doppler in analysis of
valvular regurgitation, 22A
Overestimation of regurgitant jet area by
transesophageal as compared to
transthoracic color Doppler, 68A
Poor prognosis for fetuses with prenatally
diagnosed tricuspid valve abnormalities,
205A
Validation in physiologic pulsatile flow of a
new method for noninvasive
quantification of valvular regurgitation
based on conservation of momentum, 73A
Valve prosthesis
Comparison of long-term hemodynamic
evaluation between percutaneous mitral
valvuloplasty and mitral valvular
replacement for severe mitral stenosis,
19A
Does myocardial involvement in children with
severe mitral regurgitation (MR) due to
active rheumatic carditis (ARC) influence
the outcome of mitral valve replacement
(MVR),146A
Early experience with pulmonary autograft use
for aortic valve replacement in pediatric
patients, l20A
Early and longterm results after mitral
valvuloplasty as compared with valve
replacement, 18A
Echo evaluation of immediate and late failed
mitral valve repair, 114A
Estimation of effective mitral tissue prosthetic
area using the continuity equation, 227A
Evaluation of prosthetic valve performance by
assessing the response to exercise using
Doppler echocardiography, 233A
Improved Doppler assessment of normal St.
Jude's prosthetic aortic valves using the
continuity equation, 5lA
Is there an improvement in coronary
vasodilator capacity after aortic valve
replacement?, l47A
Is ultrasonic debridement of aortic stenosis a
reliable alternative to valve replacement?,
l23A
Long term prevention of bioprosthetic heart
valve calcification: Al+++ pretreatment,
l36A
Mitral prosthesis malfunction: utility of
transesophageal echocardiography, 69A
Persistence of increased diastolic stiffness late
following aortic valve replacement, l48A
Pulmonic valve autograft: echocardiographic
factors predicting postoperative valve
prosthesis, l23A
Transesophageal echo in mitral prosthetic
dysfunction: echo-surgical correlation,
69A
Value and limitations of transesophageal color
Doppler echocardiography for the
recognition of transvalvular regurgitation
in the normally functioning St. Jude
value, 2lOA
What is happening inside implanted homograft
valve and conduit?, 124A
Valvotomy, percutaneous mitral
Percutaneous mitral valvotomy increases left
atrial compliance without affecting its
pressure-volume curve, 70A
Percutaneous mitral valvotomy using the
double balloon technique: determinant
factors of mitral regurgitation, 69A
Valvular vegetations
Prediction of risk for complications in patients
with left sided infectious endocarditis,
72A
Valvuloplasty
Early and longterm results after mitral
valvuloplasty as compared with open
commissurotomy,55A
Early and longterm results after mitral
valvuloplasty compared with valve
replacement, l8A
Valvuloplasty, balloon
Advantages of Inoue-balloon (self-positioning
balloon) in percutaneous transvenous
mitral commissurotomy (PTMC) and
aortic valvuloplasty, l8A
Balloon aortic valvuloplasty: acute and chronic
assessment of left ventricular
hemodynamics and pressure-volume
relationships, 54A
Balloon mitral valvuloplasty: a multicentre
study,70A
Catheter balloon valvuloplasty of necropsy
stenotic aortic valves: etiology of aortic
stenosis is a major factor in early
"restenosis," l6A
Clinical value of measuring atrionatriuretic
factor after balloon aortic valvuloplasty,
56A
Different immediate and long term outcome
after percutaneous balloon valvuloplasty
for severe aortic stenosis, contingent
upon the type of valve, 54A
Do hemodynamics overestimate the results of
balloon mitral valvuloplasty?, ll4A
Doppler-echo evaluation of aortic stenosis
severity pre- and post-balloon aortic
valvuloplasty, 114A
Dual balloon aortic valvuloplasty, despite
augmenting acute hemodynamic
improvement, fails to prevent
post-valvuloplasty restenosis, l48A
Failure of balloon aortic valvuloplasty to result
in sustained clinical improvement in
patients with depressed left ventricular
function, l7A
Follow-up balloon aortic valvuloplasty: results
in 192 cases, 16A
Gradual increase in left ventricular dimension
with decrease in pressure half-time of
transmitral flow following balloon mitral
valvuloplasty, 59A
Hemodynamic results and clinical follow-up in
patients undergoing repeat balloon aortic
valvuloplasty, l48A
Hemodynamic results and follow-up of patients
with iatrogenic atrial septal defect
following balloon mitral valvuloplasty,
70A
Is balloon valvuloplasty beneficial in patients
with calculated critical aortic stenosis but
low ejection fraction and pressure
gradient?, l56A
Long-term follow-up in 105 patients undergoing
percutaneous balloon mitral vai'Vuloplasty,
l8A
Long-term follow-up of patients undergoing
closed transventricular mitral valve
commissurotomy, l8A
Mechanical resistance in aortic stenosis: an
index of functional change after
valvuloplasty,147A
New developments in aortic balloon
valvuloplasty, 17A
One-two year follow-up after primarily
successful valvuloplasty for calcified
aortic stenosis, l6A
One-year clinical and Doppler
echocardiographic follow-up of patients
having double-balloon catheter balloon
valvuloplasty for mitral stenosis, ll5A
Regression of infundibular pulmonary stenosis
after successful balloon pulmonary
valvuloplasty in adults, 56A
Results and follow-up of a multicenter registry
for balloon mitral valvuloplasty, 70A
Second dilatation for restenosis following
successful balloon aortic valvuloplasty:
results, pathology and mechanism, 17A
Serial assessment of mitral regurgitation in
patients undergoing aortic valvuloplasty,
50A
Six month follow-up of mitral balloon
valvuloplasty, 17A
Valvuloplasty, percutaneous mitral
Comparison of long-term hemodynamic
evaluation between percutaneous mitral
valvuloplasty and mitral valvular
replacement for mitral stenosis, 19A
Contribution of transesophageal
echocardiography in the ultrasound
assessment of percutaneous mitral
valvuloplasty,5lA
Echo-Doppler evaluation of percutaneous
mitral valvuloplasty correlates poorly with
invasive measurements but is predictive
of sucdess, 52A
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Percutaneous mitral valvuloplasty in patients
with previous surgical commissurotomy,
55A
Predictive factors for success of percutaneous
mitral valvuloplasty, 156A
Response of atrial natriuretic factor to
percutaneous mitral valvuloplasty, 56A
Vascular reserve
Current myocardial perfusion echo
methodology precludes an accurate
assessment of coronary vascular reserve,
ll6A
Vasoactive intestinal peptide
Direct coronary vasodilation induced by
intracoronary vasoactive peptide in
human coronary arteries, 141A
Vasoconstriction
ANF blunts forearm vasoconstriction to lower
body negative pressure in essential
hypertensive patients, 83A
Intravenous nitroglycerin prevents coronary
artery vasoconstriction after PTCA, 59A
Is digital vasoconstriction a marker for
reversible pulmonary vasoconstriction in
patients with pulmonary hypertension?,
151A
Recovery of small and large artery
vasoconstriction in severe heart failure
following heart transplantation, 40A
Vascular responses to leukocyte products in
atherosclerotic primates, 2A
Vasodilation
Comparison of regional coronary vasodilatory
reserve between normal and post
angioplasty arteries in the same patient,
188A
Direct coronary vasodilation induced by
intracoronary vasoactive intestinal peptide
in human coronary arteries, l41A
Evidence for an abnormal vasodilator response
in hypertrophic cardiomyopathy, 117A
Mechanisms of impaired vasodilation in the
coronary microvasculature of patients
with dilated cardiomyopathy, 178A
Preserved flow-mediated vasodilation despite
acetylcholine-induced vasoconstriction in
atherosclerotic coronary arteries in man,
132A
Vasodilalor
Evidence for antithrombotic properties of
nitrate-vasodilators in vivo but not in
vitro, 231A
Vasodilator reserve
Superoxide dismutase (SOD) prevents
reperfusion-induced deterioration in
coronary vasodilator reserve (CVR) and
regional myocardial function, IlOA
Vasopressin
See Arginine vasopressin
Vasospasm
Comparison of acetylcholine and ergonovine in
the provocation of coronary vasospasm,
132A
Vena caval occlusions
Myocardial metabolic to mechanical energy
transfer characteristics from single vena
caval occlusions in conscious dogs, 87A
Venodilation
Nifedipine does not alter the venodilatory
response to nitroglycerin, l54A
Venous return
Does ANF influence venous return?, 171A
Ventricular assist device
First human use of the hemopump, a
catheter-mounted ventricular assist
device, 121A
Improved hemodynamic and left ventricular
unloading during acute ischemia using the
hemopump left ventricular assist device
compared to intra aortic balloon counter
pulsation, I60A
Ventricular dilatation
In the human, expression of ventricular ANF
is independent of ventricular dilatation,
lOA
Ventricular fibrillation
Differences in surgical outcome for ventricular
tachycardia and fibrillation, 214A
Disparate effects of acute and chronic
amiodarone on ventricular fibrillation
threshold in dogs, 249A
Effect of cholinergic agonist carbachol and
cyclic guanosine monophosphate on
sudden cardiac death, 91A
Favorable outcome of patients with ventricular
tachycardia or fibrillation and a normal
electrophysiologic study, 20A
Optimal catheter electrode dimensions for
non-thoracotomy cardioversionl
defibrillation, 21M
Reperfusion associated ventricular fibrillation:
potentiation by left ventricular
hypertrophy despite lidocaine
pretreatment, 127A
Ventricular fibrillation waveform
characteristics associated with successful
defibrillation using fixed low energy DC
shock,21M
Ventricular filling
Abnormal Doppler left ventricular filling
following acute myocardial infarction and
changes during early recovery, 157A
Differential effects of right ventricular pressure
and volume loading on left ventricular
filling assessed by Doppler
echocardiography, I%A
Doppler left ventricular filling pattern is closely
related to ventricular relaxation
abnormalities, 197A
Effect of decreased afterload on Doppler
indices of left ventricular filling in
pressure overload hypertrophy, 51A
Influence of the pericardium on dynamic right
and left ventricular filling, 207A
Insignificance of "load dependence" on left
ventricular relaxation and filling, 220A
Mitral opening pressure strongly influences left
ventricular peak rapid filling rate, 130A
Pulsed Doppler echocardiographic mitral valve
flow patterns and left ventricular chamber
properties in patients with previous
myocardial infarction, 209A
Ventricular function
Age-related changes in left ventricular
performance during ischemic isometric
exercise, 56A
Ambulatory left ventricular function
monitoring: are the ejection fraction
measurements reproducible?, 96A
Augmentation of myocardial function with
dynamic cardiomyoplasty in a chronic
canine model, 213A
Balloon aortic valvuloplasty: acute and chronic
assessment of left ventricular
hemodynamics and pressure-volume
relationships, 54A
Comparison of effects of prolonged exercise on
the right and left ventricles, 182A
Comparison of three indices of left ventricular
performance derived from
pressure-volume loops in conscious dogs,
86A
Coronary angioplasty in patients with severe
depression of left ventricular function,
222A
Determinants of improved global left
ventricular function after tPA and
deferred PTCA for acute MI, 92A
Determinants of left ventricular size and
function following mitral valve
replacement, 148A
Differences in neurohumoral activation in
patients with left ventricular dysfunction
with and without heart failure, 24M
Does poor cardiac function preclude benefit
from an automatic implantable
cardioverter defibrillator, 65A
Evaluation of left ventricular function
immediately after successful balloon
recanalization of chronic total coronary
occlusions, 229A
Failure of balloon aortic valvuloplasty to result
in sustained clinical improvement in
patients with depressed left ventricular
function, I7A
Impact of abnormal myocardial perfusion on
ventricular function in patients with
unstable angina, 239A
Importance of contractility in determining left
ventricular size and performance in
patients with aortic regurgitation, 71A
Improvement of global and regional left
ventricular function with intravenous
APSAC in acute myocardial infarction.
Results of a multicenter double blind trial,
26A
Initial validation of a new patient-borne
miniature device for continuous
monitoring of left ventricular function and
ST-segment,96A
Left ventricular function at rest and the
prevalence of ambulatory silent ischemia
in coronary artery disease, 203A
Left ventricular function in atrial fibrillation: a
comparison before and after
cardioversion, 207A
Long-term improvement of left ventricular
function after myocardial infarction with
and without thrombolytic therapy by late
PTCA of infarct-related artery, 26A
Modulation of the fetal left ventricular function
curve by the thoracic tissue, 136A
No difference in long term left ventricular
function after streptokinase and tissue
plasminogen activator therapy in acute
myocardial infarction, %A
Post-hypoperfusion reperfusion: orchestrated
recovery from myocardial supply/demand
imbalance maximizes heart function, 90A
Postoperative monitoring of regional left
ventricular function in man, 80A
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Preservation of ventricular performance with
reduced ischemic dysfunction by
intravenous nisoldipine during rapid atrial
pacing,46A
Quantitative regional curvature analysis:
determination of abnormal systolic and
diastolic function by assessing shape
throughout the cardiac cycle, lOOA
Rapid-onset pulmonary edema in patients with
left ventricular systolic dysfunction: a
syndrome related to right ventricular
function, 179A
Right ventricular infarction decreases left
ventricular compliance and performance
by a pericardial mechanism, 235A
Right ventricular restrictive/constrictive
physiology accompanies heart transplant
rejection, lOOA
Serial changes in left ventricular systolic and
diastolic function following successful
thrombolytic therapy of myocardial
infarction: assessment by Doppler
echocardiography, 157A
Sustained left ventricular function benefit one
year after thrombolytic therapy, 26A
Use of Doppler echocardiography in
determination of left ventricular Dp/Dt
max,60A
Ventricular infarction
Can hemodynamically significant RV infarction
be identified by two-dimensional
echocardiography?, 157A
Right ventricular infarction decreases left
ventricular compliance and performance
by a pericardial mechanism, 235A
Ventricular mass
Determinants of left ventricular size and
function following mitral valve
replacement, 148A
Gradual increase in left ventricular dimension
with decrease in pressure half-time of
transmitral flow following balloon mitral
valvuloplastY,59A
Pathological involvements of left ventricle in
chronic cor pulmonale, 151A
Relationship between left ventricular mass
regression and improved left ventricular
filling in severe hypertension, 244A
Right ventricular mass can be accurately
assessed by ultrafast computed
tomography,8A
Ventricular obstruction
Reducing left ventricular outflow tract
obstruction in patients with hypertrophic
cardiomyopathy by pacing-induced
interventricular septal pre-excitation,
117A
Ventricular relaxation
Doppler left ventricular filling pattern is closely
related to ventricular relaxation
abnormalities, 197A
Insignificance of "load dependence" on left
ventricular relaxation and filling, 220A
Left ventricular relaxation in mitral stenosis
before and after valvuloplasty, 55A
Ventricular remodeling
Concentric remodeling of the left ventricle in
hypertensive patients with normal
ventricular mass, 245A
Ventricular septal defect
Colour flow imaging as intra-operative
angiography in ventricular septal
defects-advantages and pitfalls?, 75A
Does color Doppler echocardiography detect
additional small muscular defects in
infants with a large ventricular septal
defect, 20M
Doubly-committed subarterial ventricular
septal defect: an eleven-year experience,
74A
Estimation of pulmonary pressure inventricular
septal defect; Doppler and color flow
application, 52A
Evaluation of ventricular septal defect
complicating acute myocardial infarction:
identification, localization and
differentiation from mitral regurgitation by
color Doppler flow imaging, 209A
New method for noninvasive estimation of
ventricular septal defect (VSD) shunt flow
by color Doppler: imaging of the laminar
flow convergence region on the left septal
surface, 205A
Quantitative evaluation of ventricular septal
defects by color Doppler flow imaging,
24A
Two dimensional/color Doppler assessment of
ventricular septal defects, 24A
Ventricular septal defect with aortic
regurgitation: a 35 year experience, 121A
Ventricular tacbyarrhythmias
Clinical evaluation of an implantable
cardioverter/defibrillator with
nonepicardial leads in patients with
refractory ventricular tachyarrhythmias,
215A
Holter-monitoring and programmed ventricular
stimulation to predict clinical outcome in
patients with malignant ventricular
tachyarrhythmias, 34A
Ventricular tachycardia
Absence of late potentials in patients with
repetitive monomorphic and
exercise-facilitated ventricular tachycardia
and no apparent heart disease, 177A
Activation pattern during induction and
maintenance of ventricular tachycardia in
patients with coronary artery disease,
167A
Characteristics of patients requiring epicardial
vs endocardial Nd:YAG laser
photoablation for ventricular tachycardia,
12lA
Combined therapy with type IC and IB agents:
is it effective for ventricular tachycardia,
141A
Differences in surgical outcome for ventricular
tachycardia and fibrillation, 2l4A
Does response to IA agents predict response to
IC agents in patients with sustained
ventricular tachycardia?, 174A
Electrophysiologic testing in patients with
asymptomatic nonsustained ventricular
tachycardia predicts risk of sudden death
or sustained ventricular tachycardia
within the first year but not thereafter,
19A
Endocardial isochronal patterns near the
ventricular tachycardia site of origin with
orthogonal electrode catheter array, l67A
Enhancing prediction of induced ventricular
tachycardia in patients with non-sustained
runs by the signal averaged
electrocardiogram, 34A
Etiology of polymorphic ventricular
tachycardia in the absence of prolonged
QT,2IA
Facilitation of ventricular tachycardia
induction by stimulation at its site of
origin, 167A
Fatal and non fatal recurrences after
endocardial resection: role of the
underlying etiology, 212A
Favorable outcome of patients with ventricular
tachycardia or fibrillation and a normal
electrophysiologic study, 20A
High incidence of remission in patients with
incessant ventricular tachycardia
discontinued from antiarrhythmic drugs,
33A
His-Purkinje activation during ventricular
tachycardia: a determinant of QRS
duration, 21A
Incidence and substrate of sustained bundle
branch reentry as a mechanism of
ventricular tachycardia, 174A
Late potentials and inducible ventricular
tachycardia in surgically repaired
congenital heart disease, 170A
Mechanism of inducible ventricular tachycardia
in patients with idiopathic dilatl:od
cardiomyopathy, l74A
Multiple morphologies of induced ventricular
tachycardia: role of antiarrhythmic drugs
and clinical implications, 20A
New criterion for diagnosis of sustained bundle
branch reentry tachycardia, 21A
Optimal catheter electrode dimensions for
non-thoracotomy cardioversionl
defibrillation lead systems, 21M
Periodicity of transmural and epicardial
electrograms during sinus rhythm in
patients with ventricular tachycardia,
19lA
Radiofrequency or direct current for ablation
of ventricular tachycardia?, l76A
Relation of inducibility of ventricular
arrhythmias to symptoms in patients with
hypertrophic cardiomyopathy-relevance
to induced polymorphic ventricular
tachycardia, 19A
Role of electrophysiologic testing in patients
with asymptomatic nonsustained
ventricular tachycardia: relationship to
ventricular function and the presence or
absence of coronary artery disease, 19A
Safety, efficacy and predictive value of drug
termination of ventricular tachycardia,
162A
Should the induction of nonsustained
ventricular tachycardia during baseline
electrophysiologic testing constitute a
positive study?, 20A
Spontaneous changes in ventricular
tachycardia cycle length: relevance to
antitachycardia device development, IliA
Surface ECG and intracardiac findings with the
onset of entrainment in a pacing model of
pseudoreentry ventricular tachycardia,
l85A
Sustained reentrant activation orients around
arcs of abrupt functional conduction block
in the canine post-infarction heart, l28A
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Termination of epinephrine-induced ventricular
tachycardia by adenosine in
halothane-anesthetized dogs, 249A
Time-dependent electrophysiologic changes
after experimental myocardial infarction:
parallel changes in inducibility of
ventricular arrhythmias and the
signal-averaged electrocardiogram, 22A
Transmural ventricular activation during
consecutive cycles of sustained
ventricular tachycardia, 167A
Use-dependent prolongation of ventricular
tachycardia cycle length by type IA and
IC drugs, 21A
Ventricular tachycardia is not the predominant
cause of monitored sudden death in heart
failure, 179A
Ventricular volume
Chronic reduction of left ventricular volumes
at rest and exercise in patients treated
with nitroglycerin following anterior MI,
25A
On important volumes in the left ventricle, 86A
Three-dimensional echocardiography: a
feasible non-invasive method to measure
cardiac volume, 50A
Ventricular wall motion
Echocardiographic assessment of mental stress
induced wall motion abnormalities:
comparison with exercise, 158A
Echocardiographic evaluation of segmental
wall motion early and late after
thrombolytic therapy in acute myocardial
infarction, 156A
Effects of coronary revascularization on
regional wall motion: an intraoperative
echo study, 21lA
Heterogeneity of regional motion and shape in
response to altered load, lOlA
Predictive value of In-III antimyosin uptake
for improvement of left ventricular wall
motion after thrombolysis in acute
myocardial infarction, 97A
Recovery of myocardial metabolism by PET
precedes improvement of ischemic wall
motion after PTCA, 28A
Ventriculography, radionucIide
Initial validation of a new patient-borne
miniature device for continuous
monitoring of left ventricular function and
ST-segment, %A
Ventriculotomy
Elevated right ventricular pressure increases
collagen in ventriculotomy scars in
canines, ll8A
Late electrophysiologic sequelae of
experimental right ventriculotomy with
right ventricular hypertension, 170A
Verapamil
Amiodarone on suppression of barium-induced
triggered automaticity and early
afterrepolarizations in Purkinje fibers
relative to effects of verapamil and class I
agents, 249A
AV nodal reentry incorporating His bundle:
verapamil sensitivity in retrograde fast
pathway conduction, 173A
Beta-blockers in syndrome X, 150A
Cocaine-induced contraction of vascular
smooth muscle is inhibited by calcium
channel blockade, 78A
Influence of antihypertensive therapy on
plasma hormones in cardiac
transplantation recipients: measurements
at rest and during exercise, 81A
Myocardial protection with verapamil during
ischemia and reperfusion: assessment by
magnetic resonance spectroscopy, 200A
Rate-dependent cellular uncoupling contributes
to the conduction changes in acute
ischemia and is prevented by verapamil,
l27A
Regression of atherosclerosis in cholesterol fed
rabbits: effects of fish oil and verapamil,
196A
Sequential pulse defibrillation in man: effects
of lidocaine and verapamil, 216A
Verapamil as a potent cardioprotective agent
for coronary angioplasty: first clinical
experience, 154A
Vitamin E
See also Alpha tocopherol
Model for congestive heart failure: selenium
and vitamin E deficient mini pigs, 20SA
Warming up phenomenon
Warming up phenomenon cannot be explained
by the increase incoronary flow reserve,
237A
Wolff-Parkinson-White syndrome
Age-related differences in the
electrophysiologic properties of accessory
pathways in patients with the
Wolff-Parkinson-White syndrome, 204A
Impact of coexisting heart disease on outcome
of surgery for the Wolff-Parkinson-White
syndrome, I38A
Long-term followup of 109 pediatric patients
treated for the Wolff-Parkinson-White
syndrome, 170A
Mechanism of the onset of atrial fibrillation in
the Wollf-Parkinson-White syndrome,
203A
100% specificity in localizing ventricular
preexcitation in WPW syndrome with the
ECG, lOA
Safety and efficacy of oral flecainide therapy in
patients with the Wolff-Parkinson-White
syndrome,204A
Sustained preexcited tachycardia: AV nodal
rather than true antidromic reentry as the
main mechanism, 204A
Women
Cardiac transplantation for peripartum
cardiomyopathy,2I3A
Exercise echocardiographic detection of
coronary artery disease in women, 158A
Worksite health promotion
Cardiovascular risk reduction through worksite
health promotion, I34A
Xamoterol
Absence of tachyphylaxis following chronic
therapy with xamoterol, 247A
Zinterol
,B-adrenergic agonists in nonfailing, failing, and
transplanted human hearts, 143A
